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 ABSTRACT 
In eukaryotes, start codon selection is governed by base pairing between the start 
codon and the anticodon of the initiator tRNA (Met-tRNAi) and is achieved via a 
complex machinery involving at least twelve initiation factors.  eIF2 is a heterotrimeric 
G-protein that, in its active GTP-bound state, binds and delivers the Met-tRNAi to the P-
site of the small (40S) subunit of the ribosome, in a process facilitated by multiple other 
initiation factors forming a pre-initiation complex (PIC).  The process of initiation is 
composed of two phases with distinct conformations of the PIC.  First, the PIC in an open 
conformation scans the mRNA 5’ UTR in a manner allowing for the Met-tRNAi to 
sample the nucleotides for complementarity.  Upon a cognate codon:anticodon 
interaction, the PIC then adopts a closed conformation accompanied by the irreversible 
hydrolysis of eIF2-bound GTP and Pi release.  The molecular mechanisms by which 
cognate codon:anticodon base pairing is linked to the hydrolysis of eIF2-bound GTP and 
Pi release, formation of the closed conformation, and start codon selection are not well 
understood.  
In this study, we provide genetic and biochemical evidence that suggests a new 
function for domain-III of eIF2γ in coordinating these processes and maintaining the 
equilibrium between the two conformations of the PIC.  In order to identify the structural 
elements in eIF2 essential for start codon selection, we isolated novel mutations in the 
yeast γ subunit that alter the accuracy of this process.  We identified two classes of 
mutations with opposing effects: mutations that reduce the stringency of start codon 
recognition and those that, conversely, restore initiation fidelity.  The isolated mutations 
localize to distinct regions on the surface of domain-III in close proximity of the 
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proposed binding interface between eIF2 and the 40S subunit.  We propose a model in 
which eIF2(γ) maintains a dynamic interaction with the 40S subunit during the scanning 
of the mRNA 5’ UTR.  Upon cognate codon:anticodon base pairing, however, new 
contact points between eIF2γ domain-III and the 40S subunit are created that stabilize the 
closed conformation, hence stabilizing the accommodation of the Met-tRNAi in the P-site 
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CHAPTER 1: INTRODUCTION  
  2 
As the name implies, translation is the process by which the genetic code, 
preserved by DNA and transmitted through messenger RNAs, is translated into 
functional proteins that run the metabolic processes of an organism.  The translation 
machinery is comprised of a complex set of elements including the ribosome, mRNA, 
tRNA, and many additional protein factors.  Sequence and structural similarities among 
the different kingdoms suggest a common origin for this machinery1.  Ribosomes are 
ribonucleoprotein particles that form the platform for the assembly of translation 
apparatus and perform the catalytic function of peptide bond formation, which ultimately 
leads to the synthesis of polypeptide protein chains.  They are made of two subunits.  The 
small subunit decodes the mRNA sequence and the large subunit carries the peptidyl-
transferase activity.  These two fundamental activities are linked by tRNAs that serve as 
adapters for the coded information on the mRNA and the specific amino acids that 
constitute a protein. 
The process of protein synthesis can conceptually be divided into four stages of 
initiation, elongation, termination, and ribosome recycling.  Initiation assembles the 
ribosomes at the correct start position, elongation synthesizes the proteins by adding one 
amino acid at a time to the growing peptide chains based on the information coded in the 
sequence of mRNAs, termination ends the elongating peptide chains at the correct stop 
position, and recycling prepares the ribosomes for another round of this process1-3.  
Although each stage has its own specific set of factors that facilitate its progress, for 
example, the initiation factors are involved in the initiation stage while the elongation 
factors act during elongation, some of the protein factors have overlapping functions as 
the different stages of protein synthesis are not autonomous.  For example, while EF-G 
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(elongation factor-G, eEF2 in eukaryotes) is involved in the translocation step during the 
elongation stage, it is also required for the dissociation of ribosomes after the termination 
and the release of the polypeptide chains4.  Moreover, several of the initiation factors are 
thought to also play significant functions during the recycling stage of translation, which 
prepares the ribosomes for the next round of initiation and protein synthesis5-8. 
Protein synthesis is the most energy-demanding cellular activity.  It has been 
estimated that up to 13,000 protein molecules are synthesized per second per a haploid 
cell of yeast Saccharomyces cerevisiae9.  Thus, to maintain fitness, the process of 
translation needs to be tightly controlled to ensure accuracy and speed without the 
unnecessary waste of cellular resources.  Furthermore, translational regulation is required 
for many of the essential processes in a cell.  For example, it is needed for the refinement 
of protein levels during cellular proliferation, division, differentiation, and apoptosis3,10-
12, for the temporal and spatial regulation of protein synthesis during development13,14, for 
synaptic plasticity, learning, and memory formation15,16, and for cellular response to 
external stimuli such as nutrients and environmental stress17,18. 
Considering the pivotal function of translational control in the broad spectrum of 
essential cellular activities, it comes as no surprise that any disturbance in this process 
can have pathological consequences.  Translational misregulation has been implicated in 
such illnesses as cancer (chronic myeloid leukaemia, gastric cancer), neurological 
disorders (leukoencephalopathy, fragile-X syndrome, microcephaly, autism), viral 
infections (foot-and-mouth disease, influenza), and hereditary diseases 
(hyperferritinaemia-cataract and Wolcott–Rallison syndromes, familial 
thrombocytosis)19-29.  Among the various stages of translation, initiation is the most 
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compromised in the aforementioned translational pathophysiologies since it is the most 
heavily regulated stage of protein synthesis (see Figure 1.1 for examples of translational 
regulation at the level of initiation)1,21,22,30.  
Initiation is also the most divergent stage of protein synthesis, not only among the 
three kingdoms of life but also within a single organism, as multiple pathways for 
translation initiation can exist (see Table 1.1)31.  Regardless of the specific mechanism, 
however, the ultimate goal of initiation is to assemble an elongation-competent ribosomal 
complex at the correct start codon for protein synthesis.  In the next section, we briefly 
present the current understanding of the most common mode of initiation in bacteria 
(Shine-Dalgarno dependent) and eukaryotes (5’ cap dependent).  The other pathways of 
translation initiation (listed in Table 1.1) are out of the scope of this study and will not be 
discussed here.  
  5 
1.1 Translation Initiation 
1.1.1 Initiation of Protein Synthesis in Bacteria 
The bacterial initiation machinery is composed of a relatively small number of 
factors.  A 2.5 MDa 70S ribosomal complex is formed by the small (30S) and the large 
(50S) subunits.  The 30S subunit is composed of the 16S ribosomal RNA (rRNA, ~1,500 
nucleotides) and about 21 proteins whereas the 50S subunit consists of the 23S and 5S 
rRNA elements (~2,900 and ~120 nucleotides, respectively) and about 31 proteins31-33.  
The other components of the bacterial initiation apparatus are initiation factors (IF) 1, 2, 
and 3 as well as the initiator tRNA (tRNAi)1.  The majority of proteins, both in 
prokaryotes and eukaryotes, start with a methionine amino acid.  Unlike eukaryotes, 
however, the methionine moiety of tRNAi in bacteria is formlyated (fMet-tRNAi) by 
methionyl-tRNA transformylase, which is important for its function and recognition by 
IF234-37. 
In all three kingdoms of life, the sequence of the majority of mRNAs are longer 
than the actual region that codes for the protein product as they generally contain 5’ and 
3’ untranslated regions (UTR), which usually perform some regulatory functions.  In 
bacteria, besides the 5’ UTR, a great number of mRNAs are polycistronic and contain the 
coding sequences for multiple proteins38.  Thus, the most imperative challenge for an 
initiating ribosomal complex is to identify the correct start codon.  In order to place the 
elongation-competent ribosome at the correct start site and reading frame for protein 
synthesis, bacteria take advantage of a direct physical interaction between the mRNA and 
the 30S subunit of the ribosome.  Base pairing between the Shine-Dalgarno (SD) 
sequence of the canonical mRNAs and the anti-SD sequence present at the 3’ end of the 
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16S rRNA places the start codon in the vicinity of the P-site of the 30S subunit.  The 
precise positioning of the start codon in the P-site is then adjusted by the actions of the 
three initiation factors and the binding of the fMet-tRNAi31,35,39-43. 
In bacteria, the initiation stage of protein synthesis is thought to be intimately 
linked to ribosome recycling as the binding of IF3 stimulates the release of the mRNA 
and the unacylated tRNA bound to the 30S subunit from the previous round of translation 
and prevents the rejoining of the 50S subunit8,44,45.  IF1 stimulates the activities of IF3 
and also directs the binding of the fMet-tRNAi to the P-site by binding to the A-site of the 
30S subunit, and hence blocking the access of the fMet-tRNAi46-48.  The order by which 
IF2, fMet-tRNAi, and mRNA are recruited to the 30SIF1IF3 initiation complex is not 
clear.  IF1 is thought to also stabilize the binding of IF2, which interacts with the fMet-
tRNAi and supports the binding of the latter to the 30S subunit.  The interaction between 
IF2 and fMet-tRNAi, however, is believed to be dependent on the 30S subunit35,37,42,46,49.  
Upon binding of the fMet-tRNAi, IF3 is then involved in adjusting the position of the 
start codon in the P-site of the 30S subunit so that it can base pair with the anticodon of 
fMet-tRNAi.  Moreover, it is believed that IF3 also stabilizes the binding of the fMet-
tRNAi in the P-site and confers proofreading capabilities by destabilizing mismatched 
codon:anticodon interactions35,43,45,46,50-55. 
Upon accommodation of the mRNA, which leads to the formation of a cognate 
codon:anticodon interaction and the stabilization of the initiation complex, IF1 and IF3 
are ejected and the joining of the 50S subunit is stimulated by IF2.  During this process 
the IF2-bound GTP is hydrolyzed to GDP and inorganic phosphate (Pi).  With the release 
of Pi and IF2, the fMet-tRNAi is then fully accommodated in the peptidyl-transferase 
  7 
center (PTC).  The newly formed 70S complex then proceeds to the elongation stage of 
protein synthesis where the next amino acid is delivered to the A-site by EF-Tu (EF for 
elongation factor)35,42,52,55. 
1.1.2 Initiation of Protein Synthesis in Eukaryotes 
Translation initiation in eukaryotes is achieved via a complex machinery 
involving at least twelve initiation factors.  A eukaryotic 80S ribosome is formed by the 
joining of the small (40S) and the large (60S) subunits.  Because of expansions to the 
ribosomal RNA and proteins as well as the presence of many additional protein factors, 
eukaryotic ribosomes are generally ~40% larger than their bacterial equivalents56.  The 
40S subunit consists of the 18S rRNA and 33 proteins while the 60S subunit is composed 
of three rRNA elements (25S, 5.8S, and 5S) and 46 proteins56.  Contrary to bacteria, the 
majority of mRNAs in eukaryotes are monocistronic.  Moreover, a canonical eukaryotic 
mRNA contains a 7-methylguanosine cap at its 5’ end and a poly-A tail at its 3’ end both 
of which are important for efficient translation.  Another significant feature of the 
eukaryotic mRNAs is their lack of the Shine-Dalgarno sequence1.  Therefore, the 
translation initiation machinery in eukaryotes has to rely on other mechanisms to identify 
the correct start position for protein synthesis (Figure 1.2). 
The most common mode of translation initiation in eukaryotes is through a 5’ to 3’ 
scanning mechanism57-59.  The underlying principle of this model is that initiation in 
eukaryotes is governed by base pairing between the start codon of mRNA and the 
anticodon of Met-tRNAi.  The scanning mechanism can be thought of as a series of steps 
that ultimately leads to the placement of the Met-tRNAi base-paired with the start codon 
in an elongation-competent 80S complex.  A pre-initiation complex (PIC) conducive to 
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scanning is first formed near the 5’ cap of the mRNA.  The PIC then scans the 5’ UTR in 
a manner allowing for the Met-tRNAi to sample each of the nucleotides on the mRNA for 
complementarity to the start codon.  Upon a cognate codon:anticodon interaction and 
recognition of the correct start codon, a series of structural rearrangements in the PIC 
then allows for the joining of the 60S subunit, and the resulting 80S complex proceeds to 
the elongation stage of protein synthesis where the next amino acid is delivered to the A-
site by EF1A (ortholog of bacterial EF-Tu) (Figure 1.3)30,60. 
The process of initiation, as elucidated above, starts with the loading of the Met-
tRNAi on the 40S subunit, which is delivered in the context of a ternary complex (TC) 
with a GTP molecule and eIF2 (eIF for eukaryotic initiation factor) (details of eIF2 and 
TC formation are discussed in Sections 1.2.1 and 1.2.2, respectively).  This process is 
facilitated by initiation factors 1, 1A, 3, and 5 to form the 43S PIC60-66.  Binding of the 
TC to the 40S subunit is thought to be a result of physical interactions and cooperative 
binding among these initiation factors as TC alone has a low binding affinity for the 40S 
subunit60.   
Among the aforementioned factors involved in the loading of the Met-tRNAi and 
PIC formation, eIF5 is a GTPase activating protein (GAP) that stimulates the hydrolysis 
of eIF2-bound GTP67,68.  Interestingly, eIF5 physically connects with two different 
subunits of the eIF2 complex (β and γ) via two distinct domains (C-terminal and N-
terminal domains, respectively)69-71.  It is likely that eIF5 also functions in the structural 
assembly of the PIC since it interacts with multiple other initiation factors (including 
eIF1, 1A, and 3), and recent evidence has implicated it in start codon recognition by 
mechanisms independent of its GAP function61,69-75.  eIF1 is a small ~12 kD protein 
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without an exact sequence or structural bacterial ortholog.  Nevertheless, it shares some 
common functions with the bacterial IF3 in discriminating against non-cognate start 
codons1,76.  eIF1 binds near the P-site of the 30S subunit77-79 and forms physical 
interactions with eIF2, 3, and 561,70,80-82.  eIF1A is the ortholog of bacterial IF1 and 
similarly binds over the mRNA entry channel near the A-site on the body of the 40S 
subunit79,83.  eIF1A, however, contains additional C-terminal and N-terminal tail (CTT 
and NTT, respectively) expansions that are projected toward the mRNA entry 
channel79,83.  eIF1A NTT has been shown to interact with eIF2 and eIF3, which is 
thought to stabilize the binding of the TC to the 40S subunit84.  Finally, eIF3 is a large 
multi-subunit complex that spans the entire 40S subunit on the solvent side interacting 
with both the entry and the exit channels of the mRNA85-88.  eIF3 is thought to play a 
vital function in the structural assembly of the PIC as it forms a network of interactions 
among many of its components including the mRNA and the 40S subunit as well as the 
initiation factors 1, 1A, 2, and 561,64,81,86,88,89.  Besides its involvement in TC recruitment 
and the formation of the PIC, eIF3 also plays an important function in loading the 43S 
PIC at the 5’ cap of the mRNA (see below).     
In order for the process of scanning and initiation to continue, the 43S PIC has to 
assemble at the 5’ end of the mRNA, forming a 48S PIC.  The 43S PIC can inherently 
bind to the 5’ end of mRNAs lacking any structures in their 5’ UTRs76.  The majority of 
the endogenous mRNAs, however, contain secondary structures such as stem-loops that 
require the actions of helicases and other protein factors to facilitate this process.  The 
attachment of the 43S PIC to the 5’ end of a canonical mRNA takes place through a 
complex network of interactions among the components of the eIF4F and eIF3 complexes 
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as well as eIF4B and the poly-A-binding protein (PABP)30,60.  The eIF4F complex 
consists of a cap-binding protein (eIF4E), a DEAD-box RNA helicase (eIF4A), and a 
scaffolding protein (eIF4G) that physically links eIF4E, eIF4A, PABP and eIF31,90.  The 
ultimate result of the many interactions among all these factors is the resolution of the 5’ 
UTR secondary structures by eIF4A, and potentially by other helicases, which then 
allows for the attachment of the 43S PIC via interactions with eIF3, and perhaps with 
other components of the PIC (see Hinnebusch 201190 for a review of the 43S PIC loading 
on the mRNA). 
After the assembly of the 43S PIC near the 5’ cap of the mRNA, it has to scan the 
downstream nucleotides for complementarity with the anticodon of the Met-tRNAi in 
order to locate the start codon.  In the absence of any 5’ UTR structures, the 43S PIC 
alone is capable of the 5’ to 3’ movement along the sequence of an mRNA, but the 
presence of any secondary structures necessitates the activities of the eIF4A helicase, 
eIF4B, and eIF4G of the 48S PIC76.  Remarkably, the scanning capability of the 43S PIC 
heavily depends on the presence of eIF1A and almost completely on the eIF1 protein,76 
and PIC lacking eIF1 and eIF1A is unable to locate the initiator codon91.  This 
observation suggests that the binding of the eIF1 and 1A proteins induces such structural 
rearrangements that make the 43S PIC competent for scanning the 5’ UTR of mRNAs to 
search for the start codon.  Indeed, recent biochemical and cryo-electron microcopy 
(cryo-EM) structural studies, using in vitro reconstituted PIC, have demonstrated that the 
binding of the eIF1 and 1A proteins to the 40S subunit is cooperative and induces an 
‘open’ conformation of the PIC that allows for the loading of the TC, recruitment of the 
mRNA, and presumably the scanning of the mRNA 5’ UTR63.    
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Start codon selection depends on the irreversible hydrolysis of the eIF2-bound 
GTP and the release of the inorganic phosphate92.  Another essential feature of the open 
conformation of the PIC is that the premature dissociation of Pi is blocked.  As indicated 
above, eIF5 is the GAP factor that stimulates the hydrolysis of eIF2-bound GTP.  Hence, 
a fraction of eIF2GTP is hydrolyzed to GDP and Pi in the 43S PIC92.  Structural 
arrangement of the open conformation, however, blocks the release of Pi in the absence 
of a cognate codon:anticodon interaction between the mRNA and the Met-tRNAi72,92.  
This allows for the PIC to remain in the open conformation and to continue scanning the 
5’ UTR of the mRNA until cognate codon:anticodon base pairing is reached.   
Moreover, another significant feature of the open conformation is that the Met-
tRNAi may not be fully accommodated in the P-site during the scanning process.  Based 
on structural studies, it has been proposed that the presence of the eIF1 and 1A proteins 
in the open conformation is likely to prevent the full insertion of the Met-tRNAi in the P-
site.  eIF1 binds in the vicinity of the P-site and is predicated to have a slight steric clash 
with the Met-tRNAi.  Furthermore, while the body of eIF1A binds in the A-site, its CTT 
is inserted in the mRNA channel toward the P-site where the Met-tRNAi samples the 
mRNA codons for complementarity77-79,83,93,94.  This destabilization of the Met-tRNAi in 
the P-site is important because it induces a certain dynamics and competition that 
ultimately prevents the stabilization of the Met-tRNAi binding to near-cognate codons 
and allows for only a stable cognate codon:anticodon interaction to signal start codon 
detection.   
Upon recognition of the start codon through a cognate codon:anticodon 
interaction between the mRNA and the Met-tRNAi, a series of structural rearrangements 
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in the PIC then leads to the stabilization of the ‘closed’ conformation that signals 
initiation.  Cognate codon:anticodon base pairing stabilizes TC binding to the 40S 
subunit95.  It also stabilizes the binding of the eIF1A protein by inducing an interaction 
between its CTT and the N-terminal domain (NTD) of the eIF5 protein72,75.  Recent 
evidence suggests this interaction is coupled to the dissociation of eIF1 and Pi release 
from the PIC, which are among the events essential for start codon recognition72,96 as 
they contribute to the accommodation of the Met-tRNAi in the P-site and its dissociation 
from the eIF2 complex, respectively.  As explained above, the CTT of eIF1A extends 
toward the P-site of the 40S subunit79,83; therefore, interactions with the NTD of eIF5 
may also lead to the displacement of eIF1A CTT that together with the dissociation of 
eIF1, which binds near the Met-tRNAi in the P-site77-79, would contribute to the 
accommodation of the Met-tRNAi in the P-site.     
As elucidated earlier, eIF5 also physically interacts with both the eIF1 and eIF2 
proteins61,69,71,73.  Interestingly, recent evidence has suggested that eIF1 and eIF2β 
compete for binding to eIF5 as the regions in the C-terminal domain (CTD) of eIF5 that 
bind to eIF1 overlap with its binding sites for eIF2β70.  It was further proposed that start 
codon recognition strengthens the interactions between eIF5 and eIF2β, which 
contributes to the stabilization of the closed conformation as well as to the dissociation of 
eIF170.  Thus, multiple interactions seem to contribute to the dissociation of eIF1 upon 
start codon recognition.  Genetic studies have also provided evidence for the importance 
of eIF1 release in the accuracy of start codon selection in vivo.  Mutations that increase 
the dissociation rate of eIF1, by disrupting its contact points with the 40S subunit, have 
been shown to display a Sui- (suppressor of initiation codon) phenotype by reducing the 
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stringency of start codon recognition and allowing for translation initiation from a near-
cognate UUG codon97,98.  Conversely, mutations that reduce the dissociation rate of eIF1 
have been reported to display an Ssu- (suppressor of Sui-) phenotype by restoring the 
accuracy of start codon selection and blocking translation initiation from a UUG codon 
(Martin-Marcos et al. 2013).   
After start codon recognition, in order to assemble an elongation-competent 80S 
complex, the 60S subunit has to join the 40S with the Met-tRNAi fully accommodated in 
the P-site.  60S subunit joining and the dissociation of eIF2GDP and eIF5 are mediated 
by eIF5B, a ribosome-dependent GTPase and an ortholog of bacterial IF296,99.  Efficient 
subunit joining and GTP hydrolysis, which is required for the dissociation of eIF5B itself, 
are dependent on the interactions of eIF5B with the CTT of eIF1A84,100-102.  Thus, the 
CTT of eIF1A is involved in orchestrating multiple events during the entire process of 
translation initiation.  During the scanning phase, it is positioned near the P-site and 
cooperates with eIF1 to prevent the full accommodation of the Met-tRNAi, which 
maintains the PIC in the open conformation and allows for the scanning to proceed.  
Upon cognate base pairing between the start codon and the anticodon of Met-tRNAi, 
eIF1A CTT is then repositioned from the P-site by interacting with the NTD of eIF5 that 
contributes to both the accommodation of the Met-tRNAi in the P-site and also to the 
dissociation of eIF1, which in turn further adds to the stabilization of Met-tRNAi binding 
to the P-site.  Genetic evidence has also implicated eIF1A CTT and NTT in the initiation 
of protein synthesis.  Mutations in the two tails of eIF1A have been shown to display 
opposing effects in the accuracy of start codon recognition.  Whereas mutations in the 
scanning enhancer (SE) elements of its CTT lead to a reduction in the fidelity of initiation 
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and a Sui- phenotype, mutations in its NTT display an Ssu- phenotype and restore the 
stringency of start codon selection in vivo103-105.    
Thus, start codon selection requires the coordinated actions of a number of events 
in the PIC that collectively commit the complex to begin translation.  While thus far some 
of these essential interactions among the different factors have been determined, many 
more are yet to be identified.  Understanding the full mechanistic details of translation 
initiation in eukaryotes requires mapping the entire network of interactions among its 
different components.  In this study, we have identified a new function for the eIF2 
complex essential for establishing the fidelity of protein synthesis.  Our findings suggest 
a model in which domain-III of eIF2γ also contributes to the stabilization of the closed 
conformation and Met-tRNAi binding upon a cognate codon:anticodon interaction, which 
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1.2 The eIF2 Complex 
1.2.1 eIF2: The α, The β, and The γ 
eIF2 is a heterotrimeric G-protein complex that, in its active GTP-bound state, 
binds and delivers the Met-tRNAi to the P-site of the 40S subunit106,107.  It is composed of 
the α, β, and γ subunits (encoded by SUI2108, SUI3109, and GCD11110 in S. cerevisiae, 
respectively) that are well conserved between the archaeal and the eukaryotic domains of 
life111.  There is no bacterial ortholog of eIF2.  Although a crystal structure of a 
eukaryotic complex is not yet available, multiple structures of archaeal complexes (aIF2) 
in the apo form or with GDP or different non-hydrolysable analogues of GTP have been 
determined (Figure 1.4)112-116.  The archaeal heterotrimeric complex is composed of a 
rigid core body (formed by the γ subunit, domain-III of the α subunit, and the N-terminal 
α-helix of the β subunit) and two flexible parts on each side (formed by domains -I and –
II of α and the central α-β fold and the C-terminal zinc-binding domain of β).  Due to 
high conservation between the eukaryotic and archaeal e/aIF2 complexes, the archaeal 
structures have been invaluable in analyzing the functions of the various elements in the 
eukaryotic complex.   
eIF2γ is a ~57 kDa protein that forms the core of the eIF2 complex holding the α 
and β subunits.  No physical interaction between α and β has been detected in yeast and 
archaea116-120.  Interactions between recombinant human eIF2α and β have, however, 
been reported121,122.  Structural analysis of the archaeal proteins have revealed a close 
structural homology between γ and EF-Tu (EF1A in eukaryotes)114,119,123,124.  This is 
consistent with the function of both proteins in binding tRNA in a GTP depended manner 
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and delivering it to the ribosome.  The γ subunit consists of an N-terminal G-domain and 
β-barrel structured domains -II and -III (Figure 1.5C)119,124.  Eukaryotic eIF2γ also 
contains an N-terminal tail, which varies in length among different species and is absent 
in archaea125.  The G-domain is the largest of the three domains, and it binds to the 
guanine nucleotide and contains contact points for Met-tRNAi binding.  Domain-II 
participates in binding the Met-tRNAi along with the G-domain and also binds to 
domain-III of the α subunit.  Domain-III interacts with both the G-domain and domain-
II113,114,116,119,123,124,126.  Comparison of different structures have suggested that domains -
II and -III retain a fixed position with respect to one another but can move around the G-
domain through a pivot point around the switch-I element115,119,124.  Furthermore, using in 
vitro reconstituted yeast PIC and a directed hydroxyl radical probing approach, a recent 
study has mapped domain-III of the γ subunit as the binding interface between the eIF2 
complex and the 40S subunit127.  Moreover, our findings from this study suggests a novel 
function for the γ subunit in which domain-III is involved in establishing the accuracy of 
start codon recognition through adjusting the equilibrium between the open and closed 
conformations of the PIC. 
The G-domain of eIF2γ harbors features highly conserved among all GTP-binding 
proteins, including the switch-I, switch-II, and P-loop elements.  In all G-proteins known 
so far, GTP hydrolysis is achieved mainly through the conformational rearrangements of 
the two mobile switch-I and switch-II regions128.  Indeed, large structural reorganizations 
in the two switch elements as well as in the orientation of the G-domain with respect to 
domains -II and -III have been observed in the structures of EF-Tu in complex with GDP 
versus GTP analogues129-131.  In the GTP-bound protein, the switch elements take the ‘on’ 
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position, and EF-Tu is in a closed state where domain-II is packed against the G-domain.  
When in complex with GDP, however, the switch elements are in the ‘off’ position, and 
EF-Tu is in the open state with a hole between the two domains as domain-II has moved 
away from the G-domain129,131,133.  Remarkably, the γ subunit assumes an orientation 
resembling the closed state of EF-Tu, which represents its active GTP-bound state, 
regardless of whether it is in the apo form or in complex with GDP or GDPNP (a non-
hydrolysable analogue of GTP)114,116,119,123,124,126,132.  Moreover, the switch elements of 
γ do not seem to follow the simple ‘on’ and ‘off’ scheme depending on the nucleotide 
bound.  When the switch regions of all known aIF2γ structures114,116,119,123,124,126,132 were 
superimposed, no obvious correlation between their conformation and the nucleotide 
state of the γ subunit was observed114.   
It is important to note that unlike in eukaryotes, GTP hydrolysis and the exchange 
of GDP for GTP in aIF2 is thought to be spontaneous as archaea lack homologues of 
eIF2Bε (the catalytic subunit of eIF2B) and eIF5, which serve as the GEF (guanine 
nucleotide exchange factor) and GAP factors for the eIF2 complex, respectively1.  
Therefore, it is likely that the exact conformations of the elements in the G-domain 
involved in GTP hydrolysis, such as the switch-I and switch-II regions, may differ 
between the archaeal and eukaryotic complexes.  Moreover, as elucidated above, unlike 
EF-Tu and many other GTPases, the domains of the γ subunit do not seem to undergo 
large conformational rearrangements upon GTP hydrolysis.  This observation suggests 
other protein factors in contact with the G-domain may participate in regulating its 
nucleotide-binding activity.  The eIF5 and eIF2β proteins are both logical candidates for 
this function.  The NTD of eIF5 has been reported to directly interact with the G-domain 
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of eIF2γ in yeast69.  Although the main stable contact point between the β and γ subunits 
is through the N-terminal domain of β and the G-domain of γ, the core α-β fold and the 
C-terminal domains of β may potentially have transient interactions with the switch-I 
region of the G-domain (see below).  As discussed above, the irreversible hydrolysis of 
the eIF2-bound GTP and the release of Pi is an essential step for the dissociation of Met-
tRNAi and the initiation of protein synthesis.  Moreover, as elucidated earlier, translation 
initiation in eukaryotes is a result of an orchestrated series of events that ultimately lead 
to the formation of an elongation-competent 80S complex at the start codon.  Therefore, 
by involving other factors, such as eIF5 that forms a series of networks with other players 
in this process (see Section 1.1.2), GTP hydrolysis and Pi release are physically linked 
and coordinated to other events that have to take place in order for initiation to proceed.       
eIF2α is a ~35 kDa protein with conserved sequence and structural organization 
among various organisms.  It is composed of three domains: an N-terminal β-barrel 
domain-I, a helical domain-II, and a C-terminal α-β fold domain-III (Figure 1.5A)133-135.  
Domain-III forms a rigid body that interacts with loop-1 of eIF2γ domain-II.  Domains -I 
and -II are connected via a flexible linker to domain-III and exhibit a high degree of 
conformational mobility114,133,136,137.  Eukaryotic eIF2α also contains an acidic extension 
at its C-terminus that is missing in archaea125.  Recently, it has been reported that the C-
terminal acidic tail of S. cerevisiae eIF2α potentially antagonizes Met-tRNAi binding 
(see next section)138.   
Multiple functions have been attributed to eIF2α.  Perhaps it is most widely 
studied for its global regulatory role in response to environmental factors (discussed in 
Section 1.2.3 below).  eIF2α has also been implicated in the recognition of the -3 context 
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position as well as in the accuracy of start codon selection.  The importance of context 
sequence in the efficiency of translation initiation has been well documented139-145 
although the mechanisms by which the context of a start codon is read are not yet fully 
understood.  mRNAs with optimal (or near-optimal) context are generally translated at a 
higher rate.  It should, however, be noted that multiple reports have indicated that the 
effects of context on the efficiency of translation is less pronounced in S. cerevisiae than 
in mammalian organisms and plants146-149.  Using in vitro reconstituted PIC, it was 
observed that human eIF2α cross-links to the -3 purine nucleotide of the mRNA150.  
Furthermore, it was illustrated that the efficiency of eIF2 dissociation after an eIF5-
induced GTP hydrolysis depends upon the nature of the -3 nucleotide and the α subunit 
of eIF2150.  Thus, it was proposed that the previously reported effect of mRNA on the 
dissociation of eIF2GDP after start codon recognition96 is likely to be via interactions 
between the -3 context position and the α subunit150.  Consistent with an interaction 
between eIF2α and mRNA, a recent cryo-EM model of an in vitro reconstituted 
mammalian PIC positions the α subunit near the Rps5e protein in the vicinity of the 
mRNA channel in the 40S subunit151.  Furthermore, it has also been proposed that eIF2α 
is involved in maintaining the fidelity of translation initiation as two substitutions have 
been isolated in its domain-I that reduce the stringency of start codon recognition and 
allow for initiation from a near-cognate UUG codon108,152.  The underlying mechanism 
for these Sui- mutations has not yet been determined.  Considering the conformational 
flexibility of domain-I and the precedent for an eIF2α interaction with the mRNA, it is 
possible that its Sui- mutants reduce the accuracy of start codon selection by altering the 
network of physical interactions around the mRNA exit channel.  
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eIF2β is a ~32 kDa protein composed of three conserved domains and one 
eukaryotic-specific domain.  The conserved domains consist of an unstructured N-
terminal domain that contains the α-helix-1 (α1), a core α-β fold, and a C-terminal C2-C2 
zinc-binding domain (ZBD) (Figure 1.5B)116,125,126,153,154.  Eukaryotic eIF2β also contains 
an N-terminal extension that harbors three poly-lysine boxes, which are implicated in 
binding to a common set of acidic- and aromatic-rich motifs present in the C-terminal 
domains of eIF2Bε and eIF5155-157.  It should be noted that eIF5 and eIF2Bε were later 
shown to also directly interact with the G-domain of eIF2γ through their N-terminal and 
C-terminal domains, respectively69.  Interestingly, the NTD of eIF5 is also composed of 
an α-β fold and a ZBD that bear structural homology to those of the eIF2β protein116,158.  
Moreover, it has been reported that the poly-lysine boxes in the N-terminal extension and 
the ZBD of eIF2β can also bind RNA159,160. 
Three independent structures of the β subunit either in complex with γ or with an 
αγ heterodimer in archaeon Pyrococcus furiosus or Sulfolobus solfataricus have been 
published so far114,116,126.  While a high degree of flexibility is reported with respect to the 
positions of the central α-β fold and the C-terminal ZBD, the N-terminal domain of β is 
the main contact point with the γ subunit in all three structures as its α1-helix is inserted 
between two α-helices of aIF2γ G-domain.  α1 is the most conserved region of eIF2β 
and, interestingly, is disordered in the solution structure of an isolated β subunit154.  
Moreover, studies in yeast have illustrated that substitutions in α1 of eIF2β significantly 
reduce its association with eIF2γ and lead to the loss of initiation fidelity117.  Thus, 
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interactions between α1 of e/aIF2β and domain-III of e/aIF2γ are required and potentially 
sufficient to anchor the β subunit to the eIF2 complex.  
The central α-β fold and the C-terminal ZBD of eIF2β exhibit a high degree of 
flexibility114,116,141 that is also observed in the isolated β subunit in solution154.  The two 
domains were detected in different orientations in the three aforementioned crystal 
structures.  Interestingly, the domains assume diverse positions even in the different 
complexes formed in a single crystal, as the structures of four separate molecules were 
determined in the asymmetric unit of a crystal from S. solfataricus aIF2114.  This 
observation suggests that the diverse orientations of aIF2β central and C-terminal 
domains are unlikely to be an artifact of crystal packing.  In this structure, where a 
complete heterotrimer of aIF2 is resolved, only the N-terminal domain contacts the γ 
subunit, and the other two domains are mobile and solvent-exposed114.  In the structure of 
the βγ heterodimer (with or without a GDP molecule) from P. furiosus, the core α-β 
domain is packed against the G-domain of aIF2γ while the ZBD does not contact the γ 
subunit and is solvent-exposed141.  Finally, in the second structure of aIF2 from S. 
solfataricus, which contains the full β and γ subunits but only domain-III of aIF2α 
(α3βγ) and a GDP molecule, the ZBD is in close proximity to the nucleotide-binding site 
of the γ subunit but there is no contact between the central α-β fold and aIF2γ116.   
It is interesting to note that the same region of the γ subunit is observed to interact 
with the two different domains of β reported above.  In both the structure of P. furiosus 
βγ heterodimer and the S. solfataricus α3βγ complex, the switch-I region of aIF2γ G-
domain interacts with the central α-β or the C-terminal ZBD of the β subunit, 
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respectively116141.  As elucidated above, the α-β fold and the ZBD of β exhibit a high 
degree of conformational mobility114,116,141.  Therefore, it is feasible that they may 
interact with the G-domain of γ transiently during the different events of initiation to 
allow for their coordination.  Indeed, eIF2β has been reported to contribute to Met-tRNAi 
binding in yeast161,162.  Moreover, multiple Sui- mutations have been isolated in its ZBD 
that reduce the accuracy of start codon selection163.  Our findings from this study also 
provide evidence for the involvement of eIF2β ZBD in the stabilization the closed 
conformation of the PIC (discussed in Chapter 4).   
1.2.2. Ternary Complex Formation 
Ternary complex is formed by the binding of Met-tRNAi to the active GTP-bound 
state of the eIF2 heterotrimer164-167.  TC delivers the Met-tRNAi to the P-site of the 40S 
subunit and maintains it during the scanning phase of initiation while its anticodon 
searches the sequence of the mRNA for complementarity in order to identify the 
initiation site.  Upon start codon recognition, GTP hydrolysis and Pi release then allows 
for the dissociation of Met-tRNAi from the eIF2 complex.  It has been reported that Met-
tRNAi binds to the eIF2GTP complex around 15- and 70-fold tighter than to the GDP-
bound complex in S. cerevisiae and S. solfataricus, respectively132,165, which can explain 
the dissociation of Met-tRNAi after GTP hydrolysis and start codon recognition.  It is 
interesting to note that the effect of GTP on Met-tRNAi binding to eIF2 does not seem as 
substantial as the effect of GTP on the binding of elongator tRNAs to EF-Tu.  Due to the 
conformational arrangements of its domains and switch regions in the open state, EF-
TuGDP does not contain a binding site for an aminoacylated tRNA.  By contrast, it has 
been reported that the body of Met-tRNAi can still interact with eIF2GDP and that the 
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GTP nucleotide is more involved in the recognition of the methionine moiety in 
yeast131,165.  As discussed in Section 1.2.1, unlike EF-Tu, the γ subunit of eIF2 is always 
in the closed state and, based on the available structures, does not seem to undergo large 
conformational rearrangements.  Moreover, no obvious correlation between the 
conformation of the two switch elements and the nucleotide state of eIF2γ has been 
observed114.  Thus, it seems unlikely that the GTP nucleotide alone could confer the 
entire binding affinity and the specificity of Met-tRNAi for eIF2GTP.  In agreement 
with this expectation, many studies have implicated the participation of elements in the 
body of the initiator tRNA as well the α and β subunits in Met-tRNAi binding to the eIF2 
complex132,136,161,162,165,168-174.  
The sequence of the initiator tRNA is the most conserved among all tRNA species 
throughout the three kingdoms of life175.  It has been reported that conserved features of 
the Met-tRNAi itself contributes to its recognition by eIF2γ136,165,169,170,173,174.  The 
methionine moiety of the bacterial initiator tRNA is formylated, which helps the 
initiation complex to distinguish it from the elongator methionyl tRNA176-178.  Eukaryotic 
Met-tRNAi, however, lacks the formyl modification and needs to rely on other features to 
differentiate it from the elongator Met-tRNA for binding to eIF2.  The A1:U72 base pair, 
which is specific to the Met-tRNAi, has been suggested to play an important role in its 
function and recognition by eIF2165,169,170,173,179.  When the A1:U72 base pair of the yeast 
initiator tRNA was mutated to G1:C72, which is specific to elongator tRNAs, it could 
function as an elongator tRNA in vivo179.  Moreover, it has been illustrated that the 
methionine moiety also contributes to the binding of the Met-tRNAi in a GTP dependent 
manner165,174.  It was further proposed that A1:U72 could potentially position the 
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methionine moiety in its proper binding pocket in eIF2164.  Furthermore, structural 
elements and modifications on base of the T-stem and loop of Met-tRNAi have been 
implicated in blocking its binding to EF1A180-184.  Thus, Met-tRNAi is an active 
participant in determining the specificity and affinity of its binding to the eIF2 complex. 
The extent of the α and β subunits contributions to the binding of the Met-tRNAi 
to eIF2 has been the subject of much debate.  Genetic and biochemical experiments have 
generated contradictory results for the effects of each subunit on the affinity of Met-
tRNAi for eIF2 in eukaryotes in comparison with archaea.  The archaeal α subunit has 
been shown to substantially increase the binding of the Met-tRNAi to 
aIF2113,118,132,136,137,171.  In eukaryotes, however, it is the β subunit that seem to increase 
the affinity of Met-tRNAi for eIF2 with minor or no contributions from the α 
subunit161,162,168,172.  Recently, this dispensability of eIF2α was attributed to its 
eukaryotic-specific C-terminal extension, where progressive shortening of this acidic tail 
increased the contribution of the α subunit to Met-tRNAi binding138.  Interestingly, it has 
also been reported that in the primitive eukaryote Encephalitozoon cuniculi, α and β each 
contribute equally to the affinity of Met-tRNAi for eIF2185.  This species-specific 
contribution of the α and β subunits suggests that there may potentially be subtle 
structural differences by which Met-tRNAi binds to the eIF2 complex in different 
organisms. 
Based on the close structural homology between eIF2γ and EF-Tu and mutational 
analysis in yeast and archaea, it was originally thought that the two proteins bind tRNA in 
a similar manner119,124,130,136,164.  A directed hydroxyl radical probing study, using an in 
vitro reconstituted yeast PIC, provided the first evidence that the mode of Met-tRNAi 
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binding to the eIF2 complex may in fact be different from EF-Tu127.  EF-Tu interacts 
with both the amino acid and the body of the elongator tRNAs so that its domain-III 
binds to the T-stem of the tRNA186-189.  In this recent study, however, it was reported that 
eIF2γ only interacts with the methionine moiety and the acceptor stem of the Met-tRNAi 
and contributions from the β subunit were also detected127.  It was further observed that 
eIF2γ domain-III faces helix 44 of the 40S subunit and is potentially involved in the 
binding of the TC to the PIC127, which is in good agreement with our findings in this 
study. 
While no crystal structure of a eukaryotic eIF2 in complex with Met-tRNAi is yet 
available, recently two independent structures of a partial S. solfataricus aIF2 in complex 
with GDPNP and E. coli fMet-tRNAi have been resolved113,115.  Remarkably, the mode of 
fMet-tRNAi binding is drastically different between the two structures.  The differences 
can be, at least partially, attributed to the different composition of the complexes used.  In 
one study aIF2GDPNPfMet-tRNAi was assembled using aIF2 containing full length α, 
β, and γ subunits113.  It should, however, be noted that the core α-β fold and the ZBD of 
the β subunit could not be resolved in this structure.  In the second study, a partial aIF2 
containing the full γ subunit and only domain-III of α was used to assemble an 
incomplete aIF2GDPNPfMet-tRNAi complex115.  Considering the conformational 
mobility of domains -I and -II of eIF2α as well as the core α-β fold and the ZBD of 
eIF2β, it is feasible to assume that their presence would potentially affect the mode of 
Met-tRNAi binding to the γ subunit.  It is also important to note that the Met-tRNAi may 
hold a different conformation in eIF2 alone as opposed to when in complex with the PIC.  
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Thus, more structures of both eukaryotic and archaeal TC alone and in complex with the 
PIC are needed to fully determine the structural arrangement of the Met-tRNAi on eIF2. 
1.2.3. Translational Control Through the eIF2 Complex 
In the 5’ scanning pathway for translation initiation, which is the most common 
mode of initiation in eukaryotes, the Met-tRNAi is delivered to the PIC via the ternary 
complex.  As elucidated above, Met-tRNAi binds eIF2 only when in complex with GTP.  
After each round of initiation, the GTP of eIF2 is hydrolyzed to allow for the dissociation 
of Met-tRNAi so that the process of protein synthesis can proceed.  eIF2GDP has to then 
recycle in order to form the active form of the complex (eIF2GTP) so that the Met-
tRNAi can be delivered in the next round of initiation.  Therefore, the conversion of 
eIF2GDP to eIF2GTP constitutes a rate-limiting step of translation initiation and has 
been used as an essential point of regulation in the cell. 
eIF2B is the guanine exchange factor for eIF2 that catalyzes the exchange of GDP 
for GTP62.  It is a heteropentamer with α, β, γ, δ, and ε subunits.  eIF2Bε is the catalytic 
subunit that together with γ forms the ‘catalytic’ subcomplex.  α, β, and δ, on the other 
hand, form the ‘regulatory’ subcomplex190-192.  As elucidated in the Section 1.2.1, eIF2B 
binds to the eIF2 complex through physical interactions between the C-terminal domain 
of the catalytic ε subunit and the poly-lysine boxes present in the N-terminal extension of 
eIF2β155.  An interaction between the C-terminal domain of eIF2Bε and the G-domain of 
eIF2γ, which is likely catalytic in nature, has also been reported69.  Phosphorylation of the 
serine residue at position 51 (S51) of eIF2α in eIF2GDP transforms the complex to a 
poor substrate for eIF2B that prevents the exchange of GDP for GTP.  It has been 
elucidated that the eIF2GDP complex containing the phosphorylated eIF2α binds with 
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higher affinity to eIF2B and forms a non-productive complex with the αβδ regulatory 
subcomplex that fails to associate productively with the catalytic subcomplex190,193-196.  
Consequently, the concentration of active eIF2GTP, and hence TC, in the cell is reduced 
that then leads to a global reduction in protein synthesis.  It is important to note that the 
concentration of eIF2B in the cell is lower than that of the eIF2 complex.  Therefore, 
phosphorylation of even a small fraction of eIF2α can lead to a large-scale inhibition of 
protein production. 
S51 of eIF2α is the target of phosphorylation by four different kinases that 
respond to different stimuli197,198.  The kinase GCN2 is activated in response to depletion 
of nutrients199.  As elucidated above, protein synthesis is the most energy-consuming 
process in the cells.  Therefore, it can be expected that to maintain fitness, protein 
synthesis has to be down-regulated when amino acids and nutrients are scarce.  PKR (for 
Protein Kinase RNA-dependent) is present in vertebrates and is activated by double 
stranded RNA200,201.  By inhibiting protein synthesis, PKR is part of the cellular defense 
against viral infection202.  PERK (PKR-like Endoplasmic Reticulum Kinase) is activated 
upon ER stress, for example upon activation of the unfolded protein response 
(UPR)203,204.  This allows for the coupling of the rate of protein synthesis to the folding 
capacity of the protein chaperones to avoid the formation of, often toxic, misfolded 
proteins.  Finally, HRI (Heme Regulated Inhibitor) is activated in response to heme 
deprivation in erythrocytes and other forms of oxidative stress in the cell203,205.   
Interesting, phosphorylated eIF2α can also act conversely as a positive regulator.  
It has been reported that a reduction in TC, which is a consequence of eIF2(α-P), leads to 
an increase in the translation of GCN4 mRNA (ATF4 in higher eukaryotes).  Gcn4 is a 
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transcription factor that induces the expression of a set of amino acid biosynthetic 
enzymes and stress response genes (for a review see Hinnebusch 2005206).  GCN4 
translation is under the regulatory control of four upstream ORFs (uORFs).  The AUG 
codon of the first uORF is in an optimal context sequence.  Therefore, nearly all of the 
PICs forming near the 5’ cap of GCN4 mRNA translate uORF1.  After translating 
uORF1, about 50% of the ribosomes faile to be recycled at the stop codon of uORF1 and 
continue scanning the mRNA.  When there are plenty of nutrients available, and hence 
the concentration of TC for delivering the Met-tRNAi is not limiting, the majority of the 
ribosomes reinitiate at uORF3 or uORF4.  There is not enough distance between these 
uORFs and the AUG codon of GCN4.  Consequently, the complexes that translate uORFs 
3 or 4 fail to reinitiate again at the AUG codon of GCN4.  Under nutrient-starved 
conditions, however, when eIF2α is phosphorylated and TC is limiting, a greater 
proportion of reinitiating ribosomes bypass uOFRs 3 and 4 and reinitiate at the AUG 
codon of GCN4 increasing the translation of its mRNA206.  Thus, the eIF2 complex plays 
an essential role in the translational control of cellular pathways.  It provides a link 
between the external factors and the internal processes in the cell and allows for the 




1.3 Figures and Tables 
 
Figure 1.1 Translation initiation is heavily regulated 
Protein synthesis is the most energy-consuming process in the cell.  Therefore, multiple 
layers of regulation are put in place to prevent the waste of cellular resources.  The 
majority of translational control takes place at the stage of initiation.  Multiple examples 
of regulation at this stage are represented in this schematic (examples of genes employing 
each indicated type of regulation are listed on the right).  A canonical eukaryotic mRNA 
contains an untranslated region (UTR) at its 5’ end that often performs regulatory 
functions during initiation. For example, multiple initiation sites (either AUG codons or 
Internal Ribosome Entry Sites) are used to synthesize proteins that are targeted to 
cytoplasm or different cellular organelles based on the initiation site used.  Short 
upstream ORFs (uORFs) and stem-loop structures in the 5’ UTR generally exert negative 
effects and reduce initiation from the main ORF.  The context of a start codon also 
impacts the amount of initiation.  mRNAs that contain start codons in an optimal context 
are generally translated at higher levels.  See Cazzola and Skoda 200022 for review. 
AAAA CAP AUG AUG 
Alternative initiation sites 
-C/EBPα  -int-2 
-pim-1  -BAG-1 
AAAA CAP AUG 
Upstream ORFs (uORFs) 
uORF -GCN4/ATF4   -IL7, & IL15 
-TGFβ3     -Bcl-2 
AAAA CAP AUG 
Stem-loop structures  
-PDGF2  -TGFβ1 
-Ferritin  -IGF-II 
AAAA CAP AUG 
Alternative initiation sites 
IRES -c-myc  -bFGF 
-VEGF 




Figure 1.2 Ribosome challenge: where shall I begin? 
The majority of mRNAs in all the three kingdoms of life are longer than the open reading 
frame that codes for the protein product as they contain sequences at their 5’ and 3’ 
regions that are not translated.  This leaves the ribosome with the monumental task of 
finding the correct start codon for translation.  A cartoon of a canonical eukaryotic 
mRNA with a 5’ cap and a poly-A tail is represented.   
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Figure 1.3 The scanning mechanism of translation initiation in eukaryotes 
The Met-tRNAi is loaded on the 40S subunit in the context of a ternary complex with 
GTP-bound eIF2 in a process that is facilitated by eIF1, 1A, 3, and 5 to form the 43S pre-
initiation complex.  The mRNA is activated through the actions of PABP, eIF4B, and the 
eIF4F complex (consists of eIF4E, eIF4G, and eIF4A) and is loaded on the 43S complex 
to form the 48S PIC.  The complex then scans the 5’ UTR of the mRNA allowing the 
Met-tRNAi to sample each of the nucleotides for complimentary to locate the start codon.  
Upon a cognate codon:anticodon interaction, eIF2-bound GTP is irreversibly hydrolyzed 
and Pi is release, which allows for the dissociation of Met-tRNAi from the eIF2 complex.  
Dissociation of eIF2 GDP, eIF5, and other initiation factors and the joining of the 60S 
subunit allows for the formation of an elongation-competent 80S complex that proceeds 
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Figure 1.4 Crystal structure of aIF2 
Two views of a surface-exposed representation of a partial aIF2 (full γ and β subunits 
with only domain-III of α) in complex with GDP from S. solfataricus (PDB 2QMU) are 
presented.  The γ subunit forms the center of the complex that holds α and β.  The γ 
subunit, the N-terminal domain of β, and the C-terminal domain of α (both of which bind 
to γ) form a rigid body where as the central and C-terminal domains of β and the N-
terminal and central domains of α (not depicted here) display high conformational 





β α GDP 
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Figure 1.5 Structures of eIF2α , β , and γ  subunits 
(A) NMR structure of human eIF2α (PDB 1Q8K).  The α subunit is composed of an N-
terminal β-barrel structured domain-I, a helical domain-II, and an α-β fold domain-III.  
(B) Crystal structure of aIF2β from archaeon S. solfataricus (PDB 2QMU).  The β 
subunit consists of a helical N-terminal domain (α1), a core α-β fold, and a C-terminal 
zinc-binding domain (ZBD).  (C) Crystal structure of aIF2γ in complex with GDP from 
archaeon S. solfataricus (PDB 2QMU).  The γ subunit contains an N-terminal G-domain 
and β-barrel structured domains -II and -III.  The essential features of the G-domain 
(switch-I, switch-II, and the P-loop) are marked.  Regions of the α (domain-III) and β (N-
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Table 1.1 Various pathways for translation initiation 
 
Mechanism Organisms Employed Key Principle 
Shine-Dalgarno 
Dependent Bacteria and Archaea 
Base pairing between SDa sequence of mRNA and anti-
SD of 16S rRNA positions the ribosome at the start codon 
5’-Cap 
Dependent Eukaryotes 
5’ to 3’ scanning of mRNA leader sequence until start 
codon is reached 
Shine-Dalgarno 
Independent 
Archaea and some 
Bacteria Efficiency regulated by mRNA leader sequence 
Leaderless Archaea, some in Bacteria and Eukaryotes 
Direct assembly of 70S and 80S ribosomes on the start 
codon 
Internal Initiation Eukaryotes (both viral and endogenous mRNAs) IRES
b directly recruits the 40S subunit to the start codon 
a. Shine-Dalgarno 
b. Internal Ribosome Entry Site 










CHAPTER 2: IDENTIFICATION OF NOVEL MUTATIONS IN GCD11 THAT 
ALTER THE FIDELITY OF START CODON RECOGNITION 
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2.1 Introduction 
As discussed in Chapter 1, eIF2 is a heterotrimeric GTP-binding protein complex 
at the center of the 5’ cap dependent translation initiation pathway in eukaryotes.  In its 
active GTP-bound state, eIF2 binds and delivers the Met-tRNAi to the P-site of the 40S 
subunit.  During the scanning phase of initiation, eIF2 maintains the Met-tRNAi so that it 
can sample the nucleotides of the mRNA 5’ UTR for complementarity in order to identify 
the start codon.  Upon a cognate codon:anticodon interaction between the mRNA and 
Met-tRNAi, the irreversible hydrolysis of eIF2-bound GTP is needed for the dissociation 
of Met-tRNAi and the progress of the initiation pathway.  Thus, the eIF2 complex is 
intimately involved in the events that lead to the selection of the start codon and initiation 
in eukaryotes.  Furthermore, eIF2 plays vital regulatory functions and is involved in the 
translational control of many essential cellular processes (see Section 1.2.3). 
Considering the pivotal role of eIF2 in translation initiation, we set out to closely 
examine this complex and identify features essential for start codon selection.  The γ 
subunit of eIF2 forms the central part of the complex, which holds the other two subunits, 
and directly binds to GTP and Met-tRNAi (discussed in Sections 1.2.1 and 1.2.2).  
Therefore, we focused our study on the γ subunit.  In order to identify new functional 
elements in eIF2γ that are involved in start codon selection, we employed three 
independent methods to isolate mutant variants of eIF2γ that either reduced the 
stringency of start codon recognition (Sui- class of mutants) or conversely restored 
initiation fidelity to cells harboring a Sui- mutation (Ssu- class of mutants).  
To monitor the accuracy of translation initiation in vivo, we took advantage of a 
mutant allele of the HIS4 gene (his4-301) that lacks a cognate AUG start codon208,209.  
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His4 is an essential protein in the histidine biosynthetic pathway.  Thus, otherwise wild 
type (WT), yeast cells fail to translate the his4-301 mRNA and consequently exhibit 
histidine auxotrophy.  Sui- class of mutations, however, reduces the stringency of start 
codon recognition and allows for initiation from the third in-frame (UUG) codon of his4-
301208,209.  Thus, Sui- mutants display a His+ phenotype by suppressing the histidine 
auxotrophy of cells harboring the his4-301 allele and allowing them to grow on medium 
lacking histidine, or containing only 1% of the normal histidine supplement (-His 
medium).  The Ssu- mutant alleles, on the other hand, reestablish the accuracy of start 
codon selection, block translation initiation from the UUG codon of his4-301 mRNA, and 
hence suppress the His+ phenotype restoring histidine auxotrophy in cells also expressing 
a Sui- allele (Figure 2.1). 
In order to isolate novel Ssu- mutations in eIF2γ, we took advantage of the 
recessive lethality of a known Sui- allele.  A glycine to arginine substitution at position 31 
(G31R) of the eIF5 protein (encoded by the SUI5 allele) is recessive lethal and displays a 
dominant Sui- phenotype (Figure 2.2)163.  From a pool of randomly mutated GCD11 
alleles, we selected mutants that suppressed the inviability of cells expressing the SUI5 
allele as the sole source of eIF5.  A selection scheme like this (rather than screening 
through mutants) allowed us to analyze a large pool of randomly mutated GCD11 alleles.  
The majority of the mutations identified in this way localized to a discrete surface-
exposed region in domain-III of eIF2γ.  To further study this domain and to avoid 
isolating mutations in the G-domain that reduced initiation fidelity by merely altering the 
rate of GTP hydrolysis, we then used a library containing randomly mutated GCD11 
alleles corresponding to domains -II and -III to select for mutants that displayed a His+ 
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phenotype by reducing the accuracy of start codon recognition and allowing for initiation 
of his4-301 translation from a near-cognate UUG codon.  Finally, we selectively mutated 
conserved surface-exposed residues in domain-III of eIF2γ by site-directed mutagenesis 
and screened for Sui- and Ssu- phenotypes. 
This chapter explains how each class of mutations was isolated by employing the 
various strategies stated above.  A genetic description of the isolated mutations is 
provided for each class.  Since only three mutant alleles with a potential Sui- phenotype 
were identified by either the random selection procedure or by site-directed mutagenesis, 
this chapter only briefly describes some of the basic genetic characteristics of these 
mutants, and a more detailed genetic and biochemical analysis is presented in Chapter 3.  
Many mutations, however, with a potential Ssu- phenotype were identified either by 
selecting for the suppressors of SUI5 recessive lethality from an array of randomly 
mutagenized GCD11 alleles or by site-directed mutagenesis and screening for the same 
phenotype.  Thus, it would not have been feasible to provide a comprehensive genetic 
and biochemical analysis of all the mutants.  Therefore, a genetic characterization of 
these mutants is provided in this chapter, and the alleles with the most promising genetic 
phenotypes that were then selected for a thorough biochemical analysis are presented in 
Chapter 4.  
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2.2 Materials and Methods  
Standard methods were used for culturing, transforming, plasmid shuffling, and 
construction of S. cerevisiae strains210-212.  For yeast growth assays, cultures were grown 
to saturation, diluted to OD600 of 1 or 0.5, and 5µl of 10X serial dilutions were spotted on 
the appropriate medium. 
2.2.1 Yeast Strain Constructions 
For a complete list of yeast strains see Table 2.1.  Strain NAY13, lacking the 
chromosomal GCD11 gene and harboring GCD11 on a URA3 plasmid, was constructed 
in multiple steps by deleting the TRP1 gene in EY647 (note that GCD11 is an essential 
gene in yeast.  Thus, when the chromosomal copy of GCD11 is deleted, an episomal WT 
allele is provided to the cell).  Briefly, plasmid Ep293 was first replaced with Ep517 by 
transforming strain EY647 with Ep517 using the method of lithium acetate 
transformation210.  NAY7 was then obtained by growing the resulting transformants on 
synthetic complete (SC) medium lacking leucine (SC-L), to select for the LEU2-
containing plasmid Ep517, and 5-flooric acid (5-FOA), to select against the URA3-
containing plasmid Ep293212.  TRP1 was then deleted by transforming NAY7 with the 
trp1Δ::hisG::ura3 disruption fragment of plasmid pNJY1009 and growing the resulting 
transformants on 5-FOA-containing medium as described previously213.  The resulting 
strain, NAY11, was then transformed with Ep293, and NAY13 was finally obtained by 
replacing the LEU2-containing plasmid Ep517 with Ep293, which carries the URA3 
marker.  To achieve this plasmid replacement, NAY11 was transformed with Ep293 and 
a single colony transformant was grown in SC medium lacking uracil (SC-U), to select 
for Ep293, but containing leucine to allow for loss of the LEU2-containing plasmid 
  40 
Ep517 across multiple generations.  When the culture reached saturation, it was diluted in 
SC-U medium and grown to saturation again.  Finally, it was diluted and spread on SC-U 
plates.  Single colonies were isolated and the loss of Ep517 was established by 
confirming leucine auxotrophy.  Deletion of the TRP1 gene was confirmed by PCR 
analysis of genomic DNA and by confirming tryptophan auxotrophy in NAY13.  
Strain NAY17 was generated by placing the TIF5 gene, encoding the eIF5 
protein, under the control of the GAL1 promoter in NAY13.  This promoter replacement 
was achieved by the one-step PCR strategy214 selecting for kanamycin resistance on SC 
medium containing galactose as carbon source (SCgal).  Integration of the kanMX6-
PGAL1 cassette at the correct chromosomal locus was confirmed by PCR analysis of 
NAY17 genomic DNA using primers TIF5.F2 and TIF5.R2 (see Table 2.3 for the 
sequences of all primers used in this study).  NAY17 was then transformed with a TRP1 
plasmid encoding the SUI5 allele to generate NAY25, which was the final strain used in 
the selection process.  NAY25 was confirmed to be inviable on glucose medium (where 
the expression of chromosomal PGAL1-TIF5 is shut off) and to display a His+ phenotype 
(Figure 2.2). 
Using a similar procedure explained above for NAY17, the TIF11 gene (encoding 
the eIF1A protein) was placed under the control of the GAL1 promoter in NAY13 to 
create NAY74.  Strains NAY115 and NAY117 were generated by transforming NAY13 
with single copy (sc) TRP1 plasmids containing the SUI3-2 (p4280) and SUI5 (p4281) 
alleles, respectively, using the standard lithium acetate procedure210 and selecting for 
transformants on SC medium lacking uracil and tryptophan (SC-U-W).   
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To construct strain NAY66 with a myc-tagged his4-301 allele, a fragment of his4-
301-myc10-kanMX6, beginning from 207 bp upstream of the myc10 coding sequence and 
ending 176 bp downstream of the his4-301 stop codon, was amplified from strain JCY04 
using primers CHA209 and CHA210.  NAY13 was then transformed with the PCR 
product, and transformants were selected for resistance to kanamycin.  The insertion of 
the fragment at the correct locus was confirmed by PCR analysis of NAY66 genomic 
DNA.  To generate NAY64, a portion of the HIS4 gene from 340 bp upstream to 437 bp 
downstream of the start ATG codon was amplified from the genomic DNA of WT strain 
H4 using primers PM-18 and PM-19.  NAY66 was then transformed with the PCR 
product, and transformants were selected on SC-U medium lacking histidine (SC-U-H).  
The replacement of his4-301-myc10-kanMX6 with HIS4-myc10-kanMX6 was then verified 
by PCR analysis of NAY64 genomic DNA. 
2.2.2 Plasmid Constructions 
For a complete list of plasmids see Table 2.2.  Plasmid pNA4 (encoding WT 
eIF2γ tagged with the His8 epitope at its N-terminus) was generated in two steps by i) 
creating a NcoI restriction site at the 3’end of the GCD11 coding sequence in pC2872, 
and ii) removing the first internal KpnI restriction site, both without altering the amino 
acid sequences and using the QuickChange Site-Directed Mutagenesis kit (Agilent 
Technologies) following the manufacturer’s protocol and primer sets 
g_NcoI.F1/g_NcoI.R1 and g_KpnI.F1/g_KpnI.R1, respectively.  pNA4 was verified by 
DNA sequence analysis of the region encompassing the GCD11 coding sequence.  
pNA18 was created by ligating a 2kb GCD11 HindIII fragment isolated from Ep293 at 
the HindIII site of YCplac22 to generate a sc TRP1 plasmid encoding the WT GCD11 
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allele.  Insertion was confirmed by DNA sequencing.  To create a high copy (hc) TRP1 
plasmid encoding eIF1, a 1.6kb HindIII-SacI fragment containing SUI1 isolated from 
pCFB04 was inserted between the HindIII and SacI sites of plasmid YEplac122 to create 
pNA19.  The insertion was confirmed by DNA sequencing.  pNA20 was created by first 
amplifying a 788 bp fragment surrounding the IMT4 gene (encoding tRNAiMet) from 
yeast genomic DNA using primers IMT4_HindIII.F1 and IMT4-HindIII.R1.  The PCR 
product was then digested and inserted at the HindIII site of YEplac122.  Insertion was 
confirmed by sequencing the plasmid DNA surrounding the HindIII sites.  To create a hc 
plasmid co-expressing all the four genes encoding the components of the WT TC 
(GCD11-His8, SUI3, SUI2, and IMT4), the SacI-Sbf1 fragment of pAV1732 was replaced 
by the 2.57 kb SacI-SbfI GCD11-His8 fragment from pNA4 to generate plasmid pNA21.  
pNA23, pNA24, and pNA25 were made by replacing the 2.57 kb SacI-Sbf1 fragment of 
pNA21 (containing WT GCD11-His8) with the SacI-Sbf1 fragments from pNA4-E460K, 
pNA4-R503A, and pNA4-R504A that contain mutant gcd11-His8 alleles.  The plasmids 
were verified by DNA sequence analysis of the GCD11, SUI2, and SUI3 genes.   
2.2.3 Biochemical Assays with Yeast Extracts 
For Western blot analysis, exponentially growing yeast cells (OD600 of ~0.5) were 
harvested by centrifugation and whole cells extracts (WCEs) were prepared by 
trichloroacetic acid (TCA) extraction method as previously described215.  Immunoblotting 
was performed using antibodies against the His6 epitope (abcam), eIF2α216, 
eIF2Bε/Gcd6217, eIF181, and Myc epitope (Sigma) as described.  β-galactosidase assays 
with yeast WCEs obtained from exponentially growing cells (OD600 of ~0.5) were 
performed as described previously218.  
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2.3 Results 
2.3.1 Generation of Libraries of Randomly Mutated GCD11 alleles  
We employed the error-prone PCR technique219 to generate libraries of random 
mutations in the open reading frame (ORF) of GCD11.  The mutant libraries were 
generated in a sc LEU2 plasmid containing N-terminally His8-tagged GCD11 under its 
endogenous promoter and terminator sequences (plasmid pNA4)(Figure 2.3).  Due to the 
large size of the GCD11 coding region, it was divided into two overlapping segments, 
and two pools of randomly mutated alleles were generated using the GeneMorph II 
Random Mutagenesis kit (Agilent Technologies) following the manufacturer’s protocol.  
pNA4 plasmid DNA was used as template.  The first library (L1), covering the first half 
of GCD11 (codons 1-306, which encompass the G-domain), was generated using primers 
GCD11_L1.F1 and GCD11_L1.R1.  The second library (L2), covering the second half of 
GCD11 (codons 251 to 527, which encompass the last 59 amino acids in the G-domain 
and the entirety of domains -II and -III), was created using the GCD11_L2.F1/ 
GCD11_L2.R1 primer set (Figure 2.3).  The resulting PCR fragments were digested with 
BamHI and KpnI (for the L1 library) and KpnI and NcoI (for the L2 library) and inserted 
back into pNA4 to generate two pools of randomly mutated GCD11 plasmids.  DNA 
from 171,000 bacterial transformants was pooled.  To analyze the quality of the libraries, 
a random sample of at least 30 plasmids from each library was selected and their 
respective GCD11 coding region was subjected to DNA sequencing.  The frequency of 
mutations in GCD11 was 72.4% and 86.4% in L1 and L2, respectively. Table 2.4 
displays the frequency and type of mutations generated in each library. 
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2.3.2 Identification of GCD11 Mutants that Suppress the Recessive Lethality of SUI5 
In order to identify substitutions in eIF2γ that suppress the recessive lethality of 
SUI5, libraries of yeast strains containing random GCD11 mutant alleles were first 
generated by transforming strain NAY25 (gcd11Δ, PGAL1-TIF5, sc TRP1 SUI5) with the 
L1 and L2 libraries.  Transformants were plated on SCgal medium lacking leucine, uracil, 
and tryptophan (SCgal-L-U-W) to allow for the expression of WT TIF5 and to select for 
the URA3, LEU2, and TRP1 plasmids harboring WT GCD11, mutant GCD11 alleles, and 
SUI5, respectively.  Around 1,000,000 transformants were then pooled, diluted, and 
spread on SC medium lacking leucine and tryptophan (SC-L-W) with glucose as carbon 
source, to shut off the expression of WT TIF5, and containing 5-FOA, to select for loss of 
the URA3-containing WT GCD11 plasmid.  The transformants that could survive with 
SUI5 as the sole source of eIF5 being expressed were then isolated and streaked on 
SCgal-L-U-W medium to purify single colonies for further analysis.  The resident 
plasmids were rescued and reintroduced back into NAY25 to verify that their ability to 
suppress the recessive lethality of SUI5 is indeed linked to the GCD11 mutant plasmids.  
The corresponding GCD11 mutations were identified by sequencing the region of the 
plasmid DNA corresponding to the GCD11 coding sequence.  For a schematic 
description of the selection process see Figure 2.4. 
Using the above selection scheme, numerous mutations were isolated in GCD11 
that suppressed the recessive lethality conferred by the SUI5 allele (Table 2.5 and Figure 
2.5).  Although some of the mutant plasmids isolated contained multiple missense 
mutations in GCD11, many of the point mutations such as those generating substitutions 
at asparagine 433 to glutamic acid or lysine (N433D/K), methionine at position 482 to 
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lysine or isoleucine (M482K/I), aspartic acid at 481 to glutamic acid or histidine 
(D481E/H), and leucine at position 423 to methionine (L423M) were isolated from more 
than one independent colony (i.e. they were recovered from multiple independent mutant 
plasmids).  Seven of the mutant alleles that contained the above substitutions and showed 
the strongest phenotype in suppressing the inviability of cells harboring SUI5 as the sole 
source of eIF5 were selected for further analysis; these mutant alleles included M482K, 
F297S/D481E, M482K/T488M, M482I, E341K, L423M/D481H, and N433D.  We further 
confirmed that single substitutions at positions 481 (D481A/E) and 423 (L423M) 
suppress the recessive lethality of SUI5 by generating the indicated mutations in plasmid 
pNA4 using the QuickChange Site-Directed Mutagenesis kit (Agilent Technologies) 
following the manufacturer’s protocol (Figure 2.5B).  In order to examine the extent to 
which these alleles restore growth to cells harboring SUI5 as the sole source of eIF5 
being expressed, strains with the above GCD11 mutant alleles and episomal SUI5 were 
streaked on SC-L-W medium to monitor their colony sizes (note that the expression of 
PGAL1-TIF5 is shut off since glucose is the carbon source).  Among these alleles, there is a 
range by which the mutations restore growth to cells harboring SUI5 as the sole source of 
eIF5, with M482K and L423M/D481H displaying smaller colony sizes compared to the 
F297S/D481E, M482K/T488M, M482I, and N433D mutants (Figure 2.6) 
To determine if the above mutants, which suppress the recessive lethality of SUI5, 
also suppress its slow growth (Slg-) phenotype, cells harboring the various GCD11 alleles 
and episomal SUI5 were spotted on SC-L-W medium to establish their growth 
phenotypes.  In these strains, where the chromosomal TIF5 gene is expressed in single 
copy from its endogenous promoter, the SUI5 allele confers a dominant Slg- phenotype 
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(Figure 2.7, compare the first and second rows on the +His medium).  Even though the 
isolated mutations in GCD11 restore growth to cells harboring the SUI5 allele as the sole 
source of eIF5 to different extents (Figure 2.6), they all suppress its dominant Slg- 
phenotype.  This is apparent as the transformants with the mutant alleles of GCD11 and 
SUI5 grow similarly to the strain harboring WT GCD11 and lacking the episomal SUI5 
allele (Figure 2.7, compare the rows on the +His medium). 
As these GCD11 mutants suppressed the recessive lethality and Slg- phenotypes 
of SUI5, we next assayed for their ability to suppress the His+ phenotype of SUI5 by 
blocking initiation from the UUG codon of the his4-301 allele.  As elucidated earlier, 
SUI5 reduces the fidelity of start codon recognition and allows for translation initiation 
from a near-cognate UUG codon of his4-301, consequently conferring a His+ 
phenotype163 (Figure 2.7, compare the first and second rows on the -His medium).  
Strains harboring the WT or GCD11 mutant alleles and expressing episomal SUI5 were 
spotted on SC-L-W medium supplemented with either 0.3 mM (+His) or 0.003 mM (-
His) histidine (note that in these strains the chromosomal copy of TIF5 is expressed from 
its endogenous promoter, and hence cells carrying a sc TRP1 SUI5 plasmid are viable on 
glucose medium).  Isolated GCD11 mutants exhibit various strengths in suppressing the 
dominant His+ phenotype of SUI5, with the F297/ D481E, M482K/T488M, M482I, and 
N433D alleles fully suppressing, M482K partially suppressing, E341K very weakly 
suppressing, and the L423/D481H allele failing to suppress the His+ phenotype as 
indicated by the inability of the double mutants to grow on the -His medium (Figure 2.7). 
In order to determine how universal the isolated GCD11 mutations are in blocking 
the initiation of his4-301 translation from a UUG codon, their ability to suppress the His+ 
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phenotype of Sui- mutations in other initiation factors was assayed.  A tyrosine 
substitution of the serine residue at position 264 of eIF2β (encoded by the SUI3-2 allele) 
reduces the stringency of start codon recognition and suppresses the histidine auxotrophy 
of cells harboring the his4-301 allele, hence conferring a His+ phenotype163 (Figure 2.8, 
compare the first and second rows on the -His medium).  The GCD11 mutants follow a 
similar pattern in suppressing the dominant His+ phenotype of SUI3-2, with the 
F297S/D481E, M482K/T488M, M482I, and N433D alleles fully suppressing, M482K 
partially suppressing, E341K very weakly suppressing, and the L423M/D481H allele 
failing to suppress the His+ phenotype as indicated by the inability of the double mutants 
to grow on the -His medium (Figure 2.8).   
While the GCD11 mutants display a similar behavior in suppressing the His+ 
phenotypes of SUI5 and SUI3-2, they fail to do so in the tif11-SE1*SE2*F131 mutant 
(Figure 2.37A).  tif11-SE1*SE2*F131 is a Sui- allele of the gene encoding the eIF1A 
protein105.  Since the phenotypes associated with tif11-SE1*SE2*F131 are recessive, 
M482I, E431K, N433D, M482I/E431K, and M482I/N433D mutant alleles of GCD11 
where introduced into a strain where the chromosomal TIF11 gene is under the control of 
the GAL1 promoter (PGAL1-TIF11) and tif11-SE1*SE2*F131 is expressed from a sc TRP1 
plasmid.  tif11-SE1*SE2*F131 allows for translation initiation from the UUG codon of 
his4-301, consequently conferring a His+ phenotype105 (Figure 2.37A compare the first 
and second rows on the -His medium).  The M482I, E431K, N433D, M482I/E431K, and 
M482I/N433D mutants all fail to suppress this His+ phenotype as double mutants 
harboring the indicated GCD11 alleles and tif11-SE1*SE2*F131 grow on the -His 
medium (Figure 2.37A, compare the first seven rows).  The indicated GCD11 mutants 
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also fail to suppress the Slg- and the temperature sensitivity (TS-) phenotypes associated 
with tif11-SE1*SE2*F131 (Figure 2.37B, compare the first seven rows on the +His 
medium).  Therefore, the isolated GCD11 mutants do not universally suppress the 
phenotypes associated with Sui- mutations in different initiation factors.  This finding 
suggests that the identified mutations suppress a specific defect (or a set of defects) in the 
process of translation initiation associated with particular Sui- mutations.   
To confirm that the mutant alleles of GCD11 suppress the His+/Sui- phenotypes of 
SUI3-2 by restoring the fidelity of start codon recognition and blocking translation 
initiation from the UUG codon of his4-301, the ratio of initiation from a UUG codon to 
that from an AUG was assayed in vivo using the appropriate reporter genes.  The WT 
HIS4 and his4-301 alleles were chromosomally tagged with the myc10 epitope in isogenic 
strains.  The expression level of his4-301-myc10 (UUG) and His4-myc10 (AUG) proteins 
in strains harboring episomal SUI3-2 and the various GCD11 mutants were then 
measured by Western blot analysis, and the ratios of the his4-301-myc10 protein to that of 
the His4-myc10 were calculated (UUG/AUG ratio).  In WT yeast cells, there is very 
inefficient translation initiation from a UUG codon as indicated by the low expression 
level of the his4-301-myc10 protein compared to His4-myc10 (Figure 2.9B, compare lanes 
1 and 2 in the top panel to that of the bottom).  Therefore, the ratio of UUG to AUG 
initiation is very low in WT cells (Figure 2.9C).  In cells harboring the SUI3-2 allele, 
where the fidelity of start codon recognition is reduced, however, the amount of 
translation initiation from a UUG codon is increased significantly (Figure 2.9B, compare 
lanes 1 and 2 to lanes 3 and 4) leading to an elevated UUG/AUG ratio as compared to the 
WT cells (Figure 2.9C).  Consistent with suppressing the His+ phenotype of SUI3-2, the 
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M482K, F297S/D481E, M482K/T488M, M482I, E341K, L423M/D481H, and N433D 
mutant alleles of GCD11 restore the fidelity of start codon recognition as indicated by 
their ability to lower the expression level of the his4-301-myc10 protein in cells harboring 
the SUI3-2 allele (Figure 2.9B) and to partially suppress the elevated ratio of UUG to 
AUG initiation (Figure 2.9C).  Thus, the isolated mutations in GCD11 display a bona fide 
Ssu- phenotype by restoring the fidelity of start codon recognition in vivo as indicated by 
their ability to lower the ratio of UUG to AUG initiation in cells expressing the SUI3-2 
allele. 
It has been illustrated that SUI3-2 confers a Gcd- phenotype in addition to its Sui- 
and His+ phenotypes220.  As elucidated in Section 1.2.3, translation of the GCN4 mRNA 
can serve as a genetic reporter for monitoring the stability and the loading of the ternary 
complex to the PIC.  In nutrient-replete conditions, translation of GCN4 mRNA is 
repressed.  A reduction in TC stability or binding to the 40S subunit, however, leads to 
the derepression of GCN4 expression even in nutrient-replete conditions (this is called a 
Gcd-, General control derepressed, phenotype) (Figure 2.10A)206,220.  To examine if the 
mutant alleles of GCD11, which suppress the His+ and Sui- phenotypes of SUI3-2, can 
also suppress the Gcd- phenotype conferred by SUI3-2, the expression of a GCN4-lacZ 
reporter was measured in strains harboring the various GCD11 alleles and episomal 
SUI3-2.  In WT cells, when plenty of nutrients are available in the medium, there is low 
basal translation of the GCN4-lacZ reporter.  Cells harboring the SUI3-2 allele, however, 
confer a Gcd- phenotype, derepressing the expression of the GCN4-lacZ reporter by a 
factor of ~2.8-fold (Figure 2.10B).  The M482I, E431K, N344D, M482I/E431K, and 
M482I/N433D alleles of GCD11 partially suppress this elevated expression of the GCN4-
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lacZ reporter in cells harboring SUI3-2, reducing the derepression ratio to values ≤1.7 
(Figure 2.10B). 
Similar to SUI3-2, the SUI5 allele also confers a Gcd- phenotype.  Thus, in order 
to determine if the GCD11 mutants, which suppress the recessive lethality, Slg-, and His+ 
phenotypes of SUI5, can also suppress its Gcd- phenotype, expression of the GCN4-lacZ 
reporter was measured in cells harboring the various GCD11 alleles and episomal SUI5 
cultured in SCgal-L-W medium, where WT eIF5 is expressed from the chromosomal 
PGAL1-TIF5.  As in the case of SUI3-2, GCD11 mutants partially suppress the Gcd- 
phenotype conferred by SUI5 (Figure 2.10C).  SUI5 allele results in a ~2-fold 
derepression of the GCN4-lacZ expression under non-starvation conditions, and the 
GCD11 mutants suppress the derepression ratio to values ≤1.4 (Figure 2.10C). 
It has been reported that the tif11-SE1*SE2*F131 Sui- allele also derepresses the 
expression of GCN4-lacZ under nutrient-replete conditions, conferring a Gcd- 
phenotype105 (Figure 2.37C).  To determine if the mutants of GCD11 suppress the Gcd- 
phenotype conferred by tif11-SE1*SE2*F131, as they do that conferred by SUI3-2 and 
SUI5, expression of the GCN4-lacZ reporter was measured in cells harboring the various 
GCD11 alleles and episomal tif11-SE1*SE2*F131 cultured in SC-L-W medium (note 
that in the glucose medium expression of the chromosomal PGAL1-TIF11 is shut off).  
Surprisingly, the isolated GCD11 mutants not only do not suppress, but even seem to 
increase the Gcd- phenotype of the tif11-SE1*SE2*F131 Sui- allele (Figure 2.37C).  
Whereas E431K and E431K/M482I have no effect, M482I, N433D, and N433D/M484I 
further increase expression of the GCN4-lacZ reporter by ~2.4-fold in cells harboring 
tif11-SE1*SE2*F131 under non-starvation conditions (Figure 2.37C).  This increase in 
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the Gcd- phenotype of tif11-SE1*SE2*F131 is not due to an intrinsic Gcd- phenotype of 
the GCD11 mutants, as shown next.   
The isolated GCD11 mutants do not derepress the expression of the GCN4-lacZ 
reporter in otherwise WT cells under nutrient-replete conditions (Figure 2.11A).  This 
observation suggests that the indicated substitutions in eIF2γ do not alter the stability of 
the ternary complex, for example by causing the misfolding of the protein, since a defect 
in TC formation would generally manifest itself as a Gcd- phenotype206.  In fact, GCD11 
mutants display a mild Gcn- (General control non-inducible) phenotype by failing to 
induce the expression of the GCN4-lacZ reporter even in nutrient-starvation conditions 
(Figure 2.11B).  The Gcn- phenotype conferred by the GCD11 mutant alleles is consistent 
with their suppression of the SUI3-2 and SUI5 Gcd- phenotypes.  Multiple defects can 
lead to a Gcn- phenotype (see Hinnebusch 2005206 for review).  One such defect is 
reduced AUG recognition, which reveals itself as the leaky scanning phenotype221.  A 
construct with an elongated upstream ORF1 (el-uORF1) in-frame with and overlapping 
the AUG start codon of the GCN4-lacZ allele is used as a genetic reporter for leaky 
scanning (Figure 2.12A).  In WT cells, there is low basal translation of the GCN4-lacZ 
fusion reporter since most ribosomes translate exclusively from the AUG codon of el-
uORF1.  In mutants that have a defect in AUG recognition, however, a greater proportion 
of ribosomes bypasses the AUG codon of el-uORF1 and instead initiate downstream at 
the AUG codon of GCN4-lacZ.  Thus, translation of GCN4-lacZ increases in a mutant 
that displays leaky scanning.  The GCD11 mutants exhibit a mild leaky scanning 
phenotype as they result in a weak, but significant, increase in the expression of the 
GCN4-lacZ fusion reporter (Figure 2.12A).  The Gcn- phenotype of the GCD11 mutant 
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alleles, however, cannot not be fully explained by reduced AUG recognition since the 
increase in leaky scanning is very mild, ~1.5-fold (Figure 2.12).  Nonetheless, an increase 
in leaky scanning is expected if the Ssu- mutants restore initiation fidelity by destabilizing 
the closed conformation since by making the process of start codon recognition more 
stringent, AUG recognition would also decrease to some small extent. 
To determine if the isolated GCD11 mutants exhibit any growth defects or TS- 
phenotypes, cells harboring the various GCD11 alleles were cultured in SC-L medium 
and the growth phenotypes were monitored by spot assays.  None of the various GCD11 
alleles confer any growth defects or TS- phenotypes in otherwise WT cells (Figure 
2.13A).  Moreover, the mutations do not alter the level of the eIF2γ protein (Figure 
2.13B).  Thus, their phenotypes cannot be attributed to altered protein expression. 
As discussed in Section 1.2.1, the γ subunit is the core of the eIF2 complex and 
provides the binding sites for GTP and Met-tRNAi (Figure 1.4).  It is composed of three 
domains: G-domain, which binds to GTP and Met-tRNAi and contains the binding 
platform for the β subunit, domain-II, which is involved in Met-tRNAi binding and also 
provides the binding interface with the α subunit, and domain-III, which remains mainly 
uncharacterized.  Interestingly, the majority of mutations we isolated encode substitutions 
corresponding to residues in domain-III of eIF2γ.  In order to determine the position of 
these mutations on the three-dimensional structure of the eIF2 complex, we took 
advantage of an X-ray crystal structure of the archeon S. solfataricus aIF2 in complex 
with GDP (PDB 2QMU)116.  As elucidated in Section 1.2.1, this structure, which is used 
through the remainder of this study, contains the full β and γ but only domain-III of the α 
subunit (α3βγ).  Remarkably, the Ssu- mutations localize to a discrete surface-exposed 
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area in domain-III of eIF2γ (Figure 2.14A).  The area that contains the mutations is 
distant from the interface of domain-III with the other two domains (G-domain and 
domain-II) and from the interface between γ and the α and β subunits.  Moreover, it is 
located on the opposite surface of eIF2γ from that containing the GTP and Met-tRNAi 
binding sites (Figure 2.14A).  Unfortunately, a crystal structure of the eukaryotic 40S 
subunit in complex with TC is not available.  Recently, however, directed hydroxyl 
radical probing experiments were performed to map the binding of S. cerevisiae eIF2 on 
the 40S ribosomal subunit and on Met-tRNAi127.  As elucidated in Chapter 1, these 
experiments identified domain-III of eIF2γ and helix 44 (h44) of the 18S rRNA as a key 
binding interface between the eIF2 complex and the 40S subunit.  Remarkably, the 
cluster of GCD11 Ssu- mutants maps to a surface-exposed region of domain-III that is 
proposed to be in proximity of h44 of the 40S subunit (Figure 2.14B).  This raises the 
intriguing possibility that our Ssu- mutations act by altering the physical interactions 
between the TC and the 40S subunit.   
2.3.3 Isolation of Mutations in GCD11 that Reduce Initiation Fidelity 
In order to isolate mutations that lower the stringency of start codon recognition, 
we took advantage of the his4-301 allele and selected for substitutions in eIF2γ that 
conferred a His+ phenotype by allowing the initiation of his4-301 translation from a UUG 
codon.  To avoid isolating mutants that reduced the initiation fidelity by merely 
increasing the rate of GTP hydrolysis, we avoided the G-domain and only screened the 
L2 library that contains randomly generated mutations in domains -II and -III of GCD11 
on a LEU2 plasmid.  To isolate mutant alleles conferring a His+ phenotype, a pool of 
yeast strains containing randomly mutated domains -II and -III was first created by 
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introducing the L2 library into strain NAY13 (gcd11Δ, his4-301, sc URA3 GCD11) and 
selecting for transformants on SC-L-U medium to maintain both plasmids.  The 
transformants were then pooled, diluted, and spread on SC-L medium containing 5-FOA 
to select for loss of the URA3-containing WT GCD11 plasmid.  Around 250 million 
colonies were subsequently pooled, diluted, and spread on SC-L medium either lacking 
or supplemented with 0.006 mM or 0.015 mM histidine (0.2% and 0.5% of normal 
concentration of histidine in SC medium, respectively).  The three different 
concentrations of histidine (0, 0.006 mM, and 0.015 mM) were chosen so that mutants 
with a range of His+ phenotypes could be selected.  Different Sui- mutants display various 
strengths in their His+ phenotypes, and a Sui- mutation with a weak phenotype may be 
unable to grow on medium completely lacking histidine as compared to one 
supplemented with 0.2% or 0.5% of the normal histidine level.  Transformants able to 
grow on medium lacking abundant histidine (His+ phenotype) were isolated and streaked 
on SC-L medium to purify single colonies.  The resident plasmids were rescued and 
reintroduced into NAY13 to verify that their His+ phenotypes are conferred by the mutant 
GCD11 plasmids.  The corresponding GCD11 mutations were subsequently identified by 
sequencing the plasmid DNA corresponding to the coding region of GCD11.  For a 
schematic diagram of the selection procedure see Figure 2.15.   
Two point mutations were identified through this selection process (Figure 2.16).  
55% of the recovered mutant plasmids encoded a substitution in the arginine residue at 
position 510 (R510) and 7% encoded a glycine to cysteine change in residue 418 
(G418C).  The frequency of mutants with a His+ phenotype in the initial screen was 
0.002%.  Both gcd11-R510H and gcd11-G418C alleles were recovered with similar 
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frequencies from media with the different concentrations of histidine (0, 0.006 mM, and 
0.015 mM).  Cells harboring the G418C allele are slow growing yet they exhibit a 
stronger His+ phenotype compared to those expressing the R510H allele (Figure 2.16).  
Interestingly, R510H was previously identified as a Gcd- mutant in a screen for 
spontaneous revertants of the Gcn- phenotype of gcn2-101 gcn3-101 double mutant222 
and was later shown to also display Sui- and His+ phenotypes by elevating the ratio of 
UUG to AUG initiation223.  This suggests that the selection procedure here worked well 
to isolate mutations with the desired phenotype. 
Residue R510 is extremely well conserved in eIF2γ from various organisms.  In a 
multiple sequence alignment of thirty nine different eukaryotic and archaeal e/aIF2γ 
proteins, the residue corresponding to R510 in yeast eIF2γ is always an arginine (Figure 
2.17).  In fact, the region surrounding residue R510, which contains the sequence motif 
W509R510L511I512G513 encompassing the last β-strand of domain-III, is identical in all 
organisms analyzed (Figure 2.17).  R510 is partially exposed on the surface of the γ 
subunit and is positioned at the interface of domain-III with the G-domain on the same 
face of the protein that binds to GTP and Met-tRNAi (Figure 2.18A).  The side chain of 
R510, however, is pointing inside the protein toward the G-domain and is only 2.6Å 
away from the side chain of residue D198 in the switch-II region of the G-domain (Figure 
2.18B).  Switch-II is one of the key structural elements of all GTP binding proteins (see 
section 1.2.1).  It has been widely documented that it is the structural rearrangements 
among the switch-I, switch-II, and P-loop regions, universal in all GTP binding proteins, 
that lead to GTP hydrolysis116,128,224,225.  R510 might be involved in the structural 
arrangements of the G-domain by forming a salt bridge with residue D198 of switch-II.  
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If so, then the R510H substitution may alter the rate of GTP hydrolysis and/or Pi release 
by modifying the interactions between switch-II and domain-III, hence leading to loss of 
initiation fidelity.  It is also possible that by altering the physical interactions between 
switch-II and domain-III, R510H indirectly alters the binding of the Met-tRNAi to eIF2γ 
without altering the rate of GTP hydrolysis and Pi release since, as discussed in section 
1.2.2, the structural arrangements of the switch elements in the G-domain also impact 
Met-tRNAi binding.  Yet, it is also possible that R510H reduces the affinity or alters the 
mode of eIF2 binding to the 40S subunit as R510 is located in proximity of the proposed 
interface between eIF2 and the 40S subunit127.  This possibility, however, seems less 
likely because its side chain projects inside the G-domain as explained above (Figure 
2.18C). 
Interestingly, residue G418 is also located in domain-III and is highly conserved 
among both eukaryotic and archaeal e/aIF2γ proteins (Figure 2.19).  It is in the first β-
strand (β1) of domain-III that projects into the β-barrel structure of domain-II (Figure 
2.20A).  The three eIF2γ domains are largely autonomous, and this represents the only 
instance where one domain projects into a neighboring one (Figure 2.20A).  The three-
dimensional environment of G418 is also conserved.  It is surrounded on both sides by 
strands β1 and β3 of domain-II, and its neighboring residues in β1 include several 
hydrophobic amino acids that are conserved among different organisms (Figure 2.19 and 
Figure 2.20A).   
In order to examine if other residues in β1 of domain-III besides G418 are also 
involved in maintaining the fidelity of start codon recognition, we examined if 
substitutions at nearby residues Q415, V416, and V417 confer a His+ phenotype.  
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Contrary to G418C, however, Q415L, V416A, and V417L mutants do not display a His+ 
phenotype (Figure 2.21B).  We also tested if these mutations confer any growth defects.  
Cells harboring the above GCD11 alleles were cultured in the SC-L medium, and their 
growth phenotypes were examined by spot assays at different temperatures.   While 
G418C confers a marked Slg- and cold sensitivity (Cs-) phenotypes, the Q415L, V416A, 
and V417L mutant alleles behave like WT GCD11 in the growth assays (Figure 2.21A).   
Residue G418 is not surface-exposed and lacks a side chain with a functional 
group that may interact with other proteins on the surface of eIF2γ (Figure 2.20A).  
Therefore, it is unlikely that the phenotypes of the G418C allele are a direct result of loss 
of interactions between eIF2γ and other potential binding proteins.  Moreover, it is 
positioned distant from the proposed binding interface of eIF2 and the 40S subunit 
(Figure 2.22A).  Thus, it also seems unlikely that the phenotypes of G418C are a 
consequence of altered eIF2 binding to the 40S subunit.  Domain-II of eIF2γ is thought to 
be involved in binding the Met-tRNAi as well as the α subunit (see section 
1.2.1)1,113,116,127,138.  Due to its position in β1 of domain-III, which is inserted inside the β-
barrel structure of domain-II, it is possible that the G418C substitution leads to structural 
rearrangements of domain-II that may affect GTP hydrolysis, Met-tRNAi binding, or 
interactions with the α subunit as a glycine to cysteine substitution introduces a side 
chain where none normally exists (Figure 2.22B). 
2.3.4 Identification of Mutations in GCD11 that Alter Initiation Fidelity by Site-Directed 
Mutagenesis 
Since the majority of the mutations we isolated by using the libraries of randomly 
generated GCD11 alleles localized to domain-III, we decided to study this domain in 
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more detail by mutating its remaining conserved surface-exposed residues and examining 
the mutations for Sui- and Ssu- phenotypes.  Conserved residues in domain-III that are on 
the surface of eIF2γ were mutated to alanine (A) and, when relevant, to a residue of the 
opposite charge (glutamic or aspartic acid residues were mutated to alanine and lysine, 
and arginine or lysine residues were mutated to alanine and glutamic acid) (Figure 2.23 
and Figure 2.24).  Site-directed mutagenesis was performed with the QuickChange Site-
Directed Mutagenesis kit (Agilent Technologies) following the manufacturer’s protocol 
and using primers listed in Table 2.3.  Plasmid pNA4 was used as the DNA template.  
Twenty four mutant alleles were generated by this method, listed in Table 2.6.   
The mutant plasmids were introduced into strain NAY13 (gcd11Δ, his4-301, sc 
URA3 GCD11), and the transformants were streaked on SC-L+FOA medium to select for 
loss of the URA3-containing WT GCD11 plasmid.  Among the mutant alleles created, 
only those altering the residues E460, R503, and R504 conferred growth defects.  Mutant 
alleles encoding alanine and glutamic acid substitutions of arginine residues at positions 
503 and 504 (R503A/E and R504A/E) were recessive lethal (Figure 2.31A).  Lysine 
substitution at position E460 led to a severe Slg- phenotype (Figure 2.33A) and an alanine 
substitution conferred a TS-, but not a Slg-, phenotype (Figure 2.25A).  The temperature 
sensitivity is unlikely to be a result of unstable mutant eIF2γ protein since Western blot 
analysis illustrated that even after culturing the cells for 4.4 generations at 37°C, there is 
no change in the level of E460A mutant protein compared to the WT GCD11 product 
(Figure 2.25C).  The remaining mutations did not confer any growth defects or TS- 
phenotypes (Figure 2.25A) and also did not alter the level of eIF2γ protein (Figure 
2.25B).    
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The mutant alleles were then assayed for their ability to reduce the stringency of 
start codon recognition by allowing the initiation of his4-301 translation from a UUG 
codon, consequently conferring a His+ phenotype.  Strains harboring either the WT or 
mutant GCD11 alleles were cultured in SC-L and spotted on medium containing either 
0.3mM (+His) or 0.003 mM (-His) histidine to test for suppression of the histidine 
auxotrophy conferred by the his4-301 allele.   Among all the mutants created, E460A 
presented a clear, albeit weak, His+ phenotype (Figure 2.26).   
In order to examine if any of these GCD11 mutant alleles reduce the stability of 
the TC or its binding to the 40S subunit, expression of the GCN4-lacZ reporter was 
measured under nutrient-replete conditions.  Among all of the mutant alleles, only E460A 
confers a Gcd- phenotype, derepressing expression of the GCN4-lacZ reporter by ~7-fold 
(Figure 2.27).  The residue E460 is located on the surface of domain-III on the same face 
of eIF2γ that contains the binding sites for GTP and Met-tRNAi (Figure 2.28A).  
Remarkably, E460 is positioned in proximity of the proposed binding interface between 
eIF2 and the 40S subunit (Figure 2.28B).  This raises the intriguing possibility that the 
E460A substitution may alter the affinity or the mode of eIF2 binding to h44 of the 40S 
subunit, which consequently confers its His+ and Gcd- phenotypes.   
E460 is immediately adjacent to residues R503 and R504 in the three-dimensional 
structure of eIF2 (Figure 2.29A-B).  In fact, it is possible that a salt bridge is formed 
between the side chains of E460 and R503 as they are separated by only 2.9Å (Figure 
2.29C).  As stated above, both alanine and glutamic acid substitutions at R503 as well as 
R504 are recessive lethal (Figure 2.31A).  Furthermore, the E460K substitution is also 
extremely slow growing (Figure 2.33A).  In order to confirm that the recessive lethality 
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of the R503/R504 substitutions is not due to reduced expression of the mutant proteins, 
we performed Western blot analysis and used an antibody against the His6 epitope 
(abcam) in strains where the untagged WT GCD11 was supplied on a sc URA3 plasmid 
and the tagged mutant alleles were on a sc LEU vector.  This analysis indicated that the 
level of eIF2γ containing the E460K, R503A/E, or R504A/E substitutions is comparable 
to the level of the WT protein (Figure 2.30B).  Furthermore, to examine if these mutants 
display any dominant phenotypes, we assayed the growth and His+ phenotypes and 
measured expression of the GCN4-lacZ reporter in cells harboring the WT GCD11 allele 
on a sc TRP1 plasmid and the various recessive lethal mutant alleles on a sc LEU2 
plasmid.  These analyses indicated that there is also no dominant phenotype associated 
with the E460K, R503A/E, or R504A/E mutants as they do not confer a dominant Slg- or 
Ts- phenotypes (Figure 2.30A) nor a dominant His+ or Gcd- phenotypes in cells harboring 
WT GCD11 (Figure 2.30C-D).   
The cluster of residues E460, R503, and R504 seem to carry out a critical function 
of domain-III.  Based on the Sui- and Gcd- phenotypes of the E460A strain, this function 
likely contributes to the rate or stability of TC binding (Gcd-) and the conformation of TC 
in the P-site needed for accurate start codon recognition (Sui-).  Because of the position of 
these three residues on the surface of the proposed binding interface between eIF2 and 
the 40S subunit (Figure 2.28B), it is possible that the recessive lethality of the indicated 
mutations is a result of reduced eIF2 binding.  If this is the case, then overexpression of 
the mutant TC might partially suppress this phenotype.  In order to test this possibility, 
we transformed NAY13 (gcd11Δ, his4-301, sc URA3 GCD11) with hc LEU2 plasmids 
co-expressing the four components of the TC (eIF2α, β, WT or mutant γ, and Met-
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tRNAi) and streaked the transformants on SC-L+5-FOA medium to select for loss of the 
URA3-containing WT GCD11 plasmid.  Contrary to this prediction, however, 
overexpression of the TC containing the R503A or R504A substitutions in eIF2γ does not 
suppress the recessive lethality of strains harboring these mutations (Figure 2.31A).  
Furthermore, overexpression of these mutant complexes also does not confer any 
dominant growth defects, temperature sensitivity, or His+ phenotypes (Figure 2.32).   
Ternary complex binds rapidly to the 40S subunit only when the PIC is in the 
open conformation.  Thus, an increase in the proportion of the PIC in the open 
conformation is another means by which a reduction in the rate of eIF2 binding can be 
partially suppressed.  The open conformation is stabilized by the binding of the eIF1 and 
1A proteins63.  Consequently, the proportion of the PIC in the open conformation can be 
increased by overexpressing eIF1.  To test this possibility, we introduced a hc TRP1 SUI1 
plasmid into strains harboring the WT GCD11 on a URA3 plasmid and the mutant alleles 
on a sc LEU2 plasmid.  The transformants were then streaked on SC-L-W+FOA medium 
to select for the loss of URA3 GCD11 plasmid.  Again, contrary to this predication, 
overexpression of eIF1 does not suppress the recessive lethality of R503A and R504A 
mutants (Figure 2.31B).   
We also tested if the recessive lethality conferred by the substitutions at residues 
R503 and R504 is a result of unstable TC.  Overexpression of the Met-tRNAi can be 
expected to partially suppress defects resulting from decreased Met-tRNAi binding or an 
unstable TC.  So in order to examine if the overexpression of Met-tRNAi can suppress the 
recessive lethality conferred by these GCD11 alleles, we introduced a hc TRP1 IMT4 
plasmid into strains harboring the WT GCD11 on a sc URA3 plasmid and the mutant 
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alleles on a sc LEU2 plasmid.  The transformants were then streaked on SC-L-W+FOA 
medium to select for loss of the URA3-containing WT GCD11 plasmid.  Similar to 
overexpressing eIF1, overexpressing the IMT4 gene also does not suppress the recessive 
lethality of these mutations (Figure 2.31B).  This result does not support the possibility 
that the recessive lethality of R503A and R504A is due to reduced Met-tRNAi binding or 
TC stability.   
In contrast with R503A and R504A, overexpression of TC containing the E460K 
substitution in eIF2γ does improve the severe slow growth defect conferred by the E460K 
allele (Figure 2.33A).  Similarly to R503A and R504A, however, overexpressing SUI1 or 
IMT4 has no effect (Figure 2.33B).  Thus, in addition to G418C and R510H, E460A/K 
mutant alleles are interesting candidates for further analysis in vivo and in vitro (see 
Chapter 3). 
We next set out to determine if any of our site-directed GCD11 mutant alleles 
conferred an Ssu- phenotype.  To test for the Ssu- phenotype, we examined all the 
mutants created by site-directed mutagenesis for their ability to suppress the His+ 
phenotype of SUI3-2.  Derivatives of strain NAY13 (gcd11Δ, his4-301) harboring the 
various GCD11 mutant alleles and episomal SUI3-2 were streaked on -His medium to 
examine their ability to block translation initiation from the UUG codon of his4-301 and 
restore histidine auxotrophy.  As expected, E460A (which has a weak His+ phenotype on 
its own) exacerbates the His+ phenotype of SUI3-2 (Figure 2.34).  This is evident as 
while the double mutant strain harboring E460A and SUI3-2 displays a Slg- phenotype on 
the +His medium as compared with the strain harboring SUI3-2 and WT GCD11, the two 
strains display similar growth on the -His medium.  The I466A, E494A, and E497K 
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mutants are all slow growing in combination with SUI3-2 (Figure 2.34, compare the 
streaks on the +His medium on top).  In this initial screen S468A, K479A/E, R484A/E, 
E497K, and K498E conferred partial suppression of the His+ phenotype of SUI3-2 
without affecting its growth as apparent from their ability to restore histidine auxotrophy 
in cells harboring the SUI3-2 allele (Figure 2.34, compare the streaks on the -His 
medium).   
To further confirm the suppression of SUI3-2 His+ phenotype, strains harboring 
the S468A, K479A/E, R484A/E, E497K, and K498E mutant alleles and episomal SUI3-2 
were cultured in SC-L-W and ten-fold serial dilutions were spotted on SC-L-W medium 
supplemented with 0.3 mM (+His) or 0.00075 mM (-His) histidine.  Interestingly, these 
mutants display a range in their ability to suppress the His+ phenotype of SUI3-2, with 
K479E, R484A, and R484E fully suppressing, K479A and E497E partially suppressing, 
and S468A and K498E weakly suppressing the His+ phenotype (Figure 2.35A).  
To quantify the extent to which these mutants suppress initiation from the UUG 
codon of his4-301 in cells harboring SUI3-2, we used matched HIS4-lacZ reporters 
containing either a UUG or an AUG start codon and measured the ratio of their 
respective products (UUG/AUG ratio).  In WT cells, there is relatively low background 
level of initiation from a UUG codon, and hence the ratio of his4(UUG)-lacZ to 
HIS4(AUG)-lacZ expression is very low.  SUI3-2, however, reduces the stringency of 
start codon recognition and increases the translation of his4(UUG)-lacZ, which leads to 
~2.5-fold increase in the ratio of UUG to AUG initiation compared to the WT cells 
(Figure 2.35B).  The R484A and E497K mutants display a bona fide Ssu- phenotype, 
partially suppressing the elevated ratio of UUG to AUG initiation in cells expressing the 
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SUI3-2 allele by ~40%.  The K479E mutant also weakly suppresses this ratio by ~15% 
(Figure 2.35B). 
As discussed earlier, SUI3-2 confers a Gcd- phenotype, derepressing expression of 
the GCN4-lacZ reporter by ~2.8-fold (Figure 2.35C).  In order to determine if the above 
GCD11 mutants also suppress the Gcd- phenotype conferred by the SUI3-2 allele, 
expression of the GCN4-lacZ reporter was measured in strains harboring the various 
GCD11 mutants and episomal SUI3-2.  The mutant GCD11 alleles also display a range in 
their ability to suppress the Gcd- phenotype of SUI3-2, with K479A/E, R484A/E, and 
K498E partially suppressing, K479A failing to suppress, and S468A and E497K even 
slightly increasing the derepression of GCN4-lacZ conferred by the SUI3-2 allele (Figure 
2.35C). 
To examine how universal these GCD11 mutants were in suppressing the 
phenotypes of Sui- mutations in different initiation factors, strains harboring the 
K479A/E, R484A/E, E497A/K, and K498A/E alleles were transformed with episomal 
SUI5 and tif11-SE1*SE2*F131.  Interestingly, the GCD11 mutants show distinct 
phenotypic patterns when combined with these Sui- mutations.  Among them, only 
R484E fully suppresses whereas K479E, R484A, and K498E all partially suppress the 
His+ phenotype of SUI5 (Figure 2.36A).  They all also partially suppress both the Slg- 
and the Ts- phenotypes of the SUI5 allele with the R484A/E, K479E, and K498E mutants 
exhibiting the greatest suppression (Figure 2.36B).  Moreover, K479A/E, R484A/E, and 
K498E all partially suppress the Gcd- phenotype of SUI5 (Figure 2.36C).  Note that 
K479A, however, does not suppress the His+, Slg-, or Ts- of SUI5 (Figure 2.36A-B).  It is 
interesting to note that while the E497A mutant, which does not alter the His+, Slg-, or the 
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Ts- phenotypes of SUI5, does not derepress the expression GCN4-lacZ in otherwise WT 
cells (Figure 2.27), it further increases the Gcd- phenotype of SUI5 by 2.4-fold (Figure 
2.36C).  These observations suggest that the Slg-, His+ and the Gcd- phenotypes conferred 
by the SUI5 allele may have different underlying mechanisms.   
In contrast to their phenotypes when combined with SUI3-2 or SUI5, none of the 
site-directed GCD11 mutants, suppresses the His+ phenotype of the tif11-SE1*SE2*F131 
Sui- allele (Figure 2.37A, compare the first two lanes to the last eight lanes).  Moreover, 
among all the mutants, only E497A weakly suppresses its Slg- and Ts- phenotypes (Figure 
2.37B, compare the first two lanes to the last eight lanes).  Surprisingly, whereas the 
K479A/E, E497A/K, and K498A/E alleles have no effect, R484A and R484E mutations 
exacerbate the Gcd- phenotype conferred by tif11-SE1*SE2*F131, further derepressing 
the expression of GCN4-lacZ by over 2-fold (Figure 2.37C).  Again, note that these 
mutations do not derepress the expression of GCN4-lacZ (Gcd-) in otherwise WT cells 
(Figure 2.27).  This phenotype of R484A/E is similar to that of the M482I and N433D 
mutants that were isolated as suppressors of SUI5 recessive lethality (Figure 2.37C).   
Table 2.7 summarizes our genetic analyses of the Ssu- mutations we isolated by 
either selecting for the suppressors of SUI5 recessive lethality from a pool of randomly 
mutagenized GCD11 alleles or by site-directed mutagenesis of domain-III.  It is 
promising that the mutations in GCD11 exhibit different phenotypic patterns in 
combination with the various Sui- mutants.  Different Sui- alleles (SUI3-2, SUI5, and 
tif11-SE1*SE2*F131) have distinct underlying mechanisms.  Since our GCD11 mutants 
suppress the phenotypes of some Sui- mutations but not others, it suggests that they have 
a specific mechanism and correct for a specific defect. 
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2.4 Discussion 
 In eukaryotes, base pairing between the start codon of mRNA and the anticodon 
of Met-tRNAi signals the correct start position to the ribosome.  The eIF2 complex is a 
highly conserved initiation factor that binds and delivers the Met-tRNAi to the pre-
initiation complex.  Moreover, hydrolysis of eIF2-bound GTP and Pi release are required 
for translation initiation to proceed.  Considering these vital functions of the eIF2 
complex in start codon selection, we set out to examine this factor in more detail and 
identify its domains and residues that are involved in establishing the fidelity of this 
process.  To achieve this goal, we embarked on identifying new mutations in eIF2 that 
alter the accuracy of start codon recognition. 
 eIF2γ provides the core of the complex that binds GTP and Met-tRNAi as well as 
the α and β subunits.  Thus, we focused our studies on GCD11 and looked for mutations 
that altered functions by either lowering the stringency of start codon recognition (Sui- 
phenotype) or, in an opposite manner, restoring initiation fidelity to cells already 
harboring a Sui- mutant (Ssu- phenotype).  We generated libraries of randomly mutated 
GCD11 alleles in order to identify the structural elements that are involved in this process 
without any bias.  To isolate mutations with an Ssu- phenotype, we took advantage of the 
recessive lethality conferred by the SUI5 allele and from our libraries of random GCD11 
mutants isolated those that suppressed the inviability of cells harboring SUI5 as the sole 
source of eIF5 being expressed. 
Surprisingly, the majority of the mutant alleles we isolated encode substitutions in 
domain-III of the γ subunit.  Therefore, we decided to further examine domain-III by 
mutating its conserved surface-exposed residues and screening for an Ssu- phenotype.  
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Twenty four mutations were created by site-directed mutagenesis and screened for their 
ability to suppress the His+ phenotype of the SUI3-2 allele.  Multiple additional Ssu- 
mutations were identified in this way.   
Among the various GCD11 alleles we isolated by employing the two 
aforementioned strategies, the N433D, M482I, K479E, and R484A mutants restore the 
accuracy of start codon selection in vivo and display a bona fide Ssu- phenotype by 
partially suppressing the elevated ratio of UUG to AUG initiation in cells harboring the 
SUI3-2 allele.  Moreover, they all present a similar pattern in suppressing the His+ and 
Gcd- phenotypes conferred by SUI3-2 and SUI5 as well as the Slg- phenotype of SUI5.  
These findings suggest that the above GCD11 Ssu- mutations share a common underlying 
mechanism. 
Remarkably, residues N433, M482, K479, and R484 all cluster to a distinct area 
with their side chains exposed on the surface of domain-III (Figure 2.38A).  This 
observation suggests that this specific region of eIF2γ domain-III performs an important 
function in the process of start codon selection.  Domain-III has a nicely defined β-barrel 
structure and encompasses the C-terminal segment of eIF2γ.  The area that contains the 
above residues is distant from the interface of domain-III with the other two domains and 
is located on the opposite surface of γ that contains the binding sites for GTP and Met-
tRNAi (Figure 2.38A).  Although a crystal structure of eIF2 in complex with the 40S 
subunit is not currently available, using directed hydroxyl radical cleavage experiments, a 
model of eIF2 binding to the 40S subunit has been proposed127.  Interestingly, the 
surface-exposed area of domain-III that contains the above Ssu- mutations is positioned in 
close proximity of the proposed binding interface between eIF2 and the helix h44 of the 
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40S subunit (Figure 2.38B).  This raises the intriguing possibility that our Ssu- mutants 
restore initiation fidelity by altering the interactions between eIF2 and the 40S subunit so 
that the PIC would favor the open conformation, which would consequently allow for 
scanning to continue in order to locate the cognate start codon. 
Additional support for this proposal comes from the ability of the N433D and 
M484I Ssu- mutants to suppress the recessive lethality conferred by the SUI5 allele.  Even 
though the exact causes of SUI5 recessive lethality have not yet been experimentally 
identified, considering the functions of the eIF5 protein in the PIC assembly and 
translation initiation (see Section 1.1.2), the most likely underlying mechanism(s) may 
involve alterations in the structural rearrangement of the 43S PIC that occur upon start 
codon recognition.  Thus, it is possible that the isolated mutations in GCD11 suppress the 
recessive lethality of SUI5 by offsetting its detrimental structural rearrangements through 
adjusting the mode of eIF2 binding to the 40S subunit in the PIC.   
In order to isolate novel Sui- mutations in GCD11 that reduce the stringency of 
start codon recognition, we took advantage of the histidine auxotrophy phenotype 
conferred by the his4-301 allele.  In order to avoid isolating mutations that reduce 
initiation fidelity by merely increasing the rate of GTP hydrolysis, we only used the 
mutant GCD11 library that contains random mutations in domains –II and –III to select 
for alleles that conferred a His+ phenotype by allowing for initiation from the UUG codon 
of his4-301.  We isolated the G418C and R510H alleles by employing this scheme.  
R510H was already identified as a Gcd- mutant in a screen for spontaneous revertants of 
the Gcn- phenotype of gcn2-101 gcn3-101 double mutant222 and was later shown to also 
display Sui- and His+ phenotypes by elevating the ratio of UUG  to AUG initiation223.  
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This suggests that the selection procedure here worked well to isolate mutations with the 
desired phenotype.  
Residue R510 is located in domain-III of eIF2γ.  Because of the structural 
similarities between eIF2γ and EF-Tu (see section 1.2.1), it was proposed that R510H 
lowers the accuracy of start codon selection by reducing Met-tRNAi binding to the eIF2 
complex223.  More recently, however, it has been reported that despite having similar 
structures, eIF2γ and EF-Tu bind tRNA in different manners.  Whereas domain-III of EF-
Tu plays a big part in binding tRNA, eIF2γ domain-III it is not involved in Met-tRNAi 
binding113,127.  Yet, it is possible that R510H affects the Met-tRNAi binding indirectly 
through altering the structural arrangement of the switch-II region in the G-domain.  
Although the backbone of residue R510 is positioned on the surface of domain-III, its 
side chain is not surface-exposed and in fact extends inside the protein toward the G-
domain.  The side chain of R510 is ~2.6Å distant from the side chain of residue D198 in 
the switch-II region of the G-domain.  Thus, it is likely that R510 is involved in 
maintaining the structural stability of switch-II by forming a salt bridge with D198.  
Therefore, it is an attractive possibility that the R510H mutant reduces initiation fidelity 
by destabilizing the switch-II region of the G-domain, hence increasing the rate of GTP 
hydrolysis and/or Pi release.  It is also possible that by altering the structural arrangement 
of switch-II, R510H indirectly affects Met-tRNAi binding since, as discussed in Section 
1.2.1, the positions of the essential features of the G-domain (switch-I, switch-II, and P-
loop) have direct effects on GTP as well as Met-tRNAi binding. 
Residue G418 is well conserved and is located in the first β-strand of domain-III, 
which is projected inside the β-barrel structure of domain-II.  It is not surface-exposed 
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and is positioned distant from the proposed binding interface between eIF2 and the 40S 
subunit.  Therefore, it is unlikely that the phenotypes of the G418C mutant are a result of 
altered eIF2γ binding to a partner protein or to the 40S subunit.  Domain-II of eIF2γ has 
been implicated in binding the Met-tRNAi as well as the α subunit1,113,116,127,138.  Thus, it 
is possible that G418C affects these functions by altering the structure of domain-II, as a 
cysteine substitution introduces a side chain where none had existed. 
We also screened the GCD11 mutants created by site-directed mutagenesis for the 
Sui- phenotype.  Among the twenty four mutations created, the E460A allele confers a 
clear, yet weak, His+ phenotype.  Residue E460 is located on the surface of eIF2γ on the 
same face that binds GTP and Met-tRNAi.  It is positioned in close proximity of the 
proposed binding interface between eIF2 and the 40S subunit.  This raises the interesting 
possibility that E460A lowers the fidelity of start codon recognition by altering the 
binding of eIF2 to the 40s subunit so that the PIC would favor the closed conformation, 
which would consequently lead to initiation at non-AUG codons.  
Our observations suggest that the balance of charge on the surface of eIF2γ 
domain-III is of vital importance.  E460, R503, and R504 residues are all well conserved 
(Figure 2.23) and are positioned on the surface of eIF2γ that is proposed to be near the 
binding interface between the eIF2 complex and the 40S subunit (Figure 2.28B and 
Figure 2.29).  As described in detail in Chapter 1, the eIF2 complex binds and maintains 
the Met-tRNAi during the scanning process as the anticodon of Met-tRNAi samples the 
nucleotides on the mRNA in search of the AUG start codon.  Thus, the interactions of the 
Met-tRNAi with mRNA on the 40S subunit need to be very dynamic and transient to 
allow for the sampling of the codons and scanning to proceed.  Since it is the eIF2 
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complex that holds the Met-tRNAi during this process, binding of eIF2 (or at least the γ 
subunit that directly binds the Met-tRNAi) to the 40S subunit has to be transient and 
dynamic.  A delicate balance should be maintained: if eIF2 binds too weakly to the 40S 
subunit, it would fail to initiate even at AUG codons; conversely, if eIF2 binds too tightly 
to the 40S subunit during the scanning phase, it would stabilize the closed conformation 
and initiate at non-AUG codons.  Therefore, the binding interface between eIF2γ and the 
40S subunit should have residues with positive charge to allow for the electrostatic 
interactions with the negatively charged phosphodiester backbone of the 18S rRNA.  This 
might explain why mutating R504 to other residues is lethal.  Moreover, just enough 
positive charge would be required to allow for a dynamic interaction between eIF2 and 
the 40S subunit, which might explain why an increase in the net positive charge in the 
E460A mutant leads to the loss of initiation fidelity.  There are two positively charged 
residues R503 and R504 right next to each other, and while the positive side chain of 
R504 points toward the surface of eIF2γ (where it potentially interacts with the negatively 
charged backbone of helix h44), the side chain of R503 interacts with the negative side 
chain of E460.  When residue E640 is mutated to alanine, the positive charge of R503 is 
no longer neutralized.  This increases the net positive charge near the surface of eIF2γ 
where it is proposed to bind to the 40S subunit.  Thus, this may alter the way by which 
eIF2γ interacts with the 40S subunit, which then allows for a non-AUG initiation to take 
place.  Following the same logic, the E460K mutant is extremely sick because of the 
potential electrostatic repulsion with R503, which is likely to destabilize the entire 
complex.  This may explain why overexpressing the E460K mutant TC mitigates the 
extreme growth defect conferred by the E460K allele. 
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 By employing three different methods, we isolated two classes of novel mutations 
in GCD11: mutations that lower initiation fidelity allowing for translation initiation from 
a UUG codon, and those that restore the stringency of start codon selection blocking 
translation initiation from a UUG codon.  Both classes of mutations localize to domain-
III of eIF2γ.  This suggests that domain-III has a vital function in establishing the 
stringency of start codon recognition by maintaining the equilibrium between the open 
and closed conformations.  Considering the recent structural model that identifies 
domain-III as the binding interface between eIF2 and the 40S subunit127, our findings 
point to the intriguing possibility that the mode of eIF2γ binding to the PIC via its 
domain-III is a determining factor in maintaining the equilibrium between the two 
conformations of the PIC.  To examine this possibility, detailed examination of the 
GCD11 mutants that reduce initiation fidelity and those that restore initiation fidelity are 
presented in Chapters 3 and 4, respectively.    
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2.5 Figures and Tables 
Figure 2.1 Genetic reporter for monitoring the accuracy of translation initiation in 
vivo 
(A) his4-301 is a mutant allele of the HIS4 gene that lacks a cognate AUG start codon.  
Thus, in otherwise WT cells, strains harboring the his4-301 allele exhibit histidine 
auxotrophy.  (B) Sui- class of mutants lowers the accuracy of start codon recognition and 
allows for translation initiation from the third in-frame (UUG) codon of the his4-301 
mRNA.  Thus, his4-301 strains harboring a Sui- mutation display a His+ phenotype by 
their ability to grow on -His medium  (C) Ssu- alleles, however, reestablish the fidelity of 
start codon selection and block translation initiation from the UUG codon of his4-301.  
Thus, his4-301 strains harboring both a Sui- and an Ssu- mutation display histidine 
auxotrophy, as an Ssu- mutation suppresses the His+ phenotype conferred by a Sui- allele. 
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Figure 2.2 SUI5 displays dominant Sui- and recessive lethal phenotypes 
(A) Strains harboring the SUI5 allele exhibit a dominant Sui- phenotype.  Strain NAY17 
(his4-301, PGAL1-TIF5) was transformed with either a sc TRP1 SUI5 plasmid (p4281) or 
empty TRP1 vector (YCplac22).  Four independent transformants were patched on 
SCgal-U-W medium and incubated overnight at 30°C.  The colonies were then replica 
plated on the same medium (Gal +His) or the identical medium but lacking histidine (Gal 
-His).  Only colonies that contain SUI5 are able to initiate translation from the UUG 
codon of his4-301 and grow on the -His medium (even in the presence of WT eIF5 
expressed from PGAL1-TIF5).  Schematic on the right displays the features of NAY17 
relevant for this assay.  (B) SUI5 confers a recessive lethal phenotype.  Strain NAY25 
(PGAL1-TIF5, sc TRP1 SUI5) was transformed with either a sc plasmid harboring the WT 
TIF5 allele or vector alone.  Four independent transformants were patched on SCgal-U-
W medium and incubated overnight at 30°C.  The colonies were then replica plated on 
SC-U-W medium containing glucose as carbon source.  Only transformants that express 
WT eIF5 are able to grow on glucose medium (when the WT chromosomal copy of TIF5 
is transcriptionally shut off).  Schematic on the right displays the features of strain 




















Gal +His  
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Figure 2.3 Graphical illustration of the plasmid used for the generation of randomly 
mutated GCD11 alleles 
Two libraries of randomly mutated GCD11 alleles were created corresponding to 
overlapping regions of the GCD11 coding region.  The first library (L1) encompasses 
codons 1-306 of the G-domain and was generated using primers GCD11_L1.F1 and 
GCD11_L1.F2.  The second library (L2) encompasses codons 251 to 527, which encode 
the last 59 amino acids in the G-domain and the entirety of domains -II and –III, and was 
generated using primers GCD11_L2.F1 and GCD11_L2.R1.  LEU2 (variant) and 
Ampicillin alleles code for an essential protein in leucine biosynthesis pathway and 
ampicillin resistance enzyme, respectively, and are used as selection markers in yeast and 
E. coli, respectively. 
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Figure 2.4 Selection scheme for identification of mutations in GCD11 that suppress 
the recessive lethality of SUI5   
Pools of yeast strains containing the mutant alleles of GCD11 were first generated by 
transforming strain NAY25 (gcd11Δ, PGAL1-TIF5, sc TRP1 SUI5) with the L1 and L2 
libraries and growing the cells on SCgal-L-U-W medium (galactose as carbon source to 
allow for the expression PGAL1-TIF5).  The transformants were pooled, diluted, and 
spread on SC-L-U-W medium (glucose as carbon source to shut off the expression of 
PGAL1-TIF5) with 5-FOA (to select for the loss of URA3 GCD11 plasmid).  
Transformants that could survive and grow on the glucose medium were then selected 
and streaked on SCgal-L-W medium to isolate single colonies.  gcd11* denotes randomly 
mutated GCD11 alleles. 
  select for the loss of WT GCD11 plasmid,  
                       shut off WT TIF5 
           => select for suppression of lethality  
1. Transform with mutant library on LEU2 plasmid  














4. Plate the pool on SC–L –W+5-FOA  gcd11* 
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Figure 2.5 Novel mutations identified in GCD11 that suppress the recessive lethality 
of SUI5 
(A) Plasmids rescued from the initial selection process were reintroduced into NAY25 
(gcd11Δ, PGAL1-TIF5, sc TRP1 SUI5), six independent transformants for each plasmid 
were patched on SCgal-L-W medium, and incubated at 30°C overnight.  The colonies 
were then replica plated on SC-L-W medium (glucose as carbon source) and incubated at 
30°C for two (SCgal-L-W plates) and three (SC-L-W plates) days.  WT strains 
expressing the SUI5 allele as the sole source of the eIF5 protein are inviable (compare the 
rows corresponding to WT GCD11 on the SCgal-L-W medium to those on SC-L-W).  
Only strains harboring mutant alleles of GCD11 that can suppress the recessive lethality 
of SUI5 grow on SC-L-W medium, which contains glucose as carbon source.  Color-
coding designates substitutions in the same residues that were isolated from independent 
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mutant plasmids.  (B) The D481A, D481E, and L423M mutants of GCD11 suppress the 
recessive lethality of SUI5.  D481A, D481E, and L423M single substitutions were 
generated in plasmid pNA4 by site-directed mutagenesis using the QuickChange Site-
Directed Mutagenesis kit (Agilent Technologies) following the manufacturer’s protocol 
and primer sets g_D481A.F/g_D481A.R, g_D481E.F/g_D481E.R, and 






Figure 2.6 Suppression of SUI5 recessive lethality by the GCD11 mutants 
(A) Mutations in GCD11 display a range in ability to restore growth to cells harboring 
SUI5 as the sole source of eIF5.  Plasmids rescued from the initial selection process were 
reintroduced into strain NAY25 (gcd11Δ, PGAL1-TIF5, sc TRP1 SUI5), streaked on SC-L-
W medium (where the chromosomal copy of TIF5 is shut off), and incubated at 30°C for 
five days to examine the size of individual colonies formed from single cells.  WT strain 
expressing the SUI5 allele as the sole source of the eIF5 protein is inviable.  Only strains 
harboring mutant alleles of GCD11 that can suppress the recessive lethality of SUI5 grow 
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Figure 2.7 Suppression of SUI5 His+ phenotype by the GCD11 mutants 
The GCD11 alleles harbored by plasmids A6a, A8b, B2d, B6a, C1c, C3a, and D1a all 
suppress the dominant Slg- phenotype of SUI5 (compare rows on the +His medium).  
Whereas the GCD11 alleles in plasmids A6a, A8b, B2d, B6a, and D1a fully suppress and 
that in C1c very weakly suppresses the His+ phenotype of SUI5, the mutant allele 
harbored by plasmid C3a does not do so.  Derivatives of strain NAY13 (gcd11Δ, his4-
301) harboring the WT or mutant GCD11 alleles and either expressing SUI5 from a sc 
TRP1 plasmid (p4281) or the empty vector (YCplac22) were cultured in liquid SC-L-W 
medium, ten-fold serial dilutions were spotted on SC-L-W supplemented with either 0.3 
mM (+His) or 0.003 mM (-His) histidine, and incubated at 30°C for two and five days, 
respectively.  Note that in this strain WT eIF5 is expressed in single copy from its 
endogenous chromosomal locus and is not overexpressed from the GAL1 promoter. 
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Figure 2.8 Suppression of SUI3-2 His+ phenotype by the GCD11 mutants 
Whereas the GCD11 alleles harbored by plasmids A8b, B2d, B6a, and D1a fully suppress 
and those in plasmids A6a and C1c weakly suppress the His+ phenotype of SUI3-2, the 
mutant allele harbored by plasmid C3a does not do so.  Derivatives of strain NAY13 
(gcd11Δ, his4-301) harboring the WT or mutant GCD11 alleles and expressing either 
SUI3-2 from a sc TRP1 plasmid (p4280) or the empty vector (YCplac22) were cultured in 
liquid SC-L-W, ten-fold serial dilutions were spotted on SC-L-W medium supplemented 
with either 0.3 mM (+His) or 0.0015 mM (-His) histidine, and incubated at 30°C for two 
and five days, respectively.   
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Figure 2.9 Isolated mutations in GCD11 restore initiation fidelity in cells harboring 
the SUI3-2 mutation 
(A) Expression of the his4-301-myc10  or HIS4-myc10 alleles is used as a genetic reporter 
to quantify the extent of UUG initiation.  Sui- mutations reduce fidelity and increase the 
ratio of initiation from a UUG codon to that from an AUG codon (UUG/AUG ratio).  
Ssu- mutations, conversely, restore initiation fidelity and suppress the elevated UUG to 
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expression of his4-301-myc10 relative to His4-myc10 in cells expressing SUI3-2.  Ratio of 
initiation from a UUG codon to that of an AUG codon was assayed by measuring 
expression levels of the his4-301-myc (UUG) and His4-myc10 (AUG) proteins.  Strains 
with the WT or indicated GCD11 mutant allele harboring episomal SUI3-2 (p4280) or an 
empty TRP1 vector (Ycplac22) and chromosomal his4-301-myc10 (top) or HIS4-myc10 
(bottom) were grown to mid exponential phase (OD600 ~0.5) in SC-L-W medium, and 
WCEs were subjected to Western blot analysis with antibodies against the Myc-epitope 
(Sigma) and eIF2Bε/Gcd6 (loading control).  Two different amounts of each extract 
differing by a factor of 2 were loaded in successive lanes.  (C) Western signals from 
repeat experiments (n=4) of panel A were quantified, and the mean ratios of his4-301-
myc10 to His4-myc10 (each normalized to the loading control) and standard errors of the 




Figure 2.10 Suppression of SUI5 and SUI3-2 Gcd- phenotypes by the GCD11 
mutants 
(A) GCN4-lacZ expression is used as a genetic reporter for the stability and binding of 
the ternary complex to the PIC.  GCN4 mRNA is translated at low basal levels under 
normal conditions (top).  Amino acid starvation leads to the induction of GCN4 
translation (bottom right).  A reduction in TC stability or binding, however, increases the 
translation of GCN4 mRNA even under non-starvation conditions, creating a Gcd- 
phenotype (bottom left).  (B) The Ssu- mutations in GCD11 suppress the Gcd- phenotype 
of SUI3-2.  Expression of GCN4-lacZ, with all four upstream ORFs, on a single copy 
plasmid (p180) was measured in derivatives of strain NAY13 harboring the WT or 
mutant alleles of GCD11 in the presence of episomal SUI3-2 (p4280) or an empty TRP1 
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galactopyranoside cleaved per minute per microgram of protein) were measured in WCEs 
of exponentially growing cultures (OD600 ~0.5) in SC-L-W medium.  Mean of at least 
eight independent transformants and SEM (error bars) are plotted for each mutant.  
Double mutant alleles of GCD11 harboring substitutions at positions 482 and 431 
(M42I/E431K) as well as 482 and 433 (M482I/N433D) were generated in pNA4 using 
the QuickChange Site-Directed Mutagenesis kit (Agilent Technologies) following the 
manufacturer’s protocol.  (C) The isolated mutants of GCD11 that suppress the recessive 
lethality of SUI5, also suppress its Gcd- phonotype.  Expression of GCN4-lacZ, with all 
four upstream ORFs, on a single copy plasmid (p180) was measured in derivatives of 
strain NAY25 harboring the WT or mutant alleles of GCD11 in SCgal-L-W medium (to 
allow for the expression of PGAL1-TIF5).  β-galactosidase assays were performed as in 
panel B.  Mean of at least eight independent transformants and SEM (error bars) are 
plotted for each mutant. 
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Figure 2.11 The Ssu- mutants of GCD11 display a weak Gcn- phenotype 
(A) Isolated Ssu- mutations in GCD11 do not create a Gcd- phenotype.  Expression of 
GCN4-lacZ, with all four upstream ORFs, on a single copy plasmid (p180) was measured 
in derivatives of NAY13 harboring the WT or mutant alleles of GCD11 cultured in SC-L-
U medium.  β-galactosidase activities (nanomoles of o-nitrophenyl-β-D-
galactopyranoside cleaved per minute per microgram of protein) were measured in WCEs 
of exponentially growing cultures (OD600 ~0.5).  Mean of at least twelve independent 
transformants and SEM (error bars) are plotted for each mutant.  (B) The Ssu- mutations 
of GCD11 create a weak Gcn- phenotype.  Same strains and procedure as in panel B 
except starvation was induced by the addition of 0.5mg/ml of sulfometuron (SM) for six 
hours in SC-L-U medium.  Mean of at least eight independent transformants and SEM 
(error bars) are plotted for each mutant.  A student t-test was used to determine 
significance (*p<0.05, **p<0.01).  Note that GCN4-lacZ expression is ~9-fold higher in 
























































Figure 2.12 The Ssu- mutants of GCD11 exhibit a modest leaky scanning phenotype 
(A) A construct with an elongated upstream ORF1 (el-uORF1) in-frame with and 
covering the AUG start codon of GCN4-lacZ is used as a genetic reporter for leaky 
scanning.  In WT cells, there is low basal translation of GCN4-lacZ fusion since most 
ribosomes translate from the AUG codon of el-uORF1 (left panel).  In mutants that have 
reduced AUG recognition, a greater proportion of ribosomes bypass the AUG codon of 
el-uORF1 and instead initiate downstream at GCN4-lacZ (leaky scanning).  Thus, 
translation of GCN4-lacZ mRNA increases in a mutant with a leaky scanning phenotype 
(right panel)  (B) The Ssu- mutants of GCD11 display a modest decrease in AUG 
recognition (weak leaky scanning).  Expression of GCN4-lacZ was measured in 
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galactosidase activities (nanomoles of o-nitrophenyl-β-D-galactopyranoside cleaved per 
minute per microgram of protein) were measured in WCEs of exponentially growing 
cultures (OD600 ~0.5) in SC-L-U medium.  Mean of at least eight independent 
transformants and SEM (error bars) are plotted for each mutant.  A student t-test was 






Figure 2.13 Growth phenotypes and protein levels of the Ssu- substitutions in eIF2γ  
(A) The GCD11 Ssu- mutants do not display Slg- or TS- phenotypes.  Derivatives of 
NAY13 harboring the WT or mutant alleles of GCD11 were cultured in SC-L, ten-fold 
serial dilutions were spotted on SC-L medium, and incubated at the specified 
temperatures for two (30°C and 37°C) and four days (18°C).  (B) The isolated 
substitutions in eIF2γ do not alter the expression level of their respective proteins.  
Western blot analysis of WCEs, prepared by TCA extraction, from exponentially 
growing (OD600 of ~0.5) strains of panel A were performed with antibodies again the 
His6 epitope (abcam) and eIF2Bε/Gcd6 (loading control).  Two different amounts of each 
extract differing by a factor of 2 were loaded in successive lanes.  
A6a: M482K  
A8b: F297S D481E  
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Figure 2.14 The isolated Ssu- substitutions in eIF2γ  localize to a discrete region on 
the surface of domain-III close to h44 of the 40S subunit 
(A) Three different views of a surface representation of aIF2 crystal structure containing 
the full β and γ but only domain-III of the α subunit (PDB 2QMU).  The identified Ssu- 
mutations cluster to a distinct region on the surface of eIF2γ on the opposite surface that 
harbors the binding sites for GTP and Met-tRNAi.  The side chain of the residues 
harboring the Ssu- substitutions are exposed on the surface of eIF2γ  (B) Two views of a 
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are located on the surface of domain-III in proximity of h44 of the 40S subunit.  Images 
were created using the PyMOL software207.  
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Figure 2.15 Outline of the selection scheme for isolation of Sui- mutations in GCD11 
Strain NAY13 (gcd11Δ, his4-301, sc URA3 GCD11) was transformed with the L2 library 
containing randomly mutated GCD11 alleles corresponding to domains -II and -III.  
530,000 transformants were pooled, diluted, and spread on SC-L medium containing 5-
FOA to select for loss of the WT GCD11 URA3 plasmid.  250 million colonies were then 
pooled, diluted, and spread on SC-L medium containing 0.015 mM, 0.006 mM, and 0 
mM histidine to select for GCD11 mutant plasmids that allow translation initiation from a 
non-AUG codon of the his4-301 allele and suppress the histidine auxotrophy of NAY13.  
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Figure 2.16 The G418C and R510H mutants display a His+/Sui- phenotype 
The G418C allele confers a stronger His+ phenotype compared to R510H in strains 
deleted for the chromosomal copy of GCD11 and harboring the his4-301 allele.  
Additionally, strains expressing G418C displays a marked Slg- phenotype (compare rows 
on the +His medium).  Derivatives of strain NAY13 (gcd11Δ, his4-301) harboring the 
WT or indicated mutant alleles of GCD11 were cultured in SC-L, ten-fold serial dilutions 
were then spotted on SC-L medium supplemented with 0.3 mM (+His) or 0.003 mM (-
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Figure 2.17 R510 is a highly conserved residue in domain-III of eIF2γ   
The region surrounding residue R510, which contains the sequence motif 
W509R510L511I512G513 encompassing the last β-strand of domain-III, is highly conserved 
among eukaryotes and archaea.  39 Uniprot-reviewed eukaryotic and archaeal e/aIF2γ 
sequences were aligned using the Geneious software226.  Only part of the alignment 
corresponding to the segment of domain-III containing residue R510 is shown.  
Species/sequence names are standard Uniprot identifiers227. 






Figure 2.18 R510 is located on the surface of eIF2γ  at the interphase of domain-III 
and the G-domain 
(A) Front view of a surface representation of aIF2 crystal structure (PDB 2QMU).  The 
main chain of R510 is partially surface-exposed on the same face of eIF2γ that binds GTP 
and Met-tRNAi.  (B) A cartoon view of panel A with residue R510 marked (top).  A 
magnified view of the area surrounding R510 is shown at the bottom.  R510 is located in 
the last β-strand of the β-barrel structure of domain-III at the interphase with the G-
domain.  Side chain of R510 is 2.6Å from D198 in the switch-II region of the G-domain.  
(C) R510 is also in proximity of the proposed binding interface between eIF2 and the 40S 
subunit.  Its side chain, however, does not project outward from the surface.  Instead, it 
extends inside toward the side chain of D198 in the G-domain, as shown panel B.  Model 
of TC binding to the 40S subunit is adapted Shin et al. 2011127.  Images were created 
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Figure 2.19 G418 is a highly conserved residue in domain-III of eIF2γ  
40 Uniprot-reviewed eukaryotic and archaeal e/aIF2γ sequences were aligned using the 
Geneious software226.  Only part of the alignment corresponding to the segment of 
domain-III containing residue G418 is shown.  Other substitutions created (by site-
directed mutagenesis) in the neighboring residues of G418 in the β1 of domain-III are 







Figure 2.20 G418 is located in the first β-strand of eIF2γ  domain-III  
(A) Front view of a cartoon representation of aIF2 (PDB 2QMU) (top panel).  Bottom 
panels are magnified views of the area surrounding G418.  G418 is in the β1 of domain-
III, which is inserted between β1 and β3 of the β-barrel structure of domain-II (bottom 
left).  G418 is not surface-exposed (bottom right)  (B) Among the substitutions of 
residues in the β1 of domain-III, only G418C displays a His+ phenotype.  Images were 
























Figure 2.21 The G418C mutant is slow growing, cold sensitive, and displays a strong 
His+ phenotype 
(A) The G418C allele confers marked Slg- and cold sensitivity phenotypes.  Substitutions 
in residues Q415, V416, and V417, which are all located in β1 of domain-III along with 
G418, do not create any growth defects, TS-, or His+ phenotypes.  Derivatives of strain 
NAY13 harboring the WT or indicated GCD11 mutant alleles were cultured in SC-L, ten-
fold serial dilutions were spotted on SC-L medium, and incubated at the specified 
temperatures for two (30°C and 37°C) and four (18°C) days.  Two independent 
transformants of each mutant were spotted.  (B) The G418C allele confers a strong His+ 
phenotype.  Same strains and growth conditions as in panel A, except that ten-fold serial 
dilutions were spotted on SC-L medium supplemented with 0.3 mM (+His) or 0.0006 
mM (-His) histidine and incubated at 30°C for two and three days, respectively.  Two 
independent transformants of each mutant were spotted. 


























Figure 2.22 G418 is positioned distant from the proposed interface of eIF2 with the 
40S subunit 
(A) Model of TC binding to the 40S subunit adapted from Shin et al. 2011127.  (B) A 
magnified view of panel A.  Domain-II of eIF2γ has been implicated in binding the Met-
tRNAi as well as the α subunit.  G418 residue is in β1 of domain-III that is inserted inside 
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Figure 2.23 Multiple sequence alignment of eIF2γ  domain-III displaying the 
conserved surface-exposed residues selected for site-directed mutagenesis 
Conserved surface-exposed residues in domain-III were selected for site-directed 
mutagenesis.  The residues were mutated to alanine and, when appropriate, to the residue 
of the opposite charge.  39 Uniprot-reviewed eukaryotic and archaeal e/aIF2γ sequences 











Figure 2.24 Positions of the eIF2γ  residues selected for site-directed mutagenesis on 
the crystal structure of aIF2 
Four different views displaying a surface representation of aIF2 (PDB 2QMU).  eIF2γ 
residues selected for site-directed mutagenesis are marked.  Images were created using 







































Figure 2.25 Growth phenotypes and protein levels of GCD11 mutations created by 
site-directed mutagenesis
(A) Among all the mutations created, only E460A displays a TS- phenotype.  Derivatives 
of strain NAY13 harboring the WT or mutant alleles of GCD11 were cultured in SC-L 
medium, ten-fold serial dilutions were spotted on SC-L medium, and incubated at the 
specified temperatures for two (30°C and 37°C) and four (18°C) days.  (B) Mutations do 
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exponentially growing cultures (OD600 of ~0.5), prepared by TCA extraction, was 
performed with antibodies against the His6 epitope (abcam) and eIF2Bε/Gcd6 (loading 
control).  Same strains and growth conditions as in panel A.  Two different amounts of 
each extract differing by a factor of 2 were loaded in successive lanes.  (C) The E460A 
mutant variant of eIF2γ is stable at 37°C.  Derivatives of NAY13 harboring the WT or 
E460A mutant allele of GCD11 were cultured in SC-L medium either at 30°C or at 37°C 
for 4.4 generations.  Western blot analysis was performed as in panel B. 
  
 104 
Figure 2.26 Spot assays for His+ phenotype of site-directed domain-III mutants  
Among all the point mutations generated, E460A displays a weak His+ phenotype.  
Strains (same as in Figure 2.25) were cultured in SC-L medium, ten-fold serial dilutions 
were spotted on SC-L medium supplemented with 0.3 mM (+His) or 0.003 mM (-His) 






























Figure 2.27 The E460A allele confers a Gcd- phenotype 
GCN4-lacZ expression is used as a genetic reporter for the stability and binding of the 
ternary complex to the PIC.  GCN4-lacZ mRNA is translated at low basal levels under 
nutrient-replete (high TC concentration) conditions.  Amino acid starvation, however,
leads to the induction of GCN4-lacZ translation.  A reduction in TC stability or binding 
increases the translation of GCN4-lacZ mRNA even under non-starvation conditions, 
creating a Gcd- phenotype (schematic on top).  Among the mutations generated by site-
directed mutagenesis, only E460A creates a Gcd- phenotype, increasing the translation of 
GCN4-lacZ mRNA by ~7-fold in nutrient-replete conditions.  Expression of GCN4-lacZ, 
with all four upstream ORFs, on a sc plasmid (p180) was measured in the derivatives of 
strain NAY13 harboring the WT or mutant alleles of GCD11.  β-galactosidase activities 
(nanomoles of o-nitrophenyl-β-D-galactopyranoside cleaved per minute per microgram 
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SC-L-U medium.  Mean of at least four independent transformants and SD (error bars) 
















Figure 2.28 E460 is located on the surface of domain-III in proximity of the 
interface between eIF2 the 40S subunit 
(A) Front view of a surface (left) and cartoon (right) models of aIF2 (PDB 2QMU).  
E460 resides in the β-barrel structure of domain-III and is surface-exposed.  (B) Two 
views of the model of eIF2 binding to the 40S subunit.  E460 residue is in the proximity 
of the proposed interface between eIF2 and h44 of the 40S subunit.  Position of the side 
chain of E460 is marked in the right panel.  Model of TC binding to the 40S subunit is 


















Figure 2.29 E460 side chain interacts with the side chain of R503
(A) Front view of a surface representation of aIF2 (PDB 2QMU).  R503 and R504 
residues cluster with E460 on the surface of domain-III.  (B) A magnified view of panel 
A showing the relative positions of the three residues.  Side chain of R504 projects 
outward from the surface  (C) E460 side chain is positioned 2.9Å from the side chain of 



















Figure 2.30 E460A/K, R503A/E, and R504A/E do not display dominant growth 
defects, Gcd-, or His+ phenotypes. 
(A) The E460A/K, R503A/K, and R503A/K mutants do not display dominant Slg- or TS- 
phenotypes.  Derivatives of strains NAY13 harboring a sc TRP1 GCD11 plasmid 
(pNA18) and either the WT or indicated GCD11 mutant alleles on sc LEU2 vectors were 
cultured in SC-L-U, ten-fold serial dilutions were spotted on SC-L-U medium, and 
incubated at the specified temperatures for two (30°C and 37°C) and four (18°C) days.  
(B) E460K, R503A/K, and R504A/K proteins are expressed at similar levels compared to 
the WT eIF2γ protein.  Western blot analysis of WCEs (prepared by TCA extraction) 
from exponentially growing cells (OD600 of ~0.5) cultured in SC-L-U was performed 
with antibodies again His6 epitope (abcam) and eIF2Bε/GCD6 (loading control).  Same 
strains as in panel A.  Two different amounts of each extract differing by a factor of 2 
were loaded in successive lanes.  Only the mutant GCD11 alleles (on sc LEU2 plasmids) 
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are His8-tagged; thus, only expression of the mutant proteins are depicted.  (C) E460A/K, 
R503A/K, and R503A/K do not display a dominant His+ phenotype.  Same strains and 
growth conditions as in panel A except that ten-fold serial dilutions were spotted on SC-
L-U medium supplemented with either 0.3 mM (+His) or 0.003 mM (-His) histidine and 
incubated at 30°C for two and five days, respectively.  (D) The E460A/K, R503A/K, and 
R503A/K mutants do not display a dominant Gcd- phenotype.  Expression of GCN4-lacZ, 
with all four upstream ORFs, on a sc plasmid (p180) was measured in strains depicted in 
panel A.  β-galactosidase activities (nanomoles of o-nitrophenyl-β-D-galactopyranoside 
cleaved per minute per microgram of protein) were measured in WCEs of exponentially 
growing cultures (OD600 ~0.5) in SC-L-U-W.  Mean of at least four independent 





Figure 2.31 Overexpression of eIF1, Met-tRNAi, or TC containing the R503A or 
R504A mutant variants of eIF2γ  do not suppress the recessive lethality conferred by 
the R503A or R504A alleles 
(A) Overexpression of TC containing the eIF2γ-R503A or eIF2γ-R504A mutant proteins 
does not suppress the recessive lethality of strains harboring the R503A and R504 alleles.  
Strain NAY13 (gcd11Δ, sc URA3 GCD11) was transformed with either a sc LEU2 
plasmid expressing the WT, R403A, or R504A mutant alleles of GCD11 (pNA4, pNA4-
R503A, and pNA4-R504A, respectively) or with a hc LEU2 plasmid co-expressing the 
components of the TC (SUI2, SUI3, IMT4, and GCD11, gcd11-R503A or gcd11-R504A) 
(pNA21, pNA24, and pNA25, respectively).  Transformants were streaked on SC-L 
medium with 5-FOA, to select for loss of the URA3-containing WT GCD11 plasmid, and 
incubated at 30°C for four days.  (B) Overexpression of SUI1 or IMT4 does not suppress 
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the recessive lethality conferred by the R503A and R504A alleles.  Derivatives of strain 
NAY13 harboring the WT or mutant R503A or R504 alleles were transformed with hc 
TRP1 SUI1 (pNA19), hc TRP1 IMT4 (pNA20), or empty hc vector (YEplac122).  
Transformants were streaked on SC-L-W medium with 5-FOA, to select for loss of the 




Figure 2.32 Overexpression of TC containing the R503A or R504A mutant variants 
of eIF2γ does not create growth defects or a His+ phenotype
(A) Overexpression of TC containing the eIF2γ-R503A or eIF2γ-R504A mutant proteins 
does not create growth defects.  NAY13 (gcd11Δ, his4-301, sc URA3 GCD11) either with 
a sc LEU2 plasmid harboring the WT, R503A, or R504A mutant alleles of GCD11 
(pNA4, pNA4-R503A, and pNA4-R504A, respectively) or with a hc LEU2 vector co-
expressing components of the TC (SUI2, SUI3, IMT4, and GCD11, gcd11-R503A or 
gcd11-R504A) (pNA21, pNA24, and pNA25, respectively) was cultured in SC-L-U 
medium, ten-fold serial dilutions were spotted on SC-L-U plates, and incubated at the 
specified temperatures for two (30°C and 37°C) and four days (18°C).  (B) 
Overexpression of TC containing the eIF2γ-R503A or eIF2γ-R504A mutant proteins also 
does not create a His+ phenotype.  Same strains and procedures as in panel A except that 
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Figure 2.33 Overexpression of TC containing the E460K substituion in eIF2γ  
rescues the severe growth defect conferred by the E460K allele 
(A) Cells harboring the E460K mutant allele of GCD11 are extremely slow growing.  
Overexpression of the TC containing the eIF2γ-E460K mutant protein, however, partially 
rescues this growth defect.  Strain NAY13 harboring a sc URA3 GCD11 plasmid was 
transformed with either a sc LEU2 vector expressing the WT or E460K mutant allele or 
with a hc LEU2 vector co-expressing the components of the TC (SUI2, SUI3, IMT4, and 
GCD11 or gcd11-E460K).  Transformants were streaked on SC-L medium supplemented 
with 5-FOA to select for the loss of URA3-contaning WT GCD11 plasmid.  (B) 
Overexpression of SUI1 or IMT4 does not suppress the extreme growth defect conferred 
by the E460K allele.  Strain NAY13 harboring a sc URA3 GCD11 plasmid was 
transformed with a sc LEU2 plasmid harboring the E460K allele and a hc TRP1 SUI1
(pNA19), TRP1 IMT4 (pNA20), or empty vector (YEplac122).  Transformants were then 
streaked on SC-L medium with 5-FOA to select for loss of the URA3-contaning WT 
GCD11 plasmid. 
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Figure 2.34 Suppression of SUI3-2 His+ phenotype by site-directed mutations in 
GCD11 
Double mutant strains harboring the E460A, I466A, E494A, and E497K mutant GCD11 
alleles and SUI3-2 are slow growing.  E460A enhances the His+ phenotype of SUI3-2.  
S468A, K479A/E, R484A/E, E497K, and K498E partially suppress the His+ phenotype of 
SUI3-2.  Derivatives of strain NAY13 expressing the WT or indicated GCD11 mutant 
alleles and harboring a sc TRP1 SUI3-2 plasmid (p4280) were streaked on SC-L-W 
medium supplemented with either 0.3 mM (+His) or 0.0015 mM (-His) histidine and 





















































































Figure 2.35 Suppression of SUI3-2 His+, Sui-, and Gcd- phenotypes by the GCD11 
mutants created by site-directed mutagenesis 
(A) The mutant alleles of GCD11, generated by site-directed mutagenesis, display a 
range in suppressing the His+ phenotype of SUI3-2, with K479E, R484A, and R484E fully 
suppressing, K479A and E497E partially suppressing, and S468A and K498E weakly 
suppressing the His+ phenotype.  Derivatives of NAY13 (gcd11Δ, his4-301) harboring 
the WT or indicated GCD11 alleles with a sc TRP1 SUI3-2 plasmid (p4280) were 
cultured in SC-L-W, ten-fold serial dilutions were spotted on SC-L-W medium 
supplemented with either 0.3 mM (+His) or 0.00075 mM (-His) histidine, and incubated 
at 30°C for two and five days, respectively.  (B) R484A and E497K partially suppress the 
elevated ratio of initiation from a UUG codon to that from an AUG codon in cells 
expressing the SUI3-2 allele.  UUG/AUG ratio was calculated by measuring the β-
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UUG codon.  β-galactosidase activities (nanomoles of o-nitrophenyl-β-D-
galactopyranoside cleaved per minute per microgram of protein) were measured in WCEs 
of exponentially growing cultures (OD600 ~0.5) in SC-L medium.  Mean of at least eight 
independent transformants and SEM (error bars) are plotted for each mutant.  The 
schematics of the reporters used are presented on the right.  (C) K479A/E, R484A/E, and 
K498E partially suppress and K479A does not alter whereas S468A and E497K slightly 
increase the Gcd- phenotype conferred by the SUI3-2 allele.  Expression of GCN4-lacZ, 
with all four upstream ORFs, on a sc plasmid (p180) was measured in cells harboring the 
WT or the mutant alleles of GCD11 in the presence of episomal SUI3-2.  β-galactosidase 
activities (nanomoles of o-nitrophenyl-β-D-galactopyranoside cleaved per minute per 
microgram of protein) were measured in the WCEs of exponentially growing cultures 
(OD600 ~0.5) in SC-L-W medium.  Mean of at least eight independent transformants and 
SEM (error bars) are plotted for each mutant.  A student t-test was performed to 
determine significance (*p<0.05, **p<0.01). 
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Figure 2.36 Suppression of SUI5 Slg-, His+, and Gcd- phenotypes by the GCD11 
mutants created by site-directed mutagenesis 
(A) K479E, R484A, R484E, and K498E partially suppress the His+ phenotype of SUI5.  
Derivatives of NAY13 (gcd11Δ, his4-301) harboring the WT or indicated GCD11 alleles 
with a sc TRP1 SUI5 plasmid (p4281) were cultured in SC-L-W, ten-fold serial dilutions 
were spotted on SC-L-W medium supplemented with either 0.3 mM (+His) or 0.00075 
mM (-His) histidine, and incubated at 30°C for two and five days, respectively.  (B) 
R484A and R484E partially suppress the Slg- and TS- phenotypes of SUI5.  Same strains 
and growth conditions as in panel A, except that ten-fold serial dilutions were spotted on 
SC-L-W medium and incubated at the specified temperatures for two (30°C and 37C) and 
four (18°C) days.  (C) Whereas the K479E, R484A, R484E, and K498E mutants suppress 
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mutants do not alter the derepression of GCN4-lacZ in cells harboring the SUI5 allele.  
Expression of GCN4-lacZ, with all four upstream ORFs, on a sc plasmid (p180) was 
measured in cells harboring the WT or mutant alleles of GCD11 in the presence of 
episomal SUI5.  β-galactosidase activities (nanomoles of o-nitrophenyl-β-D-
galactopyranoside cleaved per minute per microgram of protein) were measured in the 
WCEs of exponentially growing cultures (OD600 ~0.5) in SC-L-W medium.  Mean of at 
least eight independent transformants and SEM (error bars) are plotted for each mutant.  






Figure 2.37 Suppression of tif11-SE1*SE2*F131 Slg-, His+, and Gcd- phenotypes by 
the GCD11 mutants 
(A) The GCD11 mutants do not alter the His+ phenotype of tif11-SE1*SE2*F131.  
Derivatives of strain NAY74 (gcd11Δ, his4-301, PGAL1-TIF11) harboring the WT or 
indicated mutant GCD11 alleles with either a sc tif11-SE1*SE2*F131 TRP1 plasmid 
(pAS5-130) or a WT TIF11 TRP1 plasmid (pAS5-148) were cultured in SC-L-W, ten-
fold serial dilutions were spotted on SC-L-W medium supplemented with either 0.3 mM 
(+His) or 0.0015 mM (-His) histidine, and incubated at 30°C for two and six days, 
respectively.  The M482I/E431K and M482I/N433D alleles were created by site-directed 
mutagenesis as described in Figure 2.10.  (B) E431K and E497A partially suppress the 
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Sui- mutation whereas K498E exacerbates the Slg-.  Same strains and conditions as in 
panel A, except that ten-fold serial dilutions were spotted on SC-L-W medium, and 
incubated at the specified temperatures for two (30°C and 37°C) and four (18°C) days.  
(C) M482I, N433D, R484A, and R484E increase the Gcd- phenotype of tif11-
SE1*SE2*F131 by over 2-fold.  Expression of GCN4-lacZ, with all four upstream ORFs, 
on a sc plasmid (p180) was measured in the same strains as in panel A.  β-galactosidase 
activities (nanomoles of o-nitrophenyl-β-D-galactopyranoside cleaved per minute per 
microgram of protein) were measured in the WCEs of exponentially growing cultures 
(OD600 ~0.5) in SC-L-U-W medium.  Mean of at least eight independent transformants 





Figure 2.38 The Ssu- substitutions in eIF2γ  localize to a discrete region on the 
surface of domain-III 
(A) Three different views of a surface representation of aIF2 (PDB 2QMU).  Bona fide 
Ssu- mutations, which were isolated from a pool of randomly mutated GCD11 alleles or 
site-directed mutagenesis and suppress the His+, Sui-, and Gcd- phenotypes of SUI3-2, 
cluster to a distinct area in domain-III of eIF2γ with their side chains extending toward 
the surface.  (B) The Ssu- mutations of GCD11, isolated from a library of randomly 
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proximity of the proposed interface between eIF2 and h44 of the 40S subunit.  Model of 
TC binding to the 40S subunit adapted from Shin et al. 2011127.  Images were created 
using the PyMOL software207.  
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Table 2.1 List of S. cerevisiae Strains 
 
Strain Genotype Source 
EY647 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG  Ep293<GCD11 URA3 CEN4/ARS1> 
223 
JCY04 MATa ura3-52 leu2-3 leu2-112 trp1∆-63 his4-301(ACG)-myc10::KanMX sui1∆::hisG  p1200<sc URA3 SUI1> 
228 
H4 Mata leu2-3 leu2-112 ura3-52 A. Hinnebusch 
NAY7 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG  Ep517<GCD11 LEU2 CEN/ARS> This Study 
NAY11 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG ∆trp1::hisG Ep517<GCD11 LEU2 CEN/ARS> This Study 
NAY13 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG Ep293<GCD11 URA3 CEN4/ARS1> This Study 
NAY17 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG kanMX6-pGAL1-TIF5 Ep293<GCD11 URA3 CEN4/ARS1> This Study 
NAY25 
Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG 
kanMX6-pGAL1-TIF5 Ep293<GCD11 URA3 CEN4/ARS1>  p4281<TIF5-
G31R TRP1 CEN> 
This Study 
NAY41 
Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG 




Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG 
kanMX6-pGAL1-TIF5 Ep293<GCD11 URA3 CEN4/ARS1> p4280<SUI3-2 
TRP1 CEN> 
This Study 
NAY64 Matα ura3-52 leu2-3,112 ino1-13 HIS4(AUG)-myc10-kanMx6 gcd11∆::hisG trp1∆::hisG  Ep293<GCD11 URA3 CEN4/ARS1> This Study 
NAY66 Matα ura3-52 leu2-3,112 ino1-13 his4-301(UUG)- myc10-kanMx6 gcd11∆::hisG trp1∆::hisG  Ep293 <GCD11 URA3 CEN4/ARS1> This Study 
NAY74 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG KanMX-pGAL1-TIF11 Ep293<GCD11 URA3 CEN4/ARS1> This Study 
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Table 2.2 List of Plasmids 
 
Plasmid Descriptiona Source 
YCplac111 sc LEU2 yeast-E. coli shuttle vector 229 
YCplac22 sc TRP1 yeast-E. coli shuttle vector 229 
YCP50 sc URA3 yeast-E. coli shuttle vector 230 
pSB32 lc LEU2 yeast-E. coli shuttle vector  
YEplac122 hc TRP1 yeast-E. coli shuttle vector 229 
YEplac181 hc LEU2 yeast-E. coli shuttle vector 229 
pRS425 hc LEU2 yeast-E. coli shuttle vector 231 
Ep293 sc URA3 GCD11 in YCP50 223 
Ep517 lc  LEU2 GCD11 in pSB32 223 
pC2872 sc LEU2 GCD11-His8 in YCplac111 P. Alone 
pNA4 sc LEU2 GCD11-His8 in pC2872 This study 
p4281 sc TRP1 TIF5-G31R in YCplac22 81 
p4280 sc TRP1 SUI3-S264Y in YCplac22 81 
p367 sc URA3 HIS4(ATG)-lacZ 209 
p391 sc URA3 HIS4(TTG)-lacZ (his4-301) 209 
p180 sc URA3 GCN4-lacZ in YCp50 232 
pM226 (p4164) sc URA3 GCN4-lacZ with elongated uORF1 extending into GCN4 233 
pPMB24 sc URA3 SUI1-lacZ in YCP50 234 
pPMB25 sc URA3 SUI1opt-lacZ in YCP50 234 
pPMB28 sc URA3 SUI1UUU-lacZ in YCP50 234 
pCFB04 hc LEU2 SUI1 in YEplac181 97 
pAS5-148 (p5366) sc TRP1 TIF11 in YCplac22 A. Saini 
pAS5-130 (p5312) sc TRP1 tif11-SE1*-SE2*-F131 in YCplac22 A. Saini 
pNA4-A6a sc LEU2 gcd11-His8-M482K This study 
pNA4-A8b sc LEU2 gcd11-His8-F297S,D481E This study 
pNA4-B2d sc LEU2 gcd11-His8-M482K,T488M This study 
pNA4-B6a sc LEU2 gcd11-His8-M482I This study 
pNA4-C1c sc LEU2 gcd11-His8-E431K This study 
pNA4-C3a sc LEU2 gcd11-His8-L423M,D481H This study 
pNA4-D1a sc LEU2 gcd11-His8-N433D This study 
pNA4-D2c sc LEU2 gcd11-His8-N290S,M482K This study 
pNA4-MK sc LEU2 gcd11-His8-M484I,E431K This study 
pNA4-ME sc LEU2 gcd11-His8-M482I,N433D This study 
pNA4-G421C sc LEU2 gcd11-His8-G421C This study 
pNA4-L423A sc LEU2 gcd11-His8-L423A This study 
pNA4-P424A sc LEU2 gcd11-His8-P424A This study 
pNA4-E460A sc LEU2 gcd11-His8-E460A This study 
pNA4-E460K sc LEU2 gcd11-His8-E460K This study 
pNA4-M463A sc LEU2 gcd11-His8-M463A This study 
pNA4-I466A sc LEU2 gcd11-His8-I466A This study 
pNA4-G467A sc LEU2 gcd11-His8-G467A This study 
pNA4-S468A sc LEU2 gcd11-His8-S468A This study 
pNA4-T471A sc LEU2 gcd11-His8-T471A This study 
pNA4-R474A sc LEU2 gcd11-His8-R474A This study 
pNA4-R474E sc LEU2 gcd11-His8-R474E This study 
pNA4-K479A sc LEU2 gcd11-His8-K479A This study 
pNA4-K479E sc LEU2 gcd11-His8-K479E This study 
pNA4-R484A sc LEU2 gcd11-His8-R484A This study 
pNA4-R484E sc LEU2 gcd11-His8-R484E This study 
pNA4-L487A sc LEU2 gcd11-His8-L487A This study 
pNA4-E494A sc LEU2 gcd11-His8-E494A This study 
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Plasmid Descriptiona Source 
pNA4-E494K sc LEU2 gcd11-His8-E494K This study 
pNA4-E497A sc LEU2 gcd11-His8-E497A This study 
pNA4-E497K sc LEU2 gcd11-His8-E497K This study 
pNA4-K498A sc LEU2 gcd11-His8-K498A This study 
pNA4-K498E sc LEU2 gcd11-His8-K498E This study 
pNA4-R503A sc LEU2 gcd11-His8-R503A This study 
pNA4-R503E sc LEU2 gcd11-His8-R503E This study 
pNA4-R504A sc LEU2 gcd11-His8-R504A This study 
pNA4-R504E sc LEU2 gcd11-His8-R504E This study 
pNA18 sc TRP1 GCD11 in YCplac22 This study 
pNA19 hc TRP1 SUI1 in YEplac122 This study 
pNA20 hc TRP1 IMT4 in YEplac122 This study 
pAV1732 hc LEU2 GCD11-His6 SUI3 SUI2 IMT4 in pRS425 G. Pavitt 
pNA21 hc LEU2 GCD11-His8 SUI3 SUI2 IMT4 in pAV1732 This study 
pNA23 hc LEU2 gcd11-His8-E460K SUI3 SUI2 IMT4 in pNA21 This study 
pNA24 hc LEU2 gcd11-His8-R503A SUI3 SUI2 IMT4 in pNA21 This study 
pNA25 hc LEU2 gcd11-His8-R504A SUI3 SUI2 IMT4 in pNA21 This study 
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Table 2.3 List of Primers 
 
Primer Sequence Usage 
CHA209a CCAACCTATGGTTACGCTAGGC Generation of strain 
NAY66 CHA210a CGCTATTTGATACCCACTCTTGC 
PM-18b GAGCATTGCGATACGATGGG Generation of strain 
NAY64  PM-19b CGGTCTGT ACGTACTTCACC 
g_NcoI.F1 GCAGTGGTTTCCATGGTTCCTTAAGCGATGGG SDMc, to create NcoI site 
at 3’end of GCD11 CDSd g_NcoI.F2 CCCATCGCTTAAGGAACCATGGAAACCACTGC 
g_KpnI.F1 GGCGACATGACCGATCGTTCCGATGTTTATTGTAGC SDM, to remove first 
internal KpnI site in 
GCD11 CDS g_KpnI.R1 GCTACAATAAACATCGGAACGATCGGTCATGTCGCC 
IMT4_HindIII.
F1 GACATTGCAAAGCTTTGCCCAAATGAGCCAAATGCCA To amplify IMT4 gene for insertion into HindIII 
site of YEplac122 IMT4_HindIII.R1 
GACATTGCAAAGCTTGCCGTAGACGGCCTATTTCATT
GC 
GCD11_L1.F1 TCGCGCATTAGAGGTAGACA Generation of L1 library GCD11_L1.R1 TGGTGGTACGGGAATAGTCT 
GCD11_L2.F1 AGGTCGATTTAATGCGTGAAGA Generation of L2 library GCD11_L2.R1 GTTTCCCTTCCTCCTAGCCC 
TIF5_pGAL.F CTACATTAAAGAGTATCTCGTGTGTTCTTCTTTTTTTTCCGAATTCGAGCTCGTTTAAAC TIF5 promoter 
replacement TIF5_pGAL.R GTAAAATGGATCATGATTATCTCTACAAATATTAATAGACATTTTGAGATCCGGGTTTT 
TIF5.F2 CGTCACATATACATAAGCTC Verification of TIF5 
promoter replacement TIF5.R2 GAGCACCTAATTCGAAACCA 
g_Q415L.F GATCGTCTTGTCGGTCTAGTCGTCGGTGCTAAG SDM, Q415L g_Q415L.R CTTAGCACCGACGACTAGACCGACAAGACGATC 
g_V416A.F GATCGTCTTGTCGGTCAAGCTGTCGGTGCTAAGGG SDM, V416A g_V416A.R CCCTTAGCACCGACAGCTTGACCGACAAGACGATC 
g_V417L.F CGTCTTGTCGGTCAAGTCCTCGGTGCTAAGGG SDM, V417L g_V417L.R CCCTTAGCACCGAGGACTTGACCGACAAGACG 
g_G418C.F CTTGTCGGTCAAGTCGTCTGTGCTAAGGGTCATTTGC SDM, G418C g_G418C.R GCAAATGACCCTTAGCACAGACGACTTGACCGACAAG 
g_G421C.F GTCGTCGGTGCTAAGTGTCATTTGCCAAAC SDM, G421C g_G421C.R GTTTGGCAAATGACACTTAGCACCGACGAC 
g_L423A.F CGGTGCTAAGGGTCATGCTCCAAACATTTATACTG SDM, L423A g_L423A.R CAGTATAAATGTTTGGAGCATGACCCTTAGCACCG 
g_L423M.F GGTTGCCGTTAAAGCTCATATGGCAAGATTACAG SDM, L423M g_L423M.R CTGTAATCTTGCCATATGAGCTTTAACGGCAACC 
g_P424A.F GGTGCTAAGGGTCATTTGGCTAACATTTATACTG SDM, P424A g_P424A.R CAGTATAAATGTTAGCCAAATGACCCTTAGCACC 
g_E460A.F GAAAATTAGAGCCAAATGCTGTTCTTATGGTCAAC SDM, E460A g_E460A.R GTTGACCATAAGAACAGCATTTGGCTCTAATTTTC 
g_E460K.F GAAAATTAGAGCCAAATAAAGTTCTTATGGTCAAC SDM, E460K g_E460K.R GTTGACCATAAGAACTTTATTTGGCTCTAATTTTC 
g_M463A.F CCAAATGAAGTTCTTGCTGTCAACATTGGTTCTACC SDM, M463A g_M463A.R GGTAGAACCAATGTTGACAGCAAGAACTTCATTTGG 
g_I466A.F GTTCTTATGGTCAACGCTGGTTCTACCGCTACGGGGG SDM, I466A g_I466A.R CCCCCGTAGCGGTAGAACCAGCGTTGACCATAAGAA 
g_G467A.F CTTATGGTCAACATTGCTTCTACCGCTACGG SDM, G467A g_G467A.R CCGTAGCGGTAGAAGCAATGTTGACCATAAG 
g_S468A.F CTTATGGTCAACATTGGTGCTACCGCTACGGGGG SDM, S468A g_S468A.R CCCCCGTAGCGGTAGCACCAATGTTGACCATAAG 
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Primer Sequence Usage 
g_T471A.F CATTGGTTCTACCGCTGCTGGGGCTCGTGTGG SDM, T471A g_T471A.R CCACACGAGCCCCAGCAGCGGTAGAACCAATG 
g_R474A.F CCGCTACGGGGGCTGCTGTGGTTGCCGTTAAAG SDM, R474A g_R474A.R CTTTAACGGCAACCACAGCAGCCCCCGTAGCGG 
g_R474E.F CCGCTACGGGGGCTGAAGTGGTTGCCGTTAAAG SDM, R474E g_R474E.R CTTTAACGGCAACCACTTCAGCCCCCGTAGCGG 
g_K479A.F CGTGTGGTTGCCGTTGCTGCTGATATGGCAAG SDM, K479A g_K479A.R CTTGCCATATCAGCAGCAACGGCAACCACACG 
g_K479E.F CGTGTGGTTGCCGTTGAAGCTGATATGGCAAG SDM, K479E g_K479E.R CTTGCCATATCAGCTTCAACGGCAACCACACG 
g_D481A.F GGTTGCCGTTAAAGCTGCTATGGCAAGATTACAG SDM, D481A g_D481A.R CTGTAATCTTGCCATAGCAGCTTTAACGGCAACC 
g_D481E.F GGTTGCCGTTAAAGCTGAAATGGCAAGATTACAG SDM, D481E g_D481E.R CTGTAATCTTGCCATTTCAGCTTTAACGGCAACC 
g_R484A.F GCTGATATGGCAGCTTTACAGTTAACGTCGCCCG SDM, R484A g_R484A.R CGGGCGACGTTAACTGTAAAGCTGCCATATCAGC 
g_R484E.F GCTGATATGGCAGAATTACAGTTAACGTCGCCCG SDM, R484E g_R484E.R CGGGCGACGTTAACTGTAATTCTGCCATATCAGC 
g_L487A.F GATATGGCAAGATTACAGGCTACGTCGCCCGCTTG SDM, L487A g_L487A.R CAAGCGGGCGACGTAGCCTGTAATCTTGCCATATC 
g_E494A.F CGCCCGCTTGTACTGCTATTAACGAGAAGATTGC SDM, E494A g_E494A.R GCAATCTTCTCGTTAATAGCAGTACAAGCGGGCG 
g_E494K.F CGCCCGCTTGTACTAAAATTAACGAGAAGATTGC SDM, E494K g_E494K.R GCAATCTTCTCGTTAATTTTAGTACAAGCGGGCG 
g_E497A.F CGCTTGTACTGAAATTAACGCTAAGATTGCTTTGTCG SDM, E497A g_E497A.R CGACAAAGCAATCTTAGCGTTAATTTCAGTACAAGCG 
g_E497K.F CGCTTGTACTGAAATTAACAAGAAGATTGCTTTGTCG SDM, E497K g_E497K.R CGACAAAGCAATCTTCTTGTTAATTTCAGTACAAGCG 
g_K498A.F CTGAAATTAACGAGGCTATTGCTTTGTCGAG SDM, K498A g_K498A.R CTCGACAAAGCAATAGCCTCGTTAATTTCAG 
g_K498E.F CTGAAATTAACGAGGAAATTGCTTTGTCGAG SDM, K498E g_K498E.R CTCGACAAAGCAATTTCCTCGTTAATTTCAG 
g_R503A.F GAAGATTGCTTTGTCGGCTCGTATCGAAAAGC SDM, R503A g_R503A.R GCTTTTCGATACGAGCCGACAAAGCAATCTTC 
g_R503E.F GAAGATTGCTTTGTCGGAACGTATCGAAAAGC SDM, R503E g_R503E.R GCTTTTCGATACGTTCCGACAAAGCAATCTTC 
g_R504A.F GATTGCTTTGTCGAGAGCTATCGAAAAGCATTGG SDM, R504A g_R504A.R CCAATGCTTTTCGATAGCTCTCGACAAAGCAATC 
g_R504E.F GATTGCTTTGTCGAGAGAAATCGAAAAGCATTGG SDM, R504E g_R504E.R CCAATGCTTTTCGATTTCTCTCGACAAAGCAATC 
a. Ref 228                                                        
b. Ref 234 
c. SDM: Site-Directed Mutagenesis 






Table 2.4 Frequency and type of mutations in the libraries of randomly mutated 
GCD11 alleles 
                                                                      
 L1 L2 
Frequency of mutation 72.4% 86.4% 
Number of clones ~19,000 ~152,000 
Distribution of # of mutations 
per plasmid 
1 mutation 57.1% 57.9% 
2 mutations 19.0% 5.30% 
≥3 mutations 23.8% 36.8% 
Distribution of type of 
mutations in each library 
Missense 65.0% 60.0% 
Synonymous 30.0% 34.3% 
Nonsense 5.00% 5.70% 
 *Frequencies are calculated from sequencing a random sample of at least 30 plasmids for each library 
Table 2.5 List of isolated mutant alleles of GCD11 that suppressed the recessive 
lethality of SUI5
Mutanta Subsitutionsb Mutations in CDSc 
A2a L423M N433K T1269A 1301CG 
A3a E431R G1291A 
A6a M482K T1445A 
A8b F297S D481E T890C T1443A 
B1a P404T D481E C1212A T1445A 
B2d M482K T488M T1447A C1465T 
B4a M482K T1445A 
B6a M482I G1446T 
C1c E431K G1293A 
C3a L423M D481H T1267A G1441C 
C7c M482K T1445A 
D1a N433D A1299G 
D2c N290S M482K A871G T1447A 
a. Plasmid name  
b. Missense mutations in the plasmid recovered.  Color-coding designates   
   substitutions in the same residues that were isolated from independent mutant 
   plasmids. 
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Table 2.6 List of site-directed mutations created in domain-III of GCD11 
 
# Mutation Residue in CDSa Phenotype
b # Mutation Residue in CDSa Phenotype
b 
1 G421C T1261GT - 12 R484A G1451CT Sup. His+ 
2 L423A G1267CT - 13 R484E G1451AA Sup. His+ 
3 P424A G1270CT - 14 L487A G1460CT - 
4 E460A G1378CT Sui- 15 E494A G1481CT Sup. His+ 
5 E460K A1378AA Strong Slg- 16 E494K A1481AA Sup. His+ 
6 M463A G1384CT - 17 E497A G1490CT Sup. His+ 
7 I466A G1397CT - 18 E497K A1490AG Sup. His+ 
8 G467A G1400CT - 19 K498A G1493CT Sup. His+ 
9 S468A G1402CT Sup. His+* 20 K498E G1493AA Sup. His+ 
10 T471A G1412CT - 21 R503A G1508CT Recessive lethal 
11 R474A G1421CT - 22 R503E G1508AA Recessive lethal 
12 R474E G1421AA - 23 R504A G1511CT Recessive lethal 
13 K479A G1436CT Sup. His+ 24 R504E G1511AA Recessive lethal 
14 K479E G1436AA Sup. His+  
a. CDS: Coding Sequence 








Table 2.7 Suppression of the Sui-, His+, Gcd-, Slg-, and TS- phenotypes of different 




SUI3-2 SUI5 tif11-SE1*SE2*F131 
His+a Gcd-b UUG AUG-b Slg
-a Ts-a His+a Gcd-b Slg-a Ts-a His+a Gcd-b 
N433D +++ 40%ê 50%ê + NAc +++ 40%ê - - - 2.4Xé 
M482I +++ 40%ê 60%ê + NA +++ 52%ê - - - 2.3Xé 
E431K +/- 40%ê 40%ê + NA +/- 40%ê +/- +/- - - 
K479E +++ 40%ê 15%ê +/- - ++/- 50%ê - - - - 
R484A +++ 44%ê 40%ê + + ++/- 70%ê - - - 2.1Xé 
E497K +++ - 40%ê - - - - - - - - 
a ‘+’ indicates suppression, ‘-‘ indicates no effect 
b Numbers indicates percentage or fold change in the double mutant with respect to SUI3-2, SUI5, or tif11-SE1*SE2*F131 












CHAPTER 3: CHARACTERICATION OF THE MUTANT ALLELES OF GCD11 
THAT REDUCE THE STRINGENCY OF START CODON RECOGNITION 
  
  133 
3.1 Introduction 
The main characterized function of the eIF2 complex in the process of scanning 
and start codon recognition is binding the Met-tRNAi in a GTP dependent manner and 
delivering it to the P-site of the 40S subunit of the ribosome.  The hydrolysis of its bound 
GTP and the release of Pi are required for the dissociation of Met-tRNAi upon start codon 
recognition so that initiation can proceed.  The γ-subunit of eIF2 forms the core of the 
complex that binds to both GTP and Met-tRNAi.  Due to these properties of eIF2γ, the 
most likely underlying mechanism for the loss of initiation fidelity in its Sui- class of 
mutants would be an increase in the rate of GTP hydrolysis/Pi release or the dissociation 
of the Met-tRNAi.  Two Sui- mutations have been previously identified in GCD11.  A 
lysine or aspartic acid substitution of the asparagine residue at position 135 (N135K/D), 
located in the switch-I region of the G-domain, has indeed been illustrated to lower the 
initiation fidelity by increasing the dissociation of Met-tRNAi from the eIF2 
complex163,235.  Furthermore, intragenic suppressors of gcd11-N135D were shown to 
suppress its Sui- phenotype by restoring the Met-tRNAi binding235. 
As elucidated in Section 2.3.3, R510H was identified as a spontaneous mutation 
that constitutively derepressed the translation of GCN4 mRNA (Gcd- phenotype)222 and 
was later shown to also reduce the initiation fidelity creating a Sui- phenotype223.  X-ray 
crystallography of eIF2γ homologues in archaea have revealed a three-dimensional 
structure that closely resembles that of EF-Tu (see Section 1.2.1)119.  This is consistent 
with the function of both proteins in binding tRNA in a GTP dependent manner and 
delivering it to the ribosome.  Due to this structural similarity between eIF2γ and EF-Tu, 
it was proposed that the R510H mutant displays Gcd- and Sui- phenotypes by also 
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lowering the Met-tRNAi binding to eIF2223.  More recently, however, it has been reported 
that despite their similar structures, eIF2γ and EF-Tu bind tRNA and 40S in different 
manners113,127,236, whereas domain-III of EF-Tu plays an important part in binding the 
tRNA during the elongation phase of protein synthesis, eIF2γ domain-III is not involved 
in the Met-tRNAi binding.  Thus, it is unlikely that the R510H substitution directly 
reduces the Met-tRNAi binding to eIF2.  As discussed in Chapter 2, it is, however, 
possible that R510H indirectly affects Met-tRNAi binding by altering the relative position 
and stability of the switch-II region in the G-domain. 
As elucidated earlier, we set out to identify new structural elements in eIF2γ that 
are involved in establishing the fidelity of translation initiation by isolating new 
mutations that alter the stringency of start codon recognition.  We isolated three such 
mutants (G418C, E460A, and R510H) that reduce the accuracy of start codon selection 
and allow for translation initiation from a near-cognate UUG codon.  Among them, 
gcd11-R510H was already identified as a Sui- mutant but, as stated above, was not 
described in detail.  We employed genetic techniques to characterize these three alleles in 
vivo.  Based on their genetic phenotypes and their position in the three-dimensional 
structure of eIF2, which can be indicative of their potential underlying mechanisms, the 
E460A and G418C mutants were then further characterized in an in vitro reconstituted 
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3.2 Materials and Methods 
Standard methods were used for culturing, transforming, plasmid shuffling, and 
construction of S. cerevisiae strains210-212.  For yeast growth assays, cultures were grown 
to saturation, diluted to OD600 of 1 or 0.5, and 5µl of 10X serial dilutions were spotted on 
the appropriate medium. 
3.2.1 Yeast Strain Constructions 
For a list of yeast strains see Table 3.1.  The strains used for the large-scale 
purification of eIF2 were generated in multiple steps by deleting the GCN2, PEP4, SUI3, 
and SUI2 genes and replacing the his4-301 allele with WT HIS4 in NAY11.  Briefly, 
GCN2 was deleted by transforming NAY11 with the gcn2Δ::hisG::ura3 disruption 
fragment of plasmid pHQ1093 and growing the resulting transformants on 5-FOA-
containing medium as described previously213 to generate NAY69.  Deletion of GCN2 
was confirmed by PCR analysis.  LEU2-containing plasmid Ep517 was then replaced 
with Ep293, which carries the URA3 marker, to create NAY71.  To do this NAY69 was 
transformed with Ep293 using the method of lithium acetate transformation210, and 
plasmid replacement was achieved as described in section 2.2.1 for NAY13.  The loss of 
Ep517 was established by confirming leucine auxotrophy in NAY71.  Next, the his4-301 
allele was replaced with WT HIS4 to generate NAY72.  This was achieved by 
transforming strain NAY71 with a PCR fragment corresponding to a portion of the HIS4 
gene from 340 bp upstream to 437 bp downstream of the start ATG codon and selecting 
for transformants on SC-U-H medium.  Integration of the HIS4 fragment at the correct 
locus was confirmed by PCR analysis.  To obtain NAY76, the URA3-containing plasmid 
Ep293 was then shuffled with pNA4, which carries the LEU2 marker, by transforming 
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NAY72 with pNA4 and selecting for transformants on SC-L medium with 5-FOA.  The 
PEP4 gene was then deleted by replacing its coding region with the hphMX4 cassette 
using the one-step PCR strategy237 and selecting for hygromycin B resistance to generate 
NAY81.  Deletion of PEP4 was confirmed by PCR analysis.  To obtain NAY82, pNA4 
was then replaced with a sc URA3-containing plasmid pNA28 harboring the three genes 
(GCD11, SUI2, and SUI3) encoding the eIF2 complex using similar procedure explained 
above for NAY71.  The SUI3 gene was deleted by replacing its coding region with the 
kanMX4 cassette using the one-step PCR strategy214 and selecting for kanamycin 
resistance to create NAY84.  Deletion of SUI3 was confirmed by PCR analysis.  Finally, 
NAY86 was obtained by replacing the coding region of SUI2 with the natMX4 cassette 
using the one-step PCR strategy237 and selecting for nourseothricin resistance.  Deletion 
of SUI2 was confirmed by PCR analysis.  
To obtain strains NAY87, NAY89, and NAY91, which were used to purify the 
eIF2 complexes containing the WT, G418C, and E460A mutant eIF2γ proteins, 
respectively, NAY86 was transformed with pNA21, pNA26, and pNA22, and the 
transformants were plated on SC-L medium containing 5-FOA to select for loss of the 
URA3-containing plasmid pNA28.  The strains were verified again by rescuing their 
respective plasmids and subjecting them to DNA sequence analysis of the three genes 
encoding the WT or mutant eIF2 complexes. 
3.2.2. Plasmid Constructions  
For the list of plasmids used in this study see Table 3.2.  pNA28 was created by 
inserting a 7.8 SacI-XhoI fragment containing the three eIF2 genes (GCD11-His6, SUI2, 
and SUI3) from pAV1726 between the SacI-SalI sites of YCplac33.  pNA26 was made 
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by replacing the 2.57 kb SacI-Sbf1 fragment of pNA21 (containing GCD11-His8) with 
the SacI-Sbf1 fragment from pNA4-G418C that contains the mutant gcd11-G418C allele.  
The plasmid was verified by DNA sequence analysis of the GCD11, SUI2, and SUI3 
genes.  See Section 2.2.2 for details of the construction procedures for plasmids pNA4, 
pNA19, pNA20, pNA21, pNA22, pNA23, pNA4-E460A, and pNA4-G418C. 
3.2.3. Biochemical Assays with Yeast Extracts 
β-galactosidase assays with yeast WCEs obtained from exponentially growing 
cells (OD600 of ~0.5) were performed as described previously218.  To measure 
luminescence in cells harboring the dual luciferase reporter (pRaugFFuug), exponentially 
growing cultures (OD600 of ~0.5) were collected by centrifugation and resuspended in 
PBS buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO42H2O, 2 mM KH2PO4, pH 
7.4) with Complete Protease Inhibitor Cocktail (Roche), and whole cell lysates were 
generated by adding glass beads and vortexing at 4°C.  Luminescence was measured with 
a microplate luminometer (Berthold) using the Dual-Luciferase Reporter 1000 Assay 
System (Promega) following the manufacturer’s procedure.        
3.2.4. In Vitro Reconstitution Assays 
Purification of reagents.  Eukaryotic initiation factors 1, 1A, and 5 were purified 
from BL21(DE3) CodonPlus E.coli (Agilent Technologies) using the IMPAC system 
(New England Biolabs) for the purification of intein fusion proteins as described 
before238.  To generate eIF1A-Fl, eIF1A was labeled at its C-terminus with a Cys-Lys-
fluorescein dipeptide using the expressed protein ligation system as previously 
described75,239.  His8-tagged WT and mutant eIF2 complexes were overexpressed in yeast 
and purified as described127.  40S subunit was purified from yeast based on a procedure 
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described previously238.  Yeast initiator tRNA was transcribed from a hammerhead fusion 
template using T7 polymerase run off transcription, and radiolabeled [35S]Met-tRNAi and 
stoichiometrically charged Met-tRNAi were prepared as previously described238.  The 
sequence of the model mRNAs used were GGAA(UC)7UNNN(CU)10C where NNN was 
either AUG or UUG.  For all experiments the reaction buffer was composed of 30 mM 
HEPES (pH 7.5), 100 mM potassium acetate, 3 mM magnesium acetate, and 2 mM 
dithiothreitol. 
Affinity of Met-tRNAi binding to the eIF2 complex.  Binding of the Met-tRNAi to 
eIF2 was measured by a filter-binding assay as described before165.  Briefly, a limiting 
amount of [35S]Met-tRNAi (1 nM) was incubated with GDPNP (1 mM) and increasing 
concentrations of eIF2.  The reactions were filtered through an upper nitrocellulose 
membrane (Millipore), which retains the eIF2GDPNPMet-tRNAi complexes, and a 
lower Nytran Supercharge membrane (Millipore), which retains the unbound [35S]Met-
tRNAi.  The filters were then air-dried, and the radioactivity on each membrane was 
determined by the liquid scintillation counting method.   
Bench-top GTP hydrolysis.  Bench-top GTP hydrolysis assays were performed 
essentially as described before92.  A limiting concentration of [γ-32P]GTP (80 nM) was 
mixed with saturating amounts of eIF2 (0.8 µM).  To measure GTP hydrolysis in eIF2 
alone, the reactions were incubated at 26°C and then stopped by adding 100 mM EDTA 
at different time points.  To measure GTP hydrolysis in the TC, eIF2 (0.8 µM) was first 
incubated with [γ-32P]GTP (80 nM) for 10 min.  Met-tRNAi (0.8 µM) was then added, 
and the reactions were stopped by adding 100 mM EDTA at different time points.  The 
fraction of GTP hydrolyzed over time was then measured by employing thin layer 
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chromatography (TLC).  The samples were run on PEI-cellulose TLC using 0.3 M KPO4, 
pH 4.4 as the mobile phase to separate the [γ-32P]GTP  and 32Pi entities and were 
quantified by Phosphorimager analysis. 
Affinity and kinetics of TC binding to the 40S subunit.  Native gel shift assays 
were used to measure both the affinity and the kinetics of TC binding to the 40S subunit 
as described63,240.  To measure the affinity of TC binding to the 40S subunit, TC 
preassembled with eIF2 (0.8 µM), GDPNP (1 mM), and [35S]Met-tRNAi (1 nM) was 
incubated with eIF1 (1 µM), eIF1A (1 µM), mRNA (1 µM), and a range of 40S 
concentrations from 0.5 to 50 nM.  The 43SmRNA complex formation was then 
measured by native gel electrophoresis.  The dissociation constants (Kd values) were 
calculated by fitting the data with a hyperbolic or a quadratic equation.  To measure the 
rate of TC binding to the 40S subunit, 43SmRNA complexes were formed by mixing 
TC preassembled with eIF2 (250 nM), GDPNP (1 mM), and [35S]Met-tRNAi (0.6 nM) 
with eIF1 (1 µM), eIF1A (1 µM), 40S (20 nM), and mRNA (10 µM).  The reactions were 
stopped at different time points by adding ≥300-fold excess of unlabeled TC, and the rate 
of complex formation was measured by native gel electrophoresis.  Curves were fit to a 
single exponential equation to determine the observed rate constants (kobs values).  
Kinetics of TC dissociation.  Dissociation of TC from the 43SmRNA complex 
was monitored as described previously63.  43SmRNA complexes were formed by 
mixing TC preassembled with eIF2 (250 nM), GDPNP (1 mM), and [35S]Met-tRNAi (1 
nM) with eIF1 (1 µM), eIF1A (1 µM), 40S (20 nM), and mRNA (10 µM).  The reactions 
were then initiated by adding ≥370-fold excess of unlabeled TC and were stopped by 
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loading on a running native gel.  The dissociation rate constants (koff values) were 
calculated by fitting the data with a single exponential equation. 
eIF1A dissociation kinetics.  Kinetics of eIF1A dissociation was measured by 
anisotropy as previously described75.  43SmRNA complexes were first formed by 
incubating saturating amounts of TC preassembled with eIF2 (300 nM), GDPNP (1 mM), 
and Met-tRNAi (150 nM), eIF1 (1 µM), eIF5 (1 µM), 40S (120 nM), and mRNA (10µM) 
with a limiting concentration of eIF1A-Fl (15 nM).  A saturating concentration of 
unlabeled eIF1A (1 µM) was then added to chase the reaction, and changes in the 
anisotropy were measured over time using a T-format Spex Fluorolog-3 (J.Y. Horiba). 
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3.3 Results 
3.3.1 Novel Mutations in GCD11 Reduce the Fidelity of Start Codon Recognition 
A mutant allele of the HIS4 gene (his4-301) lacking a cognate start codon was 
used as a genetic reporter for the identification of mutations in GCD11 that would allow 
for initiation from a non-AUG codon.  His4 is an essential protein that is required for 
histidine biosynthesis in yeast.  Thus, in otherwise WT cells, yeast harboring the his4-301 
allele is unable to grow on medium lacking histidine.  Mutations that lower the initiation 
fidelity would consequently allow for initiation from the UUG triplet at the third in-frame 
codon of his4-301, suppress its histidine auxothrophy, and grow in the absence of 
histidine in the medium (His+ phenotype)208,209.  The G418C, E460A, and R510H mutant 
alleles isolated in GCD11 (as described in Chapter 2) all confer a His+ phenotype, 
presumably by allowing translation initiation from the in-frame UUG codon of his4-301 
(Figure 3.1A).  These mutants exhibit a range of histidine independence as G418C 
presents a strong, R510H a medium, and E460A a weak His+ phenotype, suggesting that 
they elevate initiation at UUG codons to different extents.  
In order to quantify the extent of non-AUG initiation in these mutants, we used 
genetic reporters containing either a UUG or an AUG start codon and calculated the ratio 
of their respective products (UUG/AUG ratio).  Two different sets of reporters were used: 
matched HIS4-lacZ alleles with an AUG or a UUG start codon (see Section 2.3.4) or a 
dual luciferase reporter system with the Renilla luciferase gene (Padh-Renilla) containing 
an AUG start codon and the Firefly luciferase (Pcyc-Firefly) containing a UUG start 
codon.  In WT cells, there is a small amount of background translation initiation from a 
UUG codon, and hence the ratio of UUG to AUG initiation is low (Figure 3.1B).  The 
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G418C, E460A, and R510H mutants, however, increase the ratio of initiation from a 
UUG codon to that from an AUG codon (Figure 3.1B).  The amount of increase in the 
UUG to AUG ratio in these mutants is consistent with the strength of their His+ 
phenotypes, so that G418C confers the biggest increase, R510H a moderate increase, and 
E460A produces a weak but significant increase in the ratio of UUG to AUG initiation.  
Thus, the G418C, E460A, and R510H mutations in GCD11 reduce the stringency of the 
start codon recognition and consequently confer Sui- and His+ phenotypes.    
 To examine if the Sui- and His+ phenotypes of these mutants are a result of 
reduced TC formation or impaired TC binding to the PIC, we measured the expression of 
a GCN4-lacZ reporter in the WT and mutant GCD11 strains.  As elucidated in the 
previous chapters, expression of GCN4 can serve as a genetic reporter for monitoring the 
stability and the loading of the ternary complex to the PIC.  In nutrient-replete conditions, 
translation of GCN4 mRNA is repressed.  A reduction in TC stability or in its rate of 
binding to the 40S subunit, however, leads to an increase in the expression of GCN4 even 
in nutrient-replete conditions (a Gcd- phenotype)206,220.  In WT cells, when nutrients are 
abundant, there is low basal translation of the GCN4-lacZ reporter (Figure 3.2A).  Cells 
harboring the G418C, E460A, or R510H mutant alleles, however, exhibit a Gcd- 
phenotype by increasing expression of the GCN4-lacZ reporter in nutrient-replete 
conditions (Figure 3.2A).  The extent to which these mutants derepress GCN4-lacZ 
expression correlates with the strength of their Sui- and His+ phenotypes, which may 
suggest these phenotypes have a common underlying mechanism in these mutants.    
 A Gcd- phenotype can result from a reduced rate of TC binding to the scanning 
40S subunits on the GCN4 mRNA (as discussed above and in Section 1.2.3).  Ternary 
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complex binds rapidly to the 40S subunit only when the pre-initiation complex is in the 
open conformation60.  Increasing the proportion of PIC in the open conformation can then 
be expected to partially suppress a Gcd- phenotype by further stabilizing the open 
conformation and allowing a greater fraction of the scanning 40S subunits to bind TC 
before reaching uORF4.  The eIF1 protein, along with eIF1A, binds and stabilizes the 
PIC in the open conformation63.  Consequently, overexpression of eIF1 can be expected 
to partially suppress an increase in the expression of the GCN4-lacZ reporter.  Thus, in 
order to examine if overexpression of the eIF1 protein (Sui1 in yeast) suppresses the Gcd- 
phenotype of G418C, R510H, and E460A, expression of the GCN4-lacZ reporter was 
measured in cells harboring the WT or GCD11 mutant alleles and expressing SUI1 from 
a hc TRP1 plasmid.  In agreement with this expectation, overexpressing the eIF1 protein, 
partially suppresses the Gcd- phenotype of the G418C, E460A, and R510H mutants 
(Figure 3.2A).  
As elucidated above, overexpressing the eIF1 protein further stabilizes the open 
conformation and allows for the PIC to continue scanning, which consequently leads to a 
reduction in the formation of closed conformation and initiation at a near-cognate UUG 
codon.  Thus, to examine if overexpression of eIF1 can similarly reduce the elevated ratio 
of UUG to AUG initiation in these mutants, we measured expression of the HIS4-lacZ 
reporters in isogenic strains harboring either the WT or the mutant E460A or G418C 
alleles and expressing SUI1 from a hc TRP1 plasmid. Consistent with this reasoning, 
eIF1 overexpression partially suppresses the elevated ratio of UUG to AUG initiation in 
the G418C and E460A mutants (Figure 3.2B).   
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Since overexpression of eIF1 could partially suppress the elevated ratio of UUG 
to AUG initiation and the Gcd- phenotype of the GCD11 mutants, we next tested if it can 
also suppress the His+ and the growth defects conferred by these alleles.  Spot assays 
were performed with isogenic strains (gcd11Δ, his4-301) harboring the WT or mutant 
alleles of GCD11 and expressing SUI1 from a hc TRP1 plasmid.  In agreement with 
partially reducing the ratio of UUG to AUG initiation (Figure 3.2B), overexpressing eIF1 
also partially suppresses the His+ phenotype of the GCD11 mutants (Figure 3.3A).  It, 
however, does not suppress the Slg- and the Cs- phenotypes conferred by the G418C 
allele, nor does it suppress the TS- phenotype of the E460A mutant (Figure 3.3B).   
While overexpression of the eIF1 protein is likely to partially suppress a Gcd- 
phenotype by stabilizing the open conformation of the PIC, overexpression of the Met-
tRNAi can be expected to do so by increasing the concentration of TC.  Met-tRNAi binds 
to eIF2 only when in complex with GTP165,241.  In fact, it is the irreversible hydrolysis of 
eIF2-bound GTP upon AUG recognition that leads to the dissociation of the Met-tRNAi 
from the eIF2 complex191,242.  It has also been reported that Met-tRNAi binding to eIF2 
stabilizes the binding of the GTP164.  Moreover, we found here that binding of the Met-
tRNAi to the purified eIF2 complex also reduces the spontaneous rate of GTP hydrolysis 
by eIF2 in vitro (Figure 3.4).  This was assayed by comparing the rate of GTP hydrolysis 
in the eIF2GTP complex with that in the TC (eIF2GTPMet-tRNAi).  Hence, 
overexpression of the Met-tRNAi can be expected to suppress an increase in the rate of 
GTP hydrolysis.  Yet, Met-tRNAi overexpression could also be expected to increase TC 
assembly by mass action, driving a higher proportion of the available eIF2GTP into TC.  
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Mass action may explain how overexpression of Met-tRNAi reduces the depression of 
GCN4-lacZ in nutrient-starved cells206. 
Therefore, in order to examine if overexpressing the Met-tRNAi can suppress the 
Gcd- phenotype of the GCD11 mutants, expression of the GCN4-lacZ reporter was 
measured in cells harboring either the WT or the mutant G418C or R510H alleles and 
expressing IMT4 from a hc TRP1 plasmid.  The overexpression of Met-tRNAi partially 
suppresses the derepression of GCN4-lacZ expression in the G418C and R510H mutants 
(Figure 3.2A).  Remarkably, overexpressing the Met-tRNAi reduces expression of the 
GCN4-lacZ reporter in the R510H strain by 92%, as compared to 44% and 72% in the 
WT and G418C strains, respectively.  This is in good agreement with our proposal that 
the R510H substitution is likely to increase the rate of GTP hydrolysis and/or Pi release 
by destabilizing the switch-II region of the G-domain, which then leads to an increase in 
the ratio of UUG to AUG initiation and in the expression of the GCN4-lacZ reporter (this 
hypothesis was explained in detail in Section 2.3.3 and will be discussed again at the end 
of this chapter).  
3.3.2 The E460A Mutant Promotes Formation of the Closed Conformation at a UUG 
Codon 
In an effort to uncover the mechanism for the loss of initiation fidelity conferred 
by the E460A mutant allele of GCD11, we employed biochemical assays in a 
reconstituted yeast translation initiation system238 to test our hypotheses directly.  As 
discussed in Section 2.3.4, E460 is a highly conserved surface-expose residue that is 
positioned in domain-III of eIF2γ in proximity of the proposed binding interface between 
the eIF2 complex and the 40S subunit.  Thus, based on its genetic characteristics, as 
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explained above, and its position in the three-dimensional structure of eIF2, we proposed 
that E460A substitution is likely to reduce the stringency of start codon recognition by 
altering the mode of eIF2 binding so that the PIC now favors the closed conformation 
even at non-AUG codons.  To test this hypothesis directly, we measured the affinity and 
the rate of TC binding to the 40S subunit in the yeast reconstituted translation initiation 
system. 
To measure the affinity of the ternary complex for the 40S subunit, we first 
examined if the eIF2γ-E460A mutant protein can form a TC with WT stability.  We 
determined the affinity of Met-tRNAi for eIF2 using a filter-binding assay, by measuring 
the binding of radiolabeled [35S]Met-tRNAi at increasing concentrations of eIF2.  The 
results indicated that the E460A mutant protein does not have a defect in binding Met-
tRNAi and forming a stable TC as we obtained similar Kd values for the E460A and WT 
eIF2γ proteins that were within the range of published results (Figure 3.5).  To measure 
the binding affinity of TC for the 40S subunit, we then performed electrophoretic 
mobility shift assays (EMSA) to monitor PIC formation.  The PIC was assembled in vitro 
using saturating amounts of eIF2 (containing WT or the E460A mutant eIF2γ), eIF1, 
eIF1A, and mRNA (with an AUG or a UUG codon), a limiting amount of [35S]Met-
tRNAi, and a range of 40S concentrations.  The fraction of TC bound to the 40S subunit 
(PIC formation) was then measured by native gel electrophoresis (see Material and 
Methods for more detail on all the biochemical assays performed).  Consistent with 
pervious reports, we observed a tight binding of the TC to the 43mRNA complexes.  
Moreover, our results indicate that E460A substitution in eIF2γ does not significantly 
alter the affinity of the TC for the 40S subunit with either a UUG- or an AUG-containing 
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model mRNA as we obtained similar Kd values for TC assembled with WT or the E460A 
variant of eIF2γ (Figure 3.6).  Therefore, it is unlikely that the E460A mutant reduces the 
initiation fidelity by altering the binding affinity of TC for the PIC. 
To measure the rate of TC binding to the 40S subunit, we next determined the 
kinetics of PIC formation using a similar gel shift assay.  Preformed TC 
(eIF2GDPNP[35S]Met-tRNAi) was mixed with saturating concentrations of eIF1, 
eIF1A, 40S, and mRNA.  The reaction was stopped at different time points by adding an 
excess of unlabeled TC, and the fraction of TC bound to the 40S subunit was monitored 
by native gel electrophoresis.  Remarkably, the E460A substitution increases the rate of 
TC binding exclusively at a UUG codon by 5-fold (Figure 3.7).  It has been demonstrated 
previously that the binding of TC to the 40S subunit is biphasic95.  The first phase 
corresponds to the codon-independent rapid recruitment of TC to the 40S subunit in the 
open conformation, which occurs during scanning.  The second phase is the codon-
dependent structural rearrangements that stabilizes TC binding upon cognate 
codon:anticodon base pairing and formation of the closed conformation95.  Stabilization 
of TC binding upon formation of the closed conformation is apparent as the observed rate 
of TC binding to the 40S subunit is faster at an AUG codon versus a UUG codon (Figure 
3.7, compare the rate of WT with an AUG mRNA to that with a UUG mRNA).  The 
E460A substitution alters the codon-dependent phase of TC binding as it only increases 
the rate at a UUG codon.  These results suggest that E460A reduces the stringency of start 
codon recognition by promoting the formation of the closed conformation at a near-
cognate UUG codon.  Based on the position of residue E460 near the proposed binding 
interface between eIF2 and h44 of the 40S subunit (Figure 2.28), it is likely that E460A 
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stabilizes TC binding and the closed conformation by adjusting the mode of eIF2 binding 
to the 40S subunit through altering the physical interactions between domain-III of eIF2γ 
and helix h44 of the 40S subunit, which consequently leads to translation initiation at 
non-AUG codons. 
In order to determine if the steady state equilibrium between the open and closed 
conformations is altered in E460A, we measured the rate of eIF1A dissociation from 
reconstituted PIC.  Kinetics of eIF1A dissociation is biphasic and serves as a proxy for 
the two conformations of the pre-initiation complex75.  It has been demonstrated that start 
codon recognition induces structural rearrangements in the PIC that stabilizes eIF1A 
binding and reduces the rotational freedom of its CTT through an interaction with the 
eIF5 protein75.  This is apparent as the rate of eIF1A dissociation is slower from the PIC 
reconstituted with an AUG versus a non-AUG codon (Figure 3.10A, compare the WT 
curve with an AUG to that with a UUG mRNA).  The tighter binding of eIF1A upon start 
codon recognition is manifested as an increase in the amplitude of the slower phase of the 
biphasic dissociation reaction.  Therefore, the relative amplitudes of the two kinetic 
phases of eIF1A dissociation is thought to represent the partitioning of the PIC between 
the open, scanning-conducive and closed, scanning-arrested conformations75 (Figure 3.8).  
An apparent equilibrium constant between the two conformations of the PIC can then be 
defined as the ratio of the amplitudes of the two kinetic phases of eIF1A dissociation 
(Kamp).  Higher Kamp values indicate that the closed conformation is more favored  
We used a fluorescence anisotropy-based assay to measure the kinetics of eIF1A 
dissociation from reconstituted PIC75 (see Figure 3.9 for a brief description of the 
principles of fluorescence anisotropy).  eIF1A was labeled with fluorescein at its CTT 
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using the expressed protein ligation method239,243.  PIC was first assembled with a 
limiting amount of fluorescein-labeled eIF1A (eIF1A-Fl) and saturating concentrations of 
TC, eIF1, eIF5, 40S, and mRNA.  An excess of unlabeled eIF1A was then added and 
changes in the anisotropy were measured over time.  In agreement with previous 
reports70,75,104, and as elucidated above, we observed reduced dissociation of eIF1A from 
the reconstituted PIC with an AUG versus a UUG codon (Figure 3.10A, compare the WT 
curve with an AUG to that with a UUG mRNA)).  This is manifested as the Kamp value 
for the WT with an AUG mRNA is ~4-fold larger than with a UUG mRNA (Figure 
3.10B, compare the Kamp values for the WT).  The E460A substitution in eIF2γ does not 
alter the dissociation kinetics of eIF1A from the 43SmRNA PIC (Figure 3.10, compare 
the curves and the Kamp values).  Thus, it is unlikely that the E460A mutant alters the 
steady state equilibrium between the two conformations of the PIC. 
3.3.3 Biochemical Analysis of the G418C Sui- Mutant 
To determine the underlying mechanism for the Sui- phenotype conferred by the 
G418C allele, we performed similar assays in the yeast reconstituted translation initiation 
system to assess TC stability and binding to the PIC.  We first examined the binding of 
Met-tRNAi to the eIF2 complex containing the G418C substitution in the γ subunit.  As 
discussed in Section 2.3.3, G418 residue is located in the first β-strand of domain-III that 
is projected in-between the β-barrel structure of domain-II.  Since domain-II has been 
implicated in Met-tRNAi binding1,113,127,138, we hypothesized that G418C may lower the 
stringency of start codon recognition by reducing the binding of Met-tRNAi to eIF2 
through altering the three-dimensional structure of domain-II.  Thus, in order to 
determine the binding affinity of Met-tRNAi for eIF2, we performed filter-binding assays 
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as described before165.  A limiting amount of [35S]Met-tRNAi and a range of eIF2 
concentrations were used to measure the fraction of [35S]Met-tRNAi bound to the eIF2 
complex.  In contrast with our hypothesis, as compared to the WT protein, the G418C 
variant does not significantly alter the affinity of Met-tRNAi binding to the eIF2 complex 
(Figure 3.11). 
Because of its location, as elucidated above, it is also possible that the G418C 
substitution may alter the intrinsic rate of GTP hydrolysis in eIF2 by altering the relative 
position of domain-II with respect to the G-domain.  Thus, we measured the spontaneous 
rate of GTP hydrolysis in eIF2 containing either WT or mutant eIF2γ.  A limiting amount 
of [γ-32P]GTP was incubated with a saturating concentration of eIF2, and the fraction of 
GTP hydrolyzed was measured over time by separating the [γ-32P]GTP and 32Pi entities 
using thin layer chromatography.  These experiments illustrated that the G418C 
substitution also does not increase the intrinsic rate of GTP hydrolysis in eIF2 (Figure 
3.12). 
Next we tested the possibility that the Sui- phenotype conferred by the G418C 
allele is a result of altered TC binding to the 40S subunit.  Thus, we measured the affinity 
and the rate of TC loading on the 40S subunit using a similar set up explained above for 
the E460A mutant and established that the G418C substitution does not alter the affinity 
(Figure 3.13A) or the rate of TC binding to the PIC (Figure 3.13B) at either an AUG or a 
UUG codon.  This finding is not unexpected because considering that G418 is not 
exposed on the surface of eIF2γ and is positioned away from the proposed binding 
interface between eIF2 and the 40S (Figure 2.20 and Figure 2.22), it would be unlikely 
that the G418C substitution would affect the loading of the eIF2 complex on the PIC.  
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In order to establish if the loss of initiation fidelity in G418C is due to an altered 
equilibrium between the two conformations of the PIC, we then measured the kinetics of 
eIF1A dissociation using a similar procedure described in above for the E460A mutant.  
The G418C substitution also does not alter the steady state equilibrium between the open 
and closed conformations of the PIC as it does not alter the equilibrium between the two 
phases of eIF1A dissociation as compared to WT eIF2γ (Figure 3.14).  Thus, the genetic 
phenotypes conferred by the G418C allele are unlikely to be a result of reduced TC 
stability, altered TC binding to the 40S subunit, or an increased stability of the closed 
conformation at a near-cognate UUG codon.     
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3.4 Discussion 
During the initiation stage of protein synthesis, the eIF2 complex has the vital 
function of delivering the Met-tRNAi to the P-site of the 40S subunit and maintaining it 
in a proper orientation during the scanning phase so that the anticodon of the Met-tRNAi 
can sample the codons of the mRNA leader sequence for complementarity in search of 
the start codon.  Upon arrival at the AUG start codon, the hydrolysis of eIF2-bound GTP 
and Pi release then allow for the dissociation of Met-tRNAi from eIF2.  With the 
dissociation of eIF2GDP and other initiation factors from the PIC and joining of the 
large subunit of the ribosome, the process of protein synthesis then continues to the 
elongation stage90.   
eIF2γ is the core subunit of the eIF2 complex that provides the binding sites for 
GTP and Met-tRNAi through its G-domain and domain-II1,113,127,138.  Contrary to the 
other two domains, domain-III of eIF2γ has mainly remained uncharacterized.  Recently, 
however, by using a directed hydroxyl radical probing approach, a model for the loading 
of eIF2 on the 40S subunit was proposed in which domain-III provides a key binding 
interface between eIF2 and helix h44 of the 40S subunit127.  Here, we have provided 
genetic and biochemical evidence for the involvement of eIF2γ domain-III in establishing 
the accuracy of start codon selection.  We have identified three Sui- mutations that map to 
domain-III of eIF2γ.  Interestingly, the three mutant alleles (G418C, R510H, and E460A) 
seem to lower the stringency of start codon recognition by different mechanisms, which 
suggests domain-III is involved in multiple functions during the initiation stage of protein 
synthesis. 
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All three mutant alleles we isolated confer a His+ phenotype, albeit to different 
degrees, by allowing for the initiation of his4-301 translation from a UUG codon.  In 
order to quantify the amount of non-AUG initiation in these mutants, we measured the 
expression of reporter genes with either a UUG or an AUG start codon and calculated the 
ratio of their respective products.  In agreement with their His+ phenotypes, all three Sui- 
mutants present an elevated ratio of UUG to AUG initiation compared to WT cells to 
extents that correlate with the strength of their His+ phenotype.  Moreover, all three 
mutants display a Gcd- phenotype, which is partially suppressed by overexpression of the 
eIF1 protein as well as the Met-tRNAi. 
Partial suppression of the Gcd- phenotype by eIF1 overexpression may imply that 
the GCD11 Sui- mutants reduce the rate of TC loading on the reinitiating 40S subunits so 
that increasing the prevalence of the open conformation, as a result of eIF1 
overexpression, can partially compensate for this defect.  This mechanism may also 
explain the ability of eIF1 overexpression to dampen the derepression of GCN4-lacZ 
under nutrient-starved conditions when the rate of TC loading is reduced as a result of 
low TC concentration caused by the phosphorylation of eIF2α (explained in Section 
1.2.3).  Furthermore, the partial suppression of the Sui- phenotype by eIF1 overexpression 
may suggest that the GCD11 mutants favor the closed conformation of the PIC.  It is, 
however, possible that the GCD11 Sui- mutants elevate UUG initiation by a different 
mechanism, and that eIF1 overexpression suppresses this defect indirectly by maintaining 
the PIC in the open conformation, which is presumably the mechanism by which eIF1 
overexpression reduces UUG recognition even in otherwise WT cells.  Since the E460A, 
R510H, and G418C mutants seem to reduce the fidelity of start codon recognition by 
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different mechanisms, it is more likely that the overexpression of the eIF1 protein 
partially suppresses their His+, Sui-, and Gcd- phenotypes indirectly through increasing 
the prevalence of the PIC in the open conformation.  Moreover, the failure to observe a 
suppression of the Slg-, Ts-, and Cs- phenotypes by eIF1 overexpression may suggest that 
the impact of overexpressing eIF1 is indeed indirect.  Yet, it is also possible that the 
GCD11 mutant alleles impair other aspects of the initiation pathway that cannot be 
rescued by overexpressing the eIF1 protein.   
As elucidated earlier in Section 3.3.2, overexpression of the Met-tRNAi can be 
expected to increase the concentration of TC (by mass action) and to partially suppress an 
increase in the background rate of GTP hydrolysis in eIF2.  Interestingly, in agreement 
with our proposal that R510H mutant is likely to reduce the initiation fidelity by 
increasing the intrinsic rate of GTP hydrolysis, through destabilizing the structure of 
switch-II region in the G-Domain (see Section 2.3.3), overexpressing the Met-tRNAi 
suppresses the Gcd- phenotype of the R510H mutant by over 90%.  Yet, this result is also 
consistent with the possibility that R510H indirectly affects Met-tRNAi binding to the 
eIF2 complex.  In vitro GTPase and Met-tRNAi binding assays are required to 
differentiate between these two hypotheses and establish the true underlying mechanism 
for the Sui- phenotype of R510H.  Residue R510 is very well conserved and is located in 
the last β-strand of domain-III that provides the interface between domain-III and the G-
domain.  Moreover, the entire sequence motif (W509R510L511I512G513) of the last β-strand of 
domain-III is highly conserved, which may suggest the side chains of its residues may 
play a vital function in eIF2γ (for example, by stabilizing the switch-II region as 
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discussed earlier).  Thus, it would be interesting to examine if substitutions in the 
neighboring residues of R510 also alter the fidelity of translation initiation. 
Among our three Sui- mutants, G418C displayed the strongest His+ and Gcd- 
phenotypes and had the largest increase in the ratio of initiation from a UUG codon to 
that from an AUG codon.  Therefore, we performed in-depth biochemical assays to 
determine the underlying mechanism for the loss of initiation fidelity in G418C.  Due to 
its position in the first β-strand of domain-III that is inserted inside the β-barrel structure 
of domain-II, we hypothesized that the G418C substitution reduces the binding of Met-
tRNAi to eIF2 as domain-II has been implicated in Met-tRNAi binding1,113,124,127,138.  In 
contrast with our hypothesis, however, the G418C variant of eIF2γ does not seem to 
significantly alter the affinity of the Met-tRNAi for eIF2.  
 We also confirmed that the G418C substitution does not alter the spontaneous 
rate of GTP hydrolysis in the eIF2 complex.  We cannot, however, rule out the possibility 
that it may alter the eIF5-dependent GTP hydrolysis or the dissociation of Pi in the 
context of the PIC.  This hypothesis can be examined by performing GTPase assays using 
a rapid quench method as described previously92.  Additionally, we tested the possibilities 
that the G418C substitution alters binding of the TC to the 40S subunit or directly 
disrupts the steady state equilibrium between the two conformations of the PIC, by 
stabilizing the closed conformation on a near-cognate UUG codon.  Thus, we measured 
the affinity and the kinetics of TC binding to the 40S subunit with eIF2 containing the 
G418C substitution and determined that it does not alter the binding affinity or the rate of 
TC loading on the 40S subunit.  Furthermore, the Sui- phenotype of G418C is also not 
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due to an increase in the stability of the closed conformation at a UUG codon, as the 
G418C substitution does not alter the dissociation kinetics of eIF1A.   
Albeit these results, it is still a likely possibility that G418C reduces the 
stringency of start codon recognition by altering the conformation of Met-tRNAi binding, 
without affecting its binding affinity for eIF2 since it has been previously proposed that 
structural alterations in eIF2γ can subtly alter the conformation of Met-tRNAi on the 40S 
subunit and consequently affect the fidelity of start codon recognition independent of the 
binding affinity of Met-tRNAi for eIF2235.  Unfortunately, this possibility can only be 
directly examined via determining the crystal structure of TC with the WT or the mutant 
G418C eIF2γ proteins. 
Despite its weaker in vivo Sui- phenotype, E460A was chosen for an in-depth 
biochemical analysis over the R510H mutant because, as discussed in much detail in 
Section 2.3.4, it was more likely that it plays a direct role in promoting the formation of 
closed conformation at a UUG codon through altering the physical interactions between 
eIF2 and the 40S subunit (see Section 2.3.4).  We examined if the E460A substitution 
alters the affinity or the rate of TC binding to the 40S subunit and established that 
whereas the E460A substitution does not alter the affinity, it increases the rate of TC 
loading on the 40S subunit exclusively at a UUG codon.  It has been previously 
demonstrated that binding of the TC to the 40S subunit is stabilized upon AUG 
recognition and follows a biphasic kinetics.  While the first phase represents the rapid 
recruitment of the TC to the 40S subunit, the second phase signifies the codon-depend 
structural rearrangements that take place upon AUG recognition and formation of the 
closed conformation95.  Thus, E460A promotes formation of the closed conformation of 
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the PIC at a UUG codon, which consequently leads to initiation and loss of fidelity.  This 
is quite interesting since E460A marks the first mutant of its kind identified so far; it is 
the first Sui- mutant that promotes formation of the closed conformation at a UUG codon, 
by increasing the rate of TC loading, without affecting it at an AUG codon.  Considering 
the position of residue E460 on the proposed interface between eIF2 and the 40S subunit 
(Figure 2.28), it is a likely possibility that the E460A substitution allows for the 
formation of the closed conformation at a UUG codon by adjusting the way eIF2 binds to 
the PIC through altering its physical interactions with helix h44 of the 40S subunit.  In 
other words, it is likely that E460A allows for UUG initiation by allowing eIF2γ to bind 
in a start codon recognition mode at a UUG codon. 
Although E460A promotes formation of the closed conformation by stabilizing 
binding of the TC to the 40S subunit at a UUG codon, it does not seem to alter the steady 
state equilibrium between the two conformations of the PIC as measured by the 
dissociation kinetics of the eIF1A protein.  It is important to note that the dissociation of 
eIF1A is measured by adding the chase (unlabeled eIF1A) only after the PIC has fully 
formed and reached a steady state.  The two assays, kinetics of TC loading and eIF1A 
dissociation, have very different set up and are indicative of different functions.  Whereas 
the kinetics of TC loading reveals how likely it is that the closed conformation is formed, 
the kinetics of eIF1A dissociation is a proxy for the steady state stability of each 
conformation.  In other words, it does not measure how likely it is that formation of the 
closed conformation is promoted; it measures how stable it is after forming.  Thus, 
E460A seems to promote formation of the closed conformation without affecting its 
steady state stability.  This is consistent with our current understanding of the two 
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conformations of the PIC.  Start codon recognition requires the coordinated action of a 
number of events in the PIC that collectively commit the complex to form a stable closed 
conformation and begin translation.  For example, it is not only the mode of eIF2 binding 
that participates in promoting the formation of the closed conformation (as we propose 
here), as physical interactions between eIF5 and eIF1 have to be disrupted70,72, new 
interactions between the eIF1A and eIF5 proteins should be formed72,75, and the eIF2-
bound GTP has to hydrolyzed irreversibly with the dissociation of Pi92 among many other 
events that cooperatively lead to formation and stabilization of the closed conformation 
upon start codon recognition. 
Our genetic and biochemical findings here provide evidence for the involvement 
of eIF2γ domain-III in establishing the stringency of start codon recognition.  Domain-III 
seems to perform multiple functions during the initiation stage of protein synthesis.  It is 
likely to participate in stabilizing GTP binding, through physical interactions with the 
switch-II region of the G-domain, and perhaps in maintaining the Met-tRNAi in the 
proper conformation for binding to the 40S subunit, through physical interactions with 
domain-II.  As elucidated earlier, however, further experiments are required to directly 
confirm the above hypotheses.  Most interestingly, our genetic and biochemical findings 
suggest that domain-III of eIF2γ is involved in promoting formation of the closed 
conformation upon cognate base pairing between the start codon and the anticodon of 
Met-tRNAi.  To our knowledge, this is the first report of such function for the eIF2 
complex. 
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3.5 Figures and Tables 
 
Figure 3.1 The Sui- mutants of GCD11 display a His+ phenotype and an increased 
UUG to AUG ratio 
(A) The E460A, G418C, and R510H alleles of GCD11 confer a range of His+ phenotypes, 
with G418C producing a strong, R510H a medium, and E460A a weak phenotype.  Cells 
harboring the G418C allele are also slow growing (compare the rows on the +His 
medium).  Derivatives of strain NAY13 harboring the WT or mutant alleles of GCD11 
were cultured in SC-L, ten-fold serial dilutions were spotted on SC-L medium 
supplemented with 0.3 mM (+His) or 0.003 mM (-His) histidine, and incubated at 30°C 
for two and five days, respectively.  The schematic on the right displays the features of 
the strain important for this assay.  gcd11* represents either the WT or mutant GCD11 
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phenotype by increasing the ratio of initiation from a UUG codon to that from an AUG 
codon.  UUG to AUG ratio was calculated by measuring the β-galactosidase activity 
from matched HIS4-lacZ reporters with either an AUG or a UUG start codon (on the 
right) or by measuring the luminescence from a dual luciferase reporter system with the 
Renilla luciferase gene (Padh-Renilla) containing an AUG start codon and the Firefly 
luciferase (Pcyc-Firefly) containing a UUG start codon.  β-galactosidase activities 
(nanomoles of o-nitrophenyl-β-D-galactopyranoside cleaved per minute per microgram 
of protein) were measured in WCEs of exponentially growing cultures (OD600 ~0.5) in 
SC-L medium.  Luminescence was measured from exponentially growing cultures 
(OD600 ~0.5) in SC-L medium, and relative luminescence of Firefly (UUG) to Renilla 
(AUG) genes are plotted.  Mean of at least eight independent transformants and SEM 
(error bars) are plotted for each mutant.  The schematics of the reporters used are 
presented on the graphs.  A student t-test was used to determine significance (*p<0.05, 
**p<0.01).   
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Figure 3.2 The Gcd- phenotype and the elevated UUG/AUG initiation ratio of the 
GCD11 Sui- mutants are partially suppressed by overexpression of the eIF1 protein 
(A) The G418C, E460A, and R510H Sui- alleles of GCD11 all confer a Gcd- phenotype, 
increasing expression of the GCN4-lacZ reporter in nutrient-replete conditions.  
Overexpressing eIF1 and Met-tRNAi partially suppresses the Gcd- phenotype of the 
GCD11 mutants.  Expression of the GCN4-lacZ reporter was measured in derivatives of 
strain NAY13 harboring the WT or mutant alleles of GCD11 with either an empty hc 
TRP1 vector (YEplac122) or overexpressing SUI1 or IMT4 on hc TRP1 plasmids (pNA19 
and pNA20, respectively).  β-galactosidase activities (nanomoles of o-nitrophenyl-β-D-
galactopyranoside cleaved per minute per microgram of protein) were measured in the 
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least eight independent transformants and SEM (error bars) are plotted for each mutant.  
(B) Overexpression of eIF1 reduces the ratio of initiation from a UUG codon to that from 
an AUG codon.  UUG to AUG ratio was calculated by measuring the β-galactosidase 
activity from matched HIS4-lacZ reporters (as described in Figure 3.1) in derivatives of 
NAY13 harboring the WT or mutants alleles of GCD11 with either an empty vector 
(YEplac122) or overexpressing SUI1 from a hc TRP1 plasmid (pNA19).  Same growth 




Figure 3.3 eIF1 overexpression partially suppresses the His+ phenotype of the 
GCD11 Sui- mutants but does not alter their growth phenotypes 
(A) Overexpression of the eIF1 protein partially suppresses the His+ phenotype of the 
GCD11 Sui- mutants.  Strains (same as in Figure 3.2) were cultured in SC-L-W, ten-fold 
serial dilutions were spotted on SC-L-W medium supplemented with 0.3 mM (+His) or 
0.003 mM (-His) histidine, and incubated at 30°C for two and five days, respectively.  
(B) Overexpression of the eIF1 protein does not suppress the Slg- and the CS- phenotypes 
conferred by the G418C allele nor does it mitigate the TS- phenotype of the E460A 
mutant.  Same strains and growth conditions as in panel A, except that ten-fold serial 
dilutions were spotted on SC-L-W medium and incubated at the specified temperatures 




















































Figure 3.4 Binding of the Met-tRNAi reduces the spontaneous rate of GTP 
hydrolysis in eIF2  
Met-tRNAi binding to the eIF2 complex lowers its intrinsic rate of GTP hydrolysis.  GTP 
hydrolysis was measured by adding a limiting amount of [γ-32P]GTP (80 nM) to a 
saturating concentration of eIF2 (0.8 μM).  To measure GTP hydrolysis in eIF2 alone, the 
reactions were incubated at 26°C and stopped by adding 100 mM EDTA at the specified 
time points.  To measure GTP hydrolysis in the TC, eIF2 was first incubated with [γ-
32P]GTP for 10 min.  Met-tRNAi (0.8 μM) was then added, and the reactions were 
stopped by adding 100 mM EDTA at the specified time points.  [γ-32P]GTP and 32Pi were 
separated by thin layer chromatography (PEI-cellulose TLC) and the fraction of total 32Pi 
released was quantified by PhosphorImager analysis.  All values were normalized to the 
fraction of GTP hydrolyzed (32Pi released) at 0 min for eIF2 and at 10 min for the TC.  
The curves were fit a linear regression equation.  Slopes of the regression lines are 


























Figure 3.5 E460A substitution in eIF2γ  does not alter the affinity of Met-tRNAi 
binding to the eIF2 complex 
Binding of the Met-tRNAi to eIF2 was measured in vitro by filter-binding assays.  A 
limiting amount of [35S]Met-tRNAi (1 nM) was incubated with GDPNP (1 mM) and a 
range of eIF2 concentrations.  The reactions were filtered through an upper nitrocellulose 
membrane (Millipore), which retains the eIF2 GDPNP Met-tRNAi complexes, and a 
lower Nytran Supercharge membrane (Millipore), which retains the unbound [35S]Met-
tRNAi.  The filters were then air-dried, and the radioactivity on each membrane was 
determined by the liquid scintillation counting method.  The fraction of [35S]Met-tRNAi 
bound to eIF2 at each concentration is plotted.  Data were fit with hyperbolic binding 
curves to determine the Kd values of 46.0±10.0 and 17±18 nM for WT and the E460A 








Figure 3.6 E460A does not alter the affinity of TC binding to the 43S mRNA PIC 
Preformed TC (0.8 μM eIF2, 1 mM GDPNP, 1 nM [35S]Met-tRNAi) was mixed with 
saturating concentrations of eIF1 (1 μ), eIF1A (1 μ), mRNA (1 μM), and a range of 40S 
concentrations.  The fraction of [35S]Met-tRNAi bound to the 40S subunits (PIC 
formation) was measured by native gel electrophoresis.  Data were fit with hyperbolic 
binding curves to determine the Kd values.  Averages of at least three experiments and 
SDs are reported.  The detection limit of this assay is ≤1 nM, as TC binds very tightly to 






1 eIF2 GDPNP 
Met 
Δ[40S] 
Kd, nM AUG UUG 
WT ≤1.6±0.72 ≤3.6±1.2 
E460A ≤1.9±0.66 ≤1.0±0.45 
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Figure 3.7 The E460A substitution in eIF2γ  increases the rate of TC binding to the 
43S mRNA PIC exclusively with a UUG start codon 
Preformed TC (250 nM eIF2, 1 mM GDPNP•, 1 nM [35S]Met-tRNAi) was mixed with 
saturating concentrations of eIF1 (1 μ), eIF1A (1 μM), 40S (20 nM), and mRNA (10 μM) 
with an AUG or a UUG codon.  The reactions were stopped by adding excess amount of 
unlabeled TC, and the fraction of [35S]Met-tRNAi bound to the 40S subunits (PIC 
formation) was measured over time by native gel electrophoresis.  The curves were fit 
with a single exponential equation.  Mean values from at least four experiments and 






1 eIF2 GDPNP 
Met 
Δt 
kobs, min-1 AUG UUG 
WT 13.2±0.6 6.5±1.1 
E460A 7.8±2.2 33.4±2.6 
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Figure 3.8 The eIF1A dissociation kinetics from the 43S mRNA complex serves as a 
proxy for partitioning between the open and closed conformations of the PIC 
Kinetics of eIF1A dissociation from the 43S mRNA PIC is biphasic.  Previous studies 
have indicated that the fast phase corresponds to eIF1A dissociation from the open, 
scanning-conducive PIC whereas the slow phase represents the dissociation of eIF1A 
from the closed, scanning-arrested conformation75.  Start codon recognition induces 
structural rearrangements in the PIC that stabilizes eIF1A binding and reduces the 
rotational freedom of its CTT through an interaction with the eIF5 protein.  The tighter 
binding of eIF1A upon start codon recognition is manifested as an increase in the 
amplitude of the slower phase of the biphasic dissociation reaction.  Therefore, the 
relative amplitudes of the two kinetic phases of eIF1A dissociation is thought to represent 
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Figure 3.9 Principles of fluorescence anisotropy 
When a fluorescence molecule is excited with a polarized light, the extent of the 
polarization of the emitted light can be described in terms of anisotropy.  Fluorescence 
anisotropy can be used to measure the steady state or the kinetics of binding reactions 
that can cause a change in the intrinsic tumbling of molecules.  Smaller molecules have a 
rapid molecular tumbling that leads to a greater depolarization of the excited light (top).  
Upon binding to a larger complex, however, the tumbling of the smaller molecule is 
reduced, which subsequently reduces the depolarization of the excited light increasing the 
anisotropy (bottom).  The extent of change in the depolarization of light upon binding of 
the smaller molecule to a bigger complex (i.e. change in the anisotropy of the 
fluorescence molecule) represents the binding affinity of the two molecules, which can be 
measured either at the steady state to obtain the dissociation constant or over time to 
calculate the rate of a reaction.
1A 
Fl 
Excited light Emitted light 
1A 
Fl 
Excited light Emitted light 
 Rapid tumbling of small protein leads to depolarization of light 
  Binding to a larger complex, reduces the tumbling  
 => Reduction in depolarization of light (i.e. light remains more polarized). 
Anisotropy   
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Figure 3.10 The E460A substitution in eIF2γ does not alter the dissociation kinetics 
of eIF1A from reconstituted PIC 
(A) 43S mRNA complexes were first assembled by incubating saturating amounts of TC 
(0.8 μM eIF2, 1 mM GDPNP, 150 nM Met-tRNAi), eIF1 (1 μM), eIF5 (1 μM), 40S (20 
nM), and mRNA (10 μM) with a limiting amount of eIF1A-Fl (15 nM).  An excess of
unlabeled eIF1A (1 µM) was then added, and changes in anisotropy were measured over 
time.  (B) The E460A variant of eIF2γ does not alter the Kamp values with either an AUG 
or a UUG mRNA.  The amplitudes (α1 and α2), and the rates (k1 and k2) corresponding to 
the two phases of eIF1A dissociation are also not altered with the E460A variant 
compared to the WT eIF2γ protein.  Curves from panel A were fit with a double 
exponential equation.  Mean values from at least two experiments and mean deviations 














mRNA Rbounda α1b k 1 (X103 s-1) α2b k2 (X103 s-1) Kampc 
WT 
AUG 0.21±0.016 0.11±0.13 1.8±0.71 0.89±0.16 0.27±0.33 7.9±0.15 
UUG 0.19±0.0072 0.34±0.042 5.2±0.017 0.66±0.22 0.98±0.24 1.9±0.064 
E460A 
AUG 0.21±0.033 0.13±0.27 1.9±0.33 0.87±0.042 0.26±0.27 6.7±0.32 
UUG 0.19±0.00062 0.44±0.27 3.8±0.30 0.56±0.32 0.80±0.28 1.4±0.71 
a Anisotropy of eIF1A-Fl in the presence of all PIC components 
b Fractional amplitude calculated by dividing the observed amplitude of the indicated kinetic phase by the sum of the 
observed amplitudes of both phases.  
c Defined as α2/α1.  
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Figure 3.11 The G418C substitution in eIF2γ  does not alter the affinity of Met-
tRNAi binding to the eIF2 complex 
Binding of the Met-tRNAi to eIF2 was measured in vitro by filter-binding assays.  Same 
procedure as in Figure 3.5.  The Kd values are 46±10 and 48±12 for WT and the G418C 




Figure 3.12 The G418C substitution in eIF2γ  does not alter the intrinsic rate of GTP 
hydrolysis in the eIF2 complex  
Same procedure as in Figure 3.4.  Mean value of at least two experiments and mean 
deviation (error bar) is represented for each time point.  Values are normalized to the 
background rate of hydrolysis (32Pi released) in the [γ-32P]GTP molecule alone exposed to 
the same temperature and buffer conditions of the assay.  The curves were fit a linear 
regression equation.  Slopes of the regression lines are 0.41±0.040 and 0.47±0.20 for the 














Figure 3.13 G418C does not alter the affinity or the rate of TC binding to the 
43S•mRNA PIC  
(A) The G418C variant of eIF2γ does not alter the affinity of TC binding to reconstituted 
PIC.  Same procedure as in Figure 3.6.  Means of at least two experiments and mean 
deviations are reported.  (B) The G418C substitution in eIF2γ does not alter the rate of 
TC loading on reconstituted PIC.  Same procedure as in Figure 3.7.  Means of at least 
three experiments and SDs are reported.   
kobs, min-1 AUG UUG 
WT 13±0.6 6.5±1.1 
G418C 13±0.53 5.6±0.7 
Kd, nM AUG UUG 
WT ≤1.6±0.72 ≤3.6±1.2 


















Figure 3.14 The G418C variant of eIF2γ  does not the dissociation kinetics of eIF1A 
from reconstituted PIC 
(A) Same procedure as in Figure 3.10.  (B) The G418C substitution in eIF2γ does not 
alter the Kamp values with either an AUG or a UUG mRNA.   The amplitudes (α1 and α2), 
and the rates (k1 and k2) corresponding to the two phases of eIF1A dissociation are also 
not altered with the G418C variant compared to the WT eIF2γ protein.  Curves from 
panel A were fit with a double exponential equation.  Mean values from at least two 














mRNA Rbounda α1b k 1 (X103) α2b k2 (X103) Kampc 
WT 
AUG 0.21±0.016 0.11±0.13 1.8±0.71 0.89±0.16 0.27±0.33 7.9±0.15 
UUG 0.19±0.0072 0.34±0.042 5.2±0.017 0.66±0.22 0.98±0.24 1.9±0.064 
G418C 
AUG 0.20±0.012 0.11±0.44 2.6±0.12 0.89±0.056 0.28±0.050 8.3±0.50 
UUG 0.19±0.011 0.25±0.079 8.1±0.017 0.75±0.027 1.1±0.0 3.0±0.10 
a Anisotropy of eIF1A-Fl in the presence of all PIC components 
b Fractional amplitude calculated by dividing the observed amplitude of the indicated kinetic phase by the sum of the    
  observed amplitudes of both phases.  
c Defined as α2/α1.  
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Table 3.1 List of S. cerevisiae Strains 
 
Strain Genotype Source 
NAY11 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1Δ::hisG Ep517<GCD11 LEU2 CEN/ARS> 
This 
Study 
NAY13 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG Ep293<GCD11 URA3 CEN4/ARS1> 
This 
Study 
NAY93 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11Δ::hisG trp1Δ::hisG pNA4<GCD11-His8 LEU2 CEN4/ARS1> 
This 
Study 
NAY95 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11Δ::hisG trp1Δ::hisG pNA4-G418C<gcd11-G418C-His8 LEU2 CEN4/ARS1> 
This 
Study 
NAY97 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11Δ::hisG trp1Δ::hisG pNA4-E460A<gcd11-E460A-His8 LEU2 CEN4/ARS1> 
This 
Study 
NAY99 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11Δ::hisG trp1Δ::hisG pNA4-R510H<gcd11-R510H-His8 LEU2 CEN4/ARS1> 
This 
Study 
NAY69 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11Δ::hisG trp1Δ::hisG  
gcn2Δ::hisG  Ep517<GCD11 LEU2 CEN/ARS> 
This 
Study 
NAY71 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11Δ::hisG trp1Δ::hisG  
gcn2Δ::hisG  Ep293<GCD11 URA3 CEN4/ARS1> 
This 
Study 
NAY72 Matα ura3-52 leu2-3,112 ino1-13 HIS4
+ gcd11Δ::hisG trp1Δ::hisG  gcn2Δ::hisG  
Ep293 <GCD11 URA3 CEN4/ARS1> 
This 
Study 
NAY76 Matα ura3-52 leu2-3,112 ino1-13 HIS4
+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG   
pNA4<GCD11-His8 LEU2 CEN4/ARS1> 
This 
Study 
NAY81 Matα ura3-52 leu2-3,112 ino1-13 HIS4
+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 
pep4Δ::hygB  pNA4<GCD11-His8 LEU2 CEN4/ARS1> 
This 
Study 
NAY82 Matα ura3-52 leu2-3,112 ino1-13 HIS4
+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 
pep4Δ::hygB  pNA28<sc URA3 GCD11-His6 SUI3 SUI2> 
This 
Study 
NAY84 Matα ura3-52 leu2-3,112 ino1-13 HIS4
+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 





Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 
pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA21<hc LEU2 GCD11-His8 




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 
pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA26<hc LEU2 gcd11-G418C-




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG gcn2Δ::hisG 
pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA22<hc LEU2 gcd11-E460A-
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Table 3.2 List of Plasmids 
 
Plasmid Descriptiona Source 
YCplac111 sc LEU2 yeast-E. coli shuttle vector 229 
YCplac22 sc TRP1 yeast-E. coli shuttle vector 229 
YCP50 sc URA3 yeast-E. coli shuttle vector 230 
pSB32 lc LEU2 yeast-E. coli shuttle vector  
YEplac122 hc TRP1 yeast-E. coli shuttle vector 229 
YEplac181 hc LEU2 yeast-E. coli shuttle vector 229 
pRS425 hc LEU2 yeast-E. coli shuttle vector 231 
YCplac33 sc URA3 yeast-E. coli shuttle vector 229 
Ep293 sc URA3 GCD11 in YCP50 223 
Ep517 lc  LEU2 GCD11 in pSB32 223 
pC2872 sc LEU2 GCD11-His8 in YCplac111 P. Alone 
pNA4 sc LEU2 GCD11-His8 in pC2872 This study 
pNA4-E460A sc LEU2 gcd11-His8-E460A This study 
pNA4-G418C sc LEU2 gcd11-His8-G418C This study 
pNA4-R510H sc LEU2 gcd11-His8-R510H This study 
p367 sc URA3 HIS4(ATG)-lacZ 209 
p391 sc URA3 HIS4(TTG)-lacZ (his4-301) 209 
p180 sc URA3 GCN4-lacZ in YCp50 232 
pCFB04 hc LEU2 SUI1 in YEplac181 97 
pNA19 hc TRP1 SUI1 in YEplac122 This study 
pNA20 hc TRP1 IMT4 in YEplac122 This study 
pRaugFFuug / pJDR1Fuug sc URA3 Padh-(AUG)Renilla-luciferase Pcyc-(UUG)Firefly-luciferase 
97 
pAV1726 hc LEU2 GCD11-His6 SUI3 SUI2 in pRS425  G. Pavitt 
pAV1732 hc LEU2 GCD11-His6 SUI3 SUI2 IMT4 in pAV1726 G. Pavitt 
pNA28 sc URA3 GCD11-His6 SUI2 SUI3 in YCplac33 This study 
pNA21 hc LEU2 GCD11-His8 SUI3 SUI2 IMT4 in pAV1732 This study 
pNA22 hc LEU2 gcd11-His8-E460A SUI3 SUI2 IMT4 in pNA21 This study 
pNA26 hc LEU2 gcd11-His8-G418C SUI3 SUI2 IMT4 in pNA21 This study 
a.  sc: single copy number; hc: high copy number; lc: low copy number 
  





CHAPTER 4: CHARACTERIZATION OF THE MUTANT ALLELES OF GCD11 
THAT RESTORE INITIATION FIDELITY 
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4.1 Introduction 
In eukaryotes, the initiation of protein synthesis is governed by base pairing 
between the anticodon of the Met-tRNAi and the start codon of the mRNA.  eIF2 is a 
heterotrimeric complex that delivers the Met-tRNAi to the P-site of the small subunit of 
the ribosome in a GTP dependent manner, maintains the Met-tRNAi in the proper 
orientation for scanning the leader sequence of the mRNA with the PIC in the open 
conformation, and finally releases the Met-tRNAi upon start codon recognition and 
formation of the closed conformation.  Thus, eIF2 is intimately involved in the 
identification and selection of the start codon in eukaryotes.  In order to identify the 
structural elements in eIF2 that are essential for the accuracy of start codon selection, we 
set out to identify mutations that alter the fidelity of this process.  We focused on the γ-
subunit as it forms the core of the eIF2 complex that provides the binding sites for GTP 
and the Met-tRNAi.   
As discussed in Chapter 2, to identify the essential features of eIF2γ involved in 
scanning and start codon recognition, we employed three different strategies to isolate 
mutant alleles that either reduce the accuracy of initiation (Sui- phenotype) or conversely 
restore it in cells harboring a Sui- mutant (Ssu- phenotype).  Our genetic and biochemical 
analysis of the Sui- alleles of GCD11 suggested a novel function for the eIF2 complex in 
which domain-III of the γ-subunit is involved in promoting the formation of the closed 
conformation (see Chapter 3).  We also isolated multiple mutant alleles of GCD11 that 
restore the stringency of start codon recognition and confer an Ssu- phenotype (see 
Chapter 2).  Among them, we selected the gcd11-N433D and gcd11-R484A alleles that 
presented the strongest genetic phenotype in suppressing the His+ and the elevated UUG 
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initiation in Sui- mutant cells (with reduced initiation fidelity) for further in-depth 
biochemical analysis in a reconstituted yeast translation initiation system.  These results 
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4.2 Materials and Methods 
Standard methods were used for culturing, transforming, plasmid shuffling, and 
construction of S. cerevisiae strains210-212.  For yeast growth assays, cultures were grown 
to saturation, diluted to OD600 of 1 or 0.5, and 5µl of 10X serial dilutions were spotted on 
the appropriate medium. 
4.2.1 Yeast Strain Constructions 
For a list of yeast strains see Table 4.1.  Strain NAY116 was generated by 
transforming NAY13 (gcd11Δ, his4-301, sc URA3 GCD11) with a sc TRP1 SUI3-2 
plasmid (p4280) and selecting for transformants on SC-U-W medium.  NAY156, 
NAY135, and NAY137 were created by transforming NAY116 with plasmids pNA4, 
pNA4-N433D, and pNA4-R484A, respectively.  The transformants were plated on SC-L-
W medium containing 5-FOA to select for loss of the URA3-containing plasmid Ep293. 
To obtain strains NAY105, NAY109, and NAY111, which were used to purify 
the eIF2 complexes containing the S264Y substitution in eIF2β and the WT, N433D, and 
R484A mutant variants of eIF2γ, respectively, NAY86 was transformed with plasmids 
pNA29, pNA30, and pNA31.  Transformants were plated on SC-L medium containing 5-
FOA to select for loss of the URA3-containing plasmid pNA28.  The strains were verified 
again by rescuing their respective plasmids and subjecting them to DNA sequence 
analysis of the three genes (SUI2, SUI3, and GCD11) encoding the eIF2 complex.  See 
Section 2.2.1 for details on the construction of NAY13 and Section 3.2.1 for NAY86 and 
NAY87. 
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4.2.2. Plasmid Constructions 
For the list of plasmids used in this study see Table 4.2.  Plasmid pNA29 was 
generated by replacing the XhoI-MluI fragment of pNA21 containing the WT SUI3 gene 
with the 0.85 kb SalI-MluI fragment of p4280 harboring the mutant SUI3-2 allele.  The 
plasmid was verified by DNA sequence analysis of GCD11, SUI2, and SUI3 genes.  
pNA30 and pNA31 were obtained by replacing the 2.57 kb SacI-Sbf1 fragment of 
pNA29 (containing WT GCD11-His8) with the SacI-Sbf1 fragments from plasmids 
pNA4-N433D and pNA4-R484A, respectively.  The plasmids were verified by DNA 
sequence analysis of GCD11, SUI2, and SUI3 genes.  See Section 2.2.2 for details of the 
construction procedures for plasmids pNA4-N433D and pNA-R484A and Section 3.2.2 
for pNA28 and pNA29. 
4.2.3. Biochemical Assays with Yeast Extracts 
β-galactosidase assays with yeast WCEs obtained from exponentially growing 
cells (OD600 of ~0.5) were performed as described previously218.  
4.2.4. In Vitro Reconstitution Assays 
All the biochemical assays in the in vitro reconstituted yeast translation initiation 
system were performed as described in Chapter 3 (see Section 3.2.4). 
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4.3 Results 
4.3.1 The Ssu- Mutants of GCD11 Restore Initiation Fidelity in Cells Harboring the 
SUI3-2 Allele in Vivo  
A tyrosine substitution of the serine residue at position 264 (S264Y) of eIF2β, 
encoded by the SUI3-2 allele, reduces the stringency of start codon recognition and 
confers a dominant Sui- phenotype109,152,163.  We again took advantage of the his4-301 
allele to monitor the accuracy of initiation in vivo209 (Figure 4.1A).  his4-301 is a mutant 
variant of the HIS4 gene that lacks a cognate AUG codon, which consequently confers 
histidine auxotrophy in otherwise WT cells (Figure 4.1B, compare the WT row on the 
+His and -His medium).  The SUI3-2 allele, however, reduces the fidelity of start codon 
selection and allows for translation initiation from the third in-frame (UUG) codon of 
his4-301109,152,163.  Consequently, SUI3-2 suppresses the histidine auxotrophy of cells 
harboring the his4-301 allele and confers a His+ phenotype (Figure 4.1B, compare WT 
and SUI3-2 on the -His medium).  The N433D and R484A mutant alleles of GCD11 when 
expressed in cells harboring SUI3-2, both suppress its His+ phenotype to nearly WT 
levels (Figure 4.1B).  Thus, the GCD11 mutants reestablish the fidelity of start codon 
selection in vivo and block translation initiation from the UUG codon of the his4-301 
allele so that cells expressing the SUI3-2 allele are again histidine auxotrophs. 
To quantify the extent by which these mutants suppress initiation from the UUG 
codon of his4-301 in cells harboring SUI3-2, we used matched HIS4-lacZ reporters 
containing either a UUG (his4-lacZ) or an AUG (HIS4-lacZ) start codon and measured 
the ratio of their respective products (UUG to AUG ratio) (Figure 4.1C).  In WT cells, 
there is relatively low background level of initiation from a UUG codon, and hence the 
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ratio of his4-lacZ to HIS4-lacZ expression is very low.  SUI3-2, however, reduces the 
stringency of start codon recognition and increases the frequency of UUG initiation 
elevating the UUG to AUG ratio by ~2.6-fold (Figure 4.1D, compare WT to SUI3-2).  In 
cells expressing the N433D and R484A mutant alleles of GCD11 together with SUI3-2, 
however, the ratio of initiation from a UUG codon to that from an AUG codon is reduced 
(Figure 4.1D).  As a result, gcd11-N433D completely eliminates and gcd11-R484A 
substantially reduces the elevated UUG initiation conferred by SUI3-2 restoring the 
accuracy of start codon selection in vivo. 
4.3.2 SUI3-2 Stabilizes the Closed Conformation of the PIC  
In order to identify the underlying mechanism by which the Ssu- mutants of 
GCD11 reinstate the fidelity of start codon recognition, we took advantage of a 
reconstituted yeast translation initiation system238 to directly assay the various steps 
involved in the formation of a functional pre-initiation complex.  It was originally 
proposed that SUI3-2 allows for initiation from a non-AUG codon by increasing the 
intrinsic rate of GTP hydrolysis in the eIF2 complex163.  Thus, we first examined if the 
S264Y substitution in the β subunit (the point mutation encoded by the SUI3-2 allele) 
increases the spontaneous rate of GTP hydrolysis in purified eIF2.  A limiting amount of 
[γ-32P]GTP was incubated with a saturating concentration of eIF2, and the fraction of 
GTP hydrolyzed was measured over time by separating the [γ-32P]GTP and 32Pi entities 
using thin layer chromatography.  Consistent with previous reports, we observed a low 
rate of GTP hydrolysis in WT eIF2 (Figure 4.2).  In this assay, however, the S264Y 
substitution in eIF2β does not increase the intrinsic rate of GTP hydrolysis compared to 
the WT protein (Figure 4.2).   
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SUI3-2 allows for translation initiation from a UUG codon in vivo.  Since the 
formation of the closed conformation is needed for start codon recognition, we 
hypothesized that SUI3-2 further stabilizes the closed conformation of the PIC, which 
consequently leads to initiation at non-AUG codons.  Therefore, we next determined the 
relative stability of the two conformations of the PIC by measuring the dissociation rate 
of the eIF1A protein from the in vitro reconstituted 43SmRNA complex.  
As elucidated in Chapter 3, kinetics of eIF1A dissociation from the 43SmRNA 
complexes is biphasic and serves as a proxy for measuring the partitioning of the PIC 
between the open and closed conformations75.  It has been demonstrated that start codon 
recognition induces structural rearrangements in the PIC that stabilizes eIF1A binding 
and reduces the rotational freedom of its CTT through an interaction with the eIF5 
protein75.  This is apparent as the rate of eIF1A dissociation is slower from the PIC 
reconstituted with an AUG versus a non-AUG codon (Figure 4.3A, compare the WT 
curve with an AUG to that with a UUG mRNA).  The tighter binding of eIF1A upon start 
codon recognition is manifested as an increase in the amplitude of the slower phase of the 
biphasic dissociation reaction.  Therefore, the relative amplitudes of the two kinetic 
phases of eIF1A dissociation are thought to represent the partitioning of the PIC between 
the open, scanning-conducive and closed, scanning-arrested conformations.  An apparent 
equilibrium constant (Kamp) between the two PIC conformations can then be defined as 
the ratio of the amplitudes of the two kinetic phases of eIF1A dissociation.  Higher Kamp 
values indicate that the closed conformation is more favored (Figure 3.8). 
We determined the dissociation kinetics of eIF1A from reconstituted PIC using a 
fluorescence anisotropy-based assay75.  43SmRNA PIC was first assembled with a 
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limiting amount of fluorescein labeled eIF1A (eIF1A-Fl) and saturating concentrations of 
the TC, eIF1, eIF5, 40S, and mRNA (with an AUG or a UUG codon).  An excess of 
unlabeled eIF1A was then added and changes in the anisotropy were measured over time.  
In agreement with previous studies70,75,104, and as elucidated above, we observed reduced 
dissociation of eIF1A from the reconstituted PIC with an AUG versus a UUG codon 
(Figure 4.3A, compare the WT curve with an AUG to that with a UUG mRNA).  This is 
apparent as the Kamp value with an AUG codon, when the majority of the PIC is in the 
closed conformation, is ~4-fold larger than that for a UUG codon (Figure 4.3B, compare 
the Kamp values for the WT with an AUG versus a UUG mRNA).  Moreover, as 
previously reported75, we observed that the starting anisotropy of the complex (Rbound) is 
greater for the PIC assembled with an AUG mRNA compared to that with a UUG mRNA 
(Figure 4.3B, compare the WT Rbound values), which presumably reflects the reduced 
rotational flexibility of the eIF1A CTT in the closed versus the open conformations of the 
PIC. 
Remarkably, the S264Y substitution in eIF2β increases the fraction of the PIC in 
the closed conformation relative to the open conformation at a UUG codon, increasing 
the Kamp by ~6-fold (Figure 4.3B, compare the Kamp values of WT with S264Y).  
Interestingly, we could not calculate a Kamp value for S264Y at an AUG codon as the 
dissociation kinetics of eIF1A is no longer biphasic and the data is fit with a single 
exponential function.  This indicates that the S264Y substitution in eIF2β increases the 
proportion of the PIC in the closed conformation to the point where the open 
conformation is essentially nonexistent at an AUG codon.  Thus, S264Y increases the 
steady state stability of the closed conformation at both an AUG and a UUG codon.  
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Under normal circumstances, the majority of the PICs at an AUG start codon are in the 
scanning-arrested, closed conformation whereas at a UUG codon the majority of PICs are 
in the scanning-conducive, open conformation.   Therefore, a further increase in the 
proportion of the PIC in the closed conformation is likely to have a smaller impact on 
initiation frequency at an AUG codon than at a UUG codon.  Hence, stabilization of the 
closed conformation provides a logical explanation for the loss of initiation fidelity and 
the Sui- phenotype of cells expressing the SUI3-2 mutant allele.      
It has been previously demonstrated that start codon recognition and formation of 
the closed conformation stabilizes binding of the TC to the 40S subunit95.  Thus, to 
confirm that the loss of initiation fidelity in SUI3-2 is indeed due to the stabilization of 
the closed conformation at a UUG codon, we measured the dissociation kinetics of the 
TC from reconstituted PIC.  PIC was first assembled with saturating amounts of eIF2, 
eIF1, eIF1A, 40S, and mRNA and a limiting concentration of [35S]Met-tRNAi.  The 
reactions were then initiated by adding an excess of unlabeled TC and were stopped by 
loading on a running native gel.  The fraction of TC that remained bound to the 
43SmRNA PIC was then quantified to calculate the dissociation rate of TC.  
Stabilization of the TC binding upon formation of the closed conformation is apparent as 
while there is almost no TC dissociated at an AUG codon even after 24 hours, only 50% 
of the TC remains bound to the PIC at a UUG codon after 4 hours (Figure 4.4, compare 
the WT curves with an AUG and a UUG mRNA).  Consistent with stabilizing the closed 
conformation, S264Y reduces the dissociation rate of TC from the PIC at a UUG codon 
by ~2-fold (Figure 4.4).  Thus, our results from the dissociation kinetics of eIF1A and TC 
both suggest that the reduced accuracy of start codon recognition in SUI3-2 is due to the 
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stabilization of the closed conformation, which consequently leads to initiation at non-
AUG codons.  This finding is consistent with the current understanding of the translation 
initiation mechanism in eukaryotes (discussed in Section 1.1.1) as start codon selection 
does require the formation of the closed conformation. 
4.3.3. The Ssu- Mutants of GCD11 Reduce the Stability of the Closed Conformation of the 
PIC 
As elucidated above, SUI3-2 allows for UUG initiation by stabilizing the closed 
conformation of the PIC.  Based on their ability to block translation initiation from a 
UUG codon in cells expressing the SUI3-2 allele in vivo, we hypothesized that the 
N433D and R484A Ssu- mutants of GCD11 reestablish the accuracy of start codon 
recognition by reducing the stability of the closed conformation, and hence allowing for 
the PIC to continue scanning the leader sequence of the mRNA in search of a cognate 
AUG start codon.  This hypothesis is in agreement with our proposed model that domain-
III of eIF2γ is involved in maintaining the equilibrium between the two PIC 
conformations (see Section 3.3.2) as residues N433 and R484 are positioned on a discrete 
surface-exposed locus in domain-III (Section 2.3.4 and Figure 4.7A).   
Therefore, to establish if the Ssu- mutants of GCD11 alter the stability of the two 
conformations of the PIC, we measured the dissociation kinetics of eIF1A from 
reconstituted PIC, with eIF2 containing the S264Y substitution in the β subunit and the 
N433D or R484A substitutions in the γ subunit, using the same procedure explained 
above.  Remarkably, the N433D and R484A mutants of eIF2γ both partially suppress the 
effects of S264 and increase the dissociation of eIF1A from the 43SmRNA complexes 
(Figure 4.3A).  N433D and R484A reduce the fraction of PIC in the closed conformation 
  188 
lowering the Kamp value by ~3-fold at a UUG codon (Figure 4.3B, compare the Kamp 
values).  They also lower the prevalence of the closed conformation at an AUG codon so 
that the biphasic kinetics is restored to eIF1A dissociation from PIC containing the 
S264Y substitution, albeit the Kamp values are still higher compared to the WT values 
(Figure 4.3B).   
Consistent with lowering the occurrence of the close conformation, the N433D 
and R484A mutants also reduce the Rbound values (Figure 4.3B).  As elucidated above, a 
higher Rbound value reflects reduced rotational flexibility of the eIF1A CTT in the closed 
conformation.  Thus, a reduction in the Rbound value suggests that the fraction of PIC in 
the closed conformation is reduced.  Remarkably, the N433D and R484A substitutions, 
when present with S264Y, reduce the Rbound at both AUG and UUG codons to values 
even lower than that of the WT eIF2.  Thus, our results suggest that the N433D and 
R484A mutants of GCD11 suppress the loss of initiation fidelity in cells expressing the 
SUI3-2 allele by reducing the prevalence of the closed conformation of the PIC.  
To confirm that the Ssu- mutants of GCD11 reduce the stability of the closed 
conformation by employing an alternative method, we measured the kinetics of TC 
dissociation from reconstituted PIC with eIF2 containing the S264Y substitution in the β 
subunit and the N433D or R484A substitutions in the γ subunit.  As discussed earlier, 
formation of the closed conformation stabilizes the binding of the TC to the PIC.  We 
showed above that S264Y mutant of eIF2β increases the stability of the closed 
conformation, and consequently reduces the dissociation of TC from the PIC at a UUG 
codon (Figure 4.4, compare the S264Y curve with the WT).  If the N433D and R484A 
substitutions in eIF2γ indeed reduce the stability of the closed conformation, they should 
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then increase the dissociation rate of TC containing the S264Y mutant from reconstituted 
PIC.   Confirming this expectation, N433D and R484A both increase the dissociation rate 
of TC from the 43SmRNA PIC at a UUG codon to WT levels (Figure 4.4).  Thus, our 
findings from the dissociation kinetics of eIF1A and TC from reconstituted PIC, both 
indicate that the Ssu- mutants of GCD11 block translation initiation at a UUG codon by 
reducing the stability of the closed conformation. 
Next, to examine if the loading of the TC on the 40S subunit is altered with the 
mutant eIF2 complexes containing the S264Y substitution in β and the N433D or R484A 
mutant variants of γ, we measured the affinity and the kinetics of TC binding to 
reconstituted PIC.  To determine the affinity of the TC binding to the 40S subunit, we 
performed electrophoretic mobility shift assays to monitor the PIC formation (as 
explained in Chapter 3).  The PIC was assembled in vitro using saturating concentrations 
of eIF2 (WT, S264Y, S264Y/N433D, and S264Y/R484A), eIF1, eIF1A, and mRNA 
(with an AUG or a UUG codon), a limiting amount of radiolabeled [35S]Met-tRNAi, and 
a range of 40S concentrations.  The fraction of TC bound to the 40S (PIC formation) was 
then measured by native gel electrophoresis.  In agreement with previous studies, we 
observed a tight binding of TC to the 43SmRNA complexes (Figure 4.5).  Moreover, 
our results indicate that none of the eIF2 mutant complexes significantly alter the affinity 
of the TC for the 40S subunit at either a UUG or an AUG codon (Figure 4.5).   
To measure the rate of TC binding to the 40S subunit, we next determined the 
kinetics of PIC formation using a similar gel shift assay.  Preformed TC 
(eIF2GDPNP[35S]Met-tRNAi) was mixed with saturating concentrations of eIF1, 
eIF1A, 40S, and mRNA.  The reaction was stopped at different time points by adding an 
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excess of unlabeled TC, and the fraction of TC bound to the 40S was monitored by native 
gel electrophoresis.  As discussed in Sections 1.1.2 and 3.3.2, start codon recognition 
stabilizes the binding of the TC to the 40S subunit.   Consistent with previous reports63,95, 
we observed a higher rate of TC binding to the PIC with an AUG versus a UUG codon 
(Figure 4.6, compare the kobs for the WT with an AUG to that with an UUG mRNA).  
Furthermore, these experiments established that none of the mutant eIF2 complexes 
significantly alter the observed rate of TC loading on the 40S subunit at either an AUG or 
a UUG codon (Figure 4.6).  Thus, the altered accuracy of start codon recognition 
conferred by SUI3-2 and the GCD11 Ssu- alleles is unlikely to be a result of altered rate 
TC loading on the PIC. 
Lastly, to eliminate the possibility that the mutant GCD11 alleles alter the 
intrinsic rate of GTP hydrolysis in eIF2, we measured GTP hydrolysis in purified eIF2 
containing the S264Y variant of β and the N433D or R484A substitutions in γ (as 
described above in Section 3.3.2) and established that the spontaneous rate of GTP 
hydrolysis is unaffected in these mutant complexes compared to WT eIF2 (Figure 4.2).  
Therefore, our findings suggest that the Ssu- mutants of GCD11 reestablish the fidelity of 
start codon recognition by specifically reducing the prevalence of the closed 
conformation of the PIC.   
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4.4 Discussion 
To identify the structural elements in eIF2γ involved in establishing the fidelity of 
start codon recognition, we used different strategies to isolate mutations that alter the 
fidelity of this process (see Chapter 2).  We successfully identified multiple mutant 
alleles in GCD11 that either lower the accuracy of the start codon selection (Sui- 
phenotype) or conversely reinstate it in cells with reduced initiation fidelity (Ssu- 
phenotype).  The characterization of our Sui- alleles, presented in Chapter 3, suggested a 
new function for domain-III of eIF2γ in maintaining the equilibrium between the two 
conformations of the PIC, which is essential for the fidelity of translation initiation.  In 
this chapter, we presented our in-depth analysis on two of the GCD11 Ssu- alleles, gcd11-
N433D and gcd11-R484A, that we had identified (see Chapter 2).  Our findings here 
provide further evidence for the role of domain-III of eIF2γ in establishing the accuracy 
of start codon recognition by maintaining the equilibrium between the open and closed 
conformations of the PIC. 
We first illustrated that the Ssu- mutants of GCD11 reestablish the accuracy of 
start codon selection in vivo by suppressing the Sui- phenotype of SUI3-2.  The SUI3-2 
allele, which encodes the S264Y substitution in the β subunit of the eIF2 complex, 
reduces the stringency of start codon recognition and confers a dominant Sui- 
phenotype163.  It suppresses the histidine auxotrophy in cells harboring the his4-301 allele 
(His+ phenotype) by allowing for translation initiation from a near-cognate UUG codon.  
The N433D and R484 substitutions in eIF2γ, however, suppress the His+ phenotype 
conferred by the SUI3-2 allele by blocking the translation of his4-301.  In agreement with 
this phenotype, both mutants also partially suppress the elevated ratio of UUG to AUG 
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initiation conferred by the SUI3-2 allele, measured by matched HIS4-lacZ reporters 
expressed either from a UUG or an AUG start codon.  Thus, the N433D and R484A 
mutants of GCD11 restore initiation fidelity in cells harboring SUI3-2 in vivo.  
In order to determine the underlying mechanism for our Ssu- mutants, we took 
advantage of an in vitro reconstituted yeast translation initiation system238 to monitor the 
various steps involved in the process of start codon recognition directly.  It was originally 
proposed that SUI3-2 increases the intrinsic rate of GTP hydrolysis in eIF2163.  In our 
assays, however, we did not detect any increase in the spontaneous rate of GTP 
hydrolysis in purified eIF2 containing the S264Y substitution.  This difference may result 
from variations in the set up of the two assays.  We employed a GTPase assay where we 
incubated a limiting amount of [γ-32P]GTP with a saturating concentration of eIF2 at 
26°C, stopped the reactions by adding 100 mM EDTA at different time points, separated 
the hydrolyzed γ-phosphate (32Pi) and the [γ-32P]GTP entities by thin layer 
chromatography, and calculated the fraction of 32Pi released by PhosphorImager analysis.  
In the original assay, however, the fraction of GTP hydrolyzed was inferred by the loss of 
32Pi signal in a filter-binding assay163.  In this assay [γ-32P]GTP and [3H]GTP were 
incubated at a ratio of 1:1000 with eIF2 at 37°C, the samples were applied to pre-wet 
membranes, and the amount of [γ-32P]GTP remaining bound to eIF2 was determined by 
counting the air-dried membranes without scintillation liquid.  A likely reason for the 
difference observed in the results can be attributed to the temperature at which the two 
assays were conducted.  While the original filter-binding assay was performed at 37°C, 
we measured the rate of GTP hydrolysis at 26°C.  It has been reported that the SUI3-2 
allele confers a temperature sensitivity phenotype61,244.  Thus, it is likely that the increase 
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in the spontaneous rate of GTP hydrolysis observed in the original report is due to the 
higher temperature at which the assay was conducted.  Interestingly, this may suggest 
that the underlying mechanism for the temperature sensitivity of SUI3-2 is an increase in 
the intrinsic rate of GTP hydrolysis in eIF2. 
It should also be noted that the standard laboratory growth temperature for S. 
cerevisiae is 30°C, which has been used as part of the default growth conditions 
throughout our study.  Furthermore, our biochemical assays were all performed at 26°C 
that is close to the temperature at which our in vivo experiments were conducted.  
Regardless of whether SUI3-2 increases the intrinsic rate of GTP hydrolysis, however, its 
in vivo Sui- phenotype cannot be fully explained by this defect since while the Ssu- 
mutants of GCD11 suppress the loss of initiation fidelity conferred by the SUI3-2 allele 
in vivo (at 30°C), they do not alter the intrinsic rate of GTP hydrolysis compared to WT 
eIF2. 
SUI3-2 allows for non-AUG start codon recognition, and since a stable closed 
conformation is needed for the process of initiation to ensue, we hypothesized that SUI3-
2 increases the stability of the PIC in the closed conformation at near-cognate UUG 
codons.  We measured the fraction of PIC in each conformation by determining the 
kinetics of eIF1A dissociation, and confirmed that SUI3-2 does indeed increase the 
occurrence of the closed conformation.  The increase in the stability of the PIC, however, 
is regardless of the start codon as SUI3-2 increases the proportion of PIC in the closed 
conformation both with an AUG and a UUG containing mRNA.  This is consistent with 
the report that SUI3-2 does not specifically prefer a UUG codon and increases translation 
initiation at non-AUG codons irrespective of their exact sequence163.  Our result is also in 
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agreement with a recent report implicating eIF2β is stabilizing the closed conformation, 
as it was illustrated that physical interactions between eIF2β and eIF5 are required for the 
stabilization of the closed conformation70.  Although the S264Y substitution is located in 
a different domain of eIF2β than the one interacting with eIF5, it is possible that it 
increases the stability of the closed conformation by further strengthening the interactions 
between the eIF2β and eIF5 proteins, for example by allosterically altering the structure 
of the N-terminal domain of β that contact eIF5. 
Another possibility is that SUI3-2 stabilizes the closed conformation by indirectly 
increasing the interactions between the NTD of eIF5 and the CTT of eIF1A.  As 
elucidated in Chapter 1, the NTD of eIF5 is reported to directly contact the G-domain of 
eIF2γ69.  Since interactions between the NTD of eIF5 and CTT of eIF1A have been 
reported to form upon a cognate codon:anticodon interaction72, which stabilizes the 
closed conformation, the NTD of eIF5 is then expected to move away from the G-domain 
of eIF2γ, which can also potentially contribute to the release of Pi.  This is indeed 
consistent with a recent report that the interaction between eIF5 NTD and eIF1A CTT is 
required for Pi release and eIF1 dissociation72.  Moreover, the ZBD of eIF2β, where the 
S264Y substitution is located, exhibits a high degree of flexibility and has been observed 
to potentially interact with the G-domain of γ114,116,126.  Furthermore, the NTD of eIF5 
contains a ZBD and an α-β fold domain that bear structural homology to the equivalent 
domains of eIF2β116,158.  Therefore, they can potentially compete for binding to similar 
substrates, such as the switch-I element of eIF2γ G-domain.  Moreover, as elucidated 
above, it has recently been reported that interactions between the CTD of eIF5 and the N-
terminal domain of eIF2β strengthen upon a cognate codon:anticodon interaction and is 
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needed for the stabilization of the closed conformation70.  Thus, it is likely that upon 
cognate codon:anticodon base pairing, the interactions between eIF5 CTD and eIF2β N-
terminal domain stabilizes the interactions between the ZBD of eIF2β and the G-domain 
of eIF2γ.  This then allows for the ZBD of the β subunit to replace eIF5 NTD in binding 
to eIF2γ G-domain.  Any substitution in the ZBD of eIF2β, such as S264Y, that would 
increase its interactions with the G-domain can then be expected to stabilize the closed 
conformation by increasing the dissociation rate of eIF5 NTD from the G-domain, and 
hence indirectly increasing its association with eIF1A CTT, which in turn leads to the 
stabilization of the closed conformation. 
We established that the N433D and R484A substitutions in eIF2γ reduce the 
occurrence of the closed conformation by illustrating that these mutations offset the 
effects of S264Y and increase the dissociation rate of eIF1A and TC from reconstituted 
PIC.  Residues N433 and R484 are positioned on a discrete surface-exposed area in 
domain-III of eIF2γ that is in proximity of the proposed binding interface between eIF2 
and helix h44 of the 40S subunit (Figure 4.7).  As discussed in Chapter 2, many of the 
Ssu- alleles we isolated in GCD11 localize to this very specific region of domain-III 
(Figure 2.38).  This raises the intriguing possibility that the affects of the N433D and 
R484A mutants on the equilibrium between the two conformations of the PIC is through 
altered physical interactions between domain-III of eIF2γ and helix h44 of the 40S 
subunit.  
As described in detail in Chapter 1, the eIF2 complex delivers the Met-tRNAi to 
the P-site of the 40S subunit in a GTP dependent manner and maintains it throughout the 
scanning process as the anticodon of Met-tRNAi samples the codons on the mRNA for 
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complementarity in search of the AUG start codon.  Thus, the interactions of Met-tRNAi 
with the mRNA on the 40S subunit should be dynamic and transient to allow for the 
sampling of codons during the scanning stage of initiation.  Since it is the eIF2 complex 
that holds the Met-tRNAi during this process, we expect that when the PIC is in the open 
conformation, the binding of eIF2γ to the 40S subunit has to be transient to allow for 
dynamic interactions between the Met-tRNAi and the mRNA.  Upon correct base pairing 
between the Met-tRNAi and the start codon, however, a series of events takes place in the 
PIC that collectively leads to the stabilization of the Met-tRNAi binding and the closed 
conformation, which then signals translation initiation.   
As the free energy differences between cognate and near-cognate base pairing is 
not sufficient to explain the fidelity of start codon recognition245-250, the binding of the 
Met-tRNAi to the P-site should be stabilized through additional interactions and structural 
rearrangements in the PIC upon a cognate codon:anticodon interaction.  Thus, as the open 
conformation has to have the flexibility and the dynamics to allow for scanning of the 
mRNA leader sequence, the closed conformation has to stabilize the binding of the Met-
tRNAi in the P-site to allow for initiation to proceed.  Here we propose that domain-III of 
eIF2γ participates in stabilizing the closed conformation and the binding of the Met-
tRNAi in the P-site upon cognate base pairing between the Met-tRNAi and mRNA. 
Multiple lines of evidence provide support for this proposal.  It has been 
demonstrated that start codon recognition and formation of the closed conformation does 
indeed stabilize the binding of the TC to the 40S subunit95.  Moreover, our E460A Sui- 
mutant, as described in Chapter 3, increases the rate of TC loading on the 40S subunit at 
a UUG codon, which consequently leads to the formation of the closed conformation and 
  197 
translation initiation.  Therefore, as our proposed model predicts, an increase in stability 
of the (transient) interactions between eIF2γ and the 40S subunit can lead to the 
formation of the closed conformation and start codon recognition at non-AUG codons.   
Furthermore, although recent cryo-EM reconstitution of a mammalian PIC places 
domain-III of eIF2γ facing helix h44 of the 40S subunit, which is consistent with the 
result of the previous hydroxyl radical probing study127, it does not detect any direct 
contacts between the two as domain-III is observed about 34Å away from helix h44151.  It 
is important to note that the cryo-EM model depicts the PIC in the open conformation as 
it was assembled without an mRNA.  In the hydroxyl radical probing experiment, 
however, the eIF2 complex was mapped on the 40S subunit presumably in the closed 
conformation of the PIC since it was assembled in the presence of an mRNA.  
Significantly, it was also noted that eIF2 in the cryo-EM reconstruction showed 
conformational variability indicating that eIF2γ can potentially approach helix h44 of the 
40S subunit upon codon-anticodon base pairing151.  
Since our Ssu- mutants that reduce the stability of the closed conformation are 
localized to a specific region on the surface of domain-III, it is likely that upon cognate 
base pairing between the anticodon of the Met-tRNAi and the start codon, subtle 
structural rearrangements, perhaps a result of the small changes in the free energy of base 
pairing, translates into a movement of domain-III toward helix h44 and creation of new 
contact points with the 40S subunit that help stabilize the closed conformation and 
consequently the Met-tRNAi in the P-site.  In this case the GCD11 Ssu- mutants reduce 
the stability of the closed conformation because they prevent the formation of contact 
points between domain-III and helix h44 upon codon:anticodon base pairing.  Start codon 
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recognition requires the coordinated action of a number of events in the PIC that 
collectively commit the complex to form a stable closed conformation and begin 
translation.  Here we have introduced a new player in this process and suggested a 
function for the domain-III of eIF2γ in establishing the equilibrium between the two 






4.5 Figures and Tables 
 
Figure 4.1 The Ssu- mutants of GCD11 suppress the His+ phenotype and the elevated 
ratio of UUG to AUG initiation conferred by the SUI3-2 allele 
(A) A variant of the HIS4 allele is used as a genetic reporter to monitor the accuracy of 
start codon selection.  his4-301 is a mutant allele of the HIS4 gene that lacks a cognate 
AUG start codon, which consequently confers histidine auxotrophy in otherwise WT 
cells.  The Sui- class of mutations, which lower the stringency of start codon recognition, 
allows for translation initiation from a near-cognate UUG codon of his4-301 suppressing 
the histidine auxotrophy (His+ phenotype).  The Ssu- class of mutations, however, 
reestablishes the fidelity of start codon selection and blocks translation initiation from the 
UUG codon of his4-301, hence restoring the histidine auxotrophy.  (B) The gcd11-
N433D and gcd11-R484A mutants suppress the His+ phenotype of cells expressing the 
SUI3-2 allele.  Derivatives of strain NAY13 with the WT or mutant GCD11 alleles on a 
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sc LEU2 plasmid and harboring episomal SUI3-2 (p4280) or the empty TRP1 vector 
(YCplac22) were cultured in SC-L-W, ten-fold serial dilutions were spotted on SC-L-W 
medium supplemented with 0.3 mM (+His) or 0.003 mM (-His) histidine, and incubated 
at 30°C for two and five days, respectively.  (C) Matched HIS4-lacZ reporters, containing 
a UUG (his4-lacZ) or an AUG (HIS4-lacZ) start codon, are used to measure the ratio of 
initiation from a UUG codon to that from an AUG codon.  Sui- mutations elevate the 
ratio of UUG to AUG initiation compared to WT cells by reducing the stringency of start 
codon recognition and increasing the expression of his4-lacZ from a UUG codon.  The 
Ssu- mutants, on the other hand, suppress the elevated ratio of UUG to AUG initiation 
observed in cells harboring a Sui- allele by restoring initiation fidelity and reducing the 
expression of his4-lacZ from a UUG codon.  (D) The gcd11-N433D and gcd11-R484A 
mutants suppress the elevated ratio of initiation from a UUG codon to that from an AUG 
codon in cells expressing the SUI3-2 allele.  UUG/AUG ratio was calculated in the same 
strains as in panel B by measuring the β-galactosidase activity of the HIS4-lacZ reporters 
described in panel C.  β-galactosidase activities (nanomoles of o-nitrophenyl-β-D-
galactopyranoside cleaved per minute per microgram of protein) were measured in WCEs 
of exponentially growing cultures (OD600 ~0.5) in SC-L-W medium.  Mean of at least 
eight independent transformants and SEM (error bars) are plotted for each mutant.  A 




Figure 4.2 GTP hydrolysis in the mutant eIF2 complexes 
The S264Y substitution in the β subunit and the N433D or R484A mutant variants of the 
γ subunit do not significantly alter the intrinsic rate of GTP hydrolysis in eIF2.  GTP 
hydrolysis was measured by adding a limiting amount of [γ-32P]GTP (80 nM) to a 
saturating concentration of eIF2 (0.8 μM).  The reactions were incubated at 26°C and 
stopped by adding 100 mM EDTA at the specified time points.  [γ-32P]GTP and 32Pi were 
separated by thin layer chromatography (PEI-cellulose TLC) and the fraction of total 32Pi 
released was quantified by PhosphorImager analysis.  Mean value of at least two 
experiments and mean deviation (error bar) is represented for each time point.  Values are 
normalized to the background rate of hydrolysis (32Pi release) in the [γ-32P]GTP molecule 
alone exposed to the same temperature and buffer conditions of the assay.  The curves 
were fit a linear regression equation.  Slopes of the regression lines are 0.41±0.040, 
0.24±00.014, 0.43±0.076, and 0.47±00.072 for the WT, eIF2β-S264Y, eIF2β-

















Figure 4.3 Kinetic of eIF1A dissociation from reconstituted PIC containing the WT 
or the mutant variants of the eIF2 complex 
The S264Y substitution in eIF2β reduces the dissociation of eIF1A from reconstituted 
PIC with AUG or UUG codons.  The N433D and R484A variants of eIF2γ suppress this 
defect and, conversely, increase the dissociation of eIF1A from reconstituted PIC.  (A) 
43S mRNA complexes were first assembled by incubating saturating concentrations of 
TC (0.8 μM eIF2, 1 mM GDPNP, 150 nM Met-tRNAi), eIF1 (1 μM), eIF5 (1μM), 40S 
(120 nM), and mRNA (10 µM) with a limiting amount of eIF1A-Fl (15 nM).  An excess 
of unlabeled eIF1A was then added, and changes in anisotropy were measured over time.  
(B) S264Y increases the Kamp value at a UUG codon by 6-fold.  A Kamp value for S264Y 
at an AUG codon could not be calculated as the dissection kinetics of eIF1A was no 















mRNA Rbounda α1b k 1 (X103 s-1) α2b k2 (X103 s-1) Kampc 
WT 
AUG 0.21±0.016 0.11±0.13 1.8±0.71 0.89±0.16 0.27±0.33 7.9±0.15 
UUG 0.19±0.0072 0.34±0.042 5.2±0.017 0.66±0.22 0.98±0.24 1.9±0.064 
S264Y 
AUG 0.22±0.0022 0.94±0.013 1.8±0.15 
UUG 0.20±0.013 0.080±0.19 36±1.9 0.92±0.017 0.39±0.10 12±0.21 
S264Y 
N433D 
AUG 0.18±0.0032 0.063±0.74 2.3±0.077 0.94±0.049 0.25±0.26 17±0.79 
UUG 0.17±0.0072 0.16±0.056 2.0±0 0.84±0.0063 0.48±0.083 5.2±0.063 
S264Y 
R484A 
AUG 0.19±0.00016 0.080±0.31 2.0±0.36 1.40±0.70 0.22±0.18 19±0.96 
UUG 0.17±0.003 0.23±0.73 1.5±0.40 0.84±0.024 0.46±0.087 4.0±0.91 
a Anisotropy of eIF1A-Fl in the presence of all PIC components. 
b Fractional amplitude calculated by dividing the observed amplitude of the indicated kinetic phase by the sum of the observed  
  amplitudes of both phases.  
c Defined as α2/α1.  
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value of S264Y by ~ 3-fold at a UUG codon.  They also restore the biphasic kinetics of 
eIF1A dissociation at an AUG codon.  N433D and R484A also reduce the Rbound values 
both with a UUG and an AUG containing mRNA.  Curves from panel A were fit with a 
double exponential equation, except for S264Y with an AUG mRNA that was fit with a 
single exponential function.  Mean values from at least two experiments and mean 




Figure 4.4 Dissociation kinetics of TC from reconstituted PIC with WT and mutant 
eIF2 
TC dissociates more rapidly from the 43S mRNA complexes with a UUG versus an 
AUG codon as start codon recognition stabilizes the binding of the TC to the PIC.  The 
S264Y variant of eIF2β, however, reduces the dissociation rate of TC at a UUG codon by 
~2-folds.  The N433D and R484A substitutions in eIF2γ, on the other hand, suppress this 
defect restoring the rate of TC dissociation to WT levels.  PIC was assembled by mixing 
saturating concentrations of eIF2 (250 nM), GDPNP (1 mM), eIF1 (1 μM), eIF1A (1 
μM), 40S (20 nM), and mRNA (10 μM) and a limiting amount of [35S]Met-tRNAi (1 
nM).  To measure the koff, the reactions were then initiated by adding an excess of 
unlabeled TC and were stopped by loading on a running native gel.  Curves were fit with 

















UUG 0.18±0.0062 0.093±0.0044 0.21±0.026 0.22±0.033 
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Figure 4.5 Affinity of TC binding to reconstituted PIC assembled with WT and 
mutant eIF2  
eIF2 containing the S264Y variant of β and the N433D or R484A substitutions in γ does 
not significantly alter the rate of TC loading on 43 SmRNA complexes with an AUG or a 
UUG codon.  Preformed TC (0.8 μM eIF2, 1 mM GDPNP, 1 nM [35S]Met-tRNAi) was 
mixed with saturating concentrations of eIF1 (1 μ), eIF1A (1 μ), mRNA (1 μM), and a 
range of 40S concentrations.  The fraction of [35S]Met-tRNAi bound to the 40S subunits 
(PIC formation) was measured by native gel electrophoresis.  The data were fit with 
hyperbolic or quadratic binding curves to determine the Kd values.  Means of at least two 
experiments and mean deviations are reported.  The detection limit of this assay is ≤1 nM 
















AUG ≤1.6±0.72 ≤0.91±0.13 ≤2.2±0.70 ≤1.9±0.10 
Kd, 





UUG ≤3.6±1.2 ≤1.5±0.40 ≤2.0±0.82 ≤2.8±0.97 
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Figure 4.6 Kinetics of TC binding to reconstituted PIC assembled with WT and 
mutant eIF2  
eIF2 containing the S264Y substitution in the β subunit and the N433D or R484A mutant 
variants of the γ subunit does not significantly alter the rate of TC loading on 43 SmRNA 
complexes with an AUG or a UUG codon.  Preformed TC (250 nM eIF2, 1 mM GDPNP, 
1 nM [35S]Met-tRNAi) was mixed with saturating concentrations of eIF1 (1 μ), eIF1A (1 
μM), 40S (20 nM), and mRNA (10 μM).  The reactions were stopped by adding excess 
amount of unlabeled TC, and the fraction of [35S]Met-tRNAi bound to the 40S subunits 
(PIC formation) was measured over time by native gel electrophoresis.  The curves were 
fit with a single exponential function.  Means of at least two experiments and mean 
















AUG 13±0.6 19±0.14 25±0.53 9.0±0.36 
kobs, 





UUG 6.5±1.1 6.2±0.16 8.7±0.44 3.0±0.0050 
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Figure 4.7 Positions of the isolated Sui- and Ssu- mutations on the structure of eIF2 
(A) Three views of a surface-exposed representation of aIF2 (PDB 2QMU) with the 
positions of the isolated Sui- (E460A, R510H) and Ssu- (N433D, K479E, R484A, 
M482I/K) substitutions in domain-III marked.  (B) Two views of the model of eIF2 
binding to h44 of the 40S subunit.  The Isolated Sui- and Ssu- substitutions in eIF2γ are in 
proximity of the proposed binding interface between eIF2 and helix h44.  Model of TC 
binding to the 40S subunit is adapted from Shin et al. 2011127.  Images were created using 
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Table 4.1 List of S. cerevisiae Strains 
 
Strain Genotype Source 
NAY13 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) gcd11∆::hisG trp1∆::hisG Ep293<GCD11 URA3 CEN4/ARS1> 
This 
Study 
NAY116 Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) ∆gcd11::hisG ∆trp1::hisG Ep293<GCD11 URA3 CEN4/ARS1> p4280 <SUI3-2 TRP1,CEN> 
This 
Study 




Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) ∆gcd11::hisG ∆trp1::hisG 





Matα ura3-52 leu2-3,112 ino1-13 his4-301(ACG) ∆gcd11::hisG ∆trp1::hisG 





Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG 
gcn2Δ::hisG pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA28<sc URA3 




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG 
gcn2Δ::hisG pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA21<hc LEU2 




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG 
gcn2Δ::hisG pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA29<hc LEU2 




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG 
gcn2Δ::hisG pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA30<hc LEU2 




Matα ura3-52 leu2-3,112 ino1-13 HIS4+ gcd11Δ::hisG trp1Δ::hisG 
gcn2Δ::hisG pep4Δ::hygB sui3Δ::kanMX4 sui2Δ::hphMX4 pNA31<hc LEU2 
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Table 4.2 List of Plasmids 
 
Plasmid Descriptiona Source 
YCplac111 sc LEU2 yeast-E. coli shuttle vector 229 
YCplac22 sc TRP1 yeast-E. coli shuttle vector 229 
YCP50 sc URA3 yeast-E. coli shuttle vector 230 
pSB32 lc LEU2 yeast-E. coli shuttle vector  
pRS425 hc LEU2 yeast-E. coli shuttle vector 231 
YCplac33 sc URA3 yeast-E. coli shuttle vector 229 
Ep293 sc URA3 GCD11 in YCP50 223 
Ep517 lc  LEU2 GCD11 in pSB32 223 
pC2872 sc LEU2 GCD11-His8 in YCplac111 P. Alone 
pNA4 sc LEU2 GCD11-His8 in pC2872 This study 
pNA4-N433D sc LEU2 gcd11-His8-N433D This study 
pNA4-R484A sc LEU2 gcd11-His8-R484A This study 
p4280 sc TRP1 SUI3-2 in YCplac22 81 
p367 sc URA3 HIS4(ATG)-lacZ 209 
p391 sc URA3 HIS4(TTG)-lacZ (his4-301) 209 
p180 sc URA3 GCN4-lacZ in YCp50 232 
pAV1726 hc LEU2 GCD11-His6 SUI3 SUI2 in pRS425  G. Pavitt 
pAV1732 hc LEU2 GCD11-His6 SUI3 SUI2 IMT4 in pAV1726 G. Pavitt 
pNA28 sc URA3 GCD11-His6 SUI2 SUI3 in YCplac33 This study 
pNA21 hc LEU2 GCD11-His8 SUI3 SUI2 IMT4 in pAV1732 This study 
pNA29 hc LEU2 GCD11-His8 SUI3-2 SUI2 IMT4 in pNA21 This study 
pNA30 hc LEU2 gcd11-N433D-His8 SUI3-2 SUI2 IMT4 in pNA29 This study 
pNA31 hc LEU2 gcd11-R484A-His8 SUI3-2 SUI2 IMT4 in pNA29 This study 
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Initiation, elongation, termination, and recycling of the ribosomal complexes 
constitute the four major stages of protein synthesis.  Initiation is the most heavily 
regulated stage that sets the reading frame for the translation of the mRNA sequence into 
a fully functional protein product.  In eukaryotes, this process is governed by base pairing 
between the anticodon of the Met-tRNAi and the start codon of the mRNA and is 
mediated through the actions of at least twelve initiation factors and the small subunit of 
the ribosome.  The stage of initiation itself can be divided into two main phases of 
scanning and start codon selection, and the PIC exists in two conformations 
corresponding to each phase.  During the scanning of the mRNA 5’ UTR, the PIC is in an 
‘open’ conformation, which allows for the Met-tRNAi to search the mRNA leader 
sequence for complimentary to identify the start codon.  Upon cognate codon:anticodon 
base pairing, however, the coordinated actions of a number of events in the PIC 
collectively commit the complex to form a more stable ‘closed’ conformation and begin 
translation.  For example, physical interactions between eIF5 and eIF1 has to be 
disrupted70,72, new interactions between the eIF1A and eIF5 proteins should be 
formed72,75, and the eIF2-bound GTP has to get hydrolyzed irreversibly with the 
dissociation of Pi92 among many other events that cooperatively lead to formation and 
stabilization of the closed conformation.   
The ultimate goal of the structural rearrangements in the PIC, upon a cognate 
codon:anticodon interaction, is to stabilize the binding of the Met-tRNAi in a fully 
accommodated mode in the P-site of the 40S subunit as multiple lines of evidence have 
suggested that the Met-tRNAi is not fully inserted in the P-site during the scanning phase 
of initiation30,60.  Since the Met-tRNAi has to interact with each and every nucleotide in 
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the mRNA 5’ UTR to identify the start codon, it is logical that it has to maintain a 
dynamic and transient interaction with the mRNA during the scanning phase of initiation.  
Moreover, preventing the full accommodation of the Met-tRNAi in the P-site reduces the 
stability of its binding, which consequently lowers the probability of initiation at near-
cognate codons. 
Since the free energy difference between a cognate and a near-cognate base 
pairing is not sufficient to explain the fidelity of start codon recognition245-250, however, 
the binding of the Met-tRNAi to the P-site should be stabilized through additional 
interactions and structural rearrangements in the PIC upon formation of the cognate 
codon:anticodon interaction.  eIF2 is a logical candidate to perform a critical function in 
this process since it is the complex that binds and holds the Met-tRNAi during the entire 
process of initiation.  Our findings in this study indeed have provided support for the 
involvement of the γ subunit of eIF2 in stabilizing the closed conformation upon cognate 
base pairing between the Met-tRNAi and mRNA. 
Our genetic and biochemical analyses here have confirmed the involvement of 
eIF2γ domain-III in establishing the stringency of start codon recognition.  Domain-III 
seems to perform multiple functions during the initiation stage of protein synthesis.  It is 
likely to participate in stabilizing GTP binding, through physical interactions with the 
switch-II region of the G-domain, and perhaps in maintaining the Met-tRNAi in the 
proper conformation for binding to the 40S subunit, through physical interactions with 
domain-II.  As elucidated earlier, however, further experiments are required to directly 
confirm the above hypotheses.  Most interestingly, our findings suggested that domain-III 
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of eIF2γ is involved in stabilizing the closed conformation of the PIC upon cognate base 
pairing between the start codon and the anticodon of Met-tRNAi.    
Based on our evidence and our current understanding of the mechanism of start 
codon recognition in eukaryotes, we proposed a model in which domain-III of eIF2γ 
maintains a transient interaction with helix h44 of the 40S subunit during the scanning 
phase of initiation.  A cognate codon:anticodon interaction, however, leads to subtle 
structural rearrangements in the Met-tRNAi, for example due to the free energy of 
cognate base pairing, that induces a movement of eIF2γ domain-III toward h44, which 
consequently leads to the formation of more stable contact points between eIF2 and the 
40S subunit.  This, in turn, contributes to the stabilization of Met-tRNAi binding in the P-
site of the 40S subunit. 
It is important to note that during the entire process of translation initiation, the 
PIC maintains a dynamic structure and exists in equilibrium between the open and closed 
conformations.  A collection of small structural rearrangements in the many components 
of the PIC can then further stabilize one or the other conformation depending on the 
environment, for example the sequence or structure of the mRNA 5’ UTR.  Dividing the 
vital decision of start codon selection among multiple different protein factors creates 
resilience and allows the process to have a buffer zone against environmental assaults, for 
example spontaneous mutations in any of its essential players.  It also allows for multiple 
levels of regulation, which makes the entire process adaptable to external factors.  
Therefore, to fully understand how exactly start codon selection is achieved, the intricate 
network of interactions among its many players need to be established.  In this study, we 
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